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ABSTRACT!
!
!
RECOMBINANT SURFACTANTS DERIVED FROM THE NATURALLY
OCCURRING PROTEIN OLEOSIN
Kevin Bryce Vargo
Daniel A. Hammer
Surfactants are molecules of key importance in the food, chemical and pharmaceutical
industries due to their ability to stabilize interfaces and self-assemble in solution.
Commercial surfactants are typically chemically synthesized making the material
extremely difficult to functionalize for biological applications. Therefore there is a need
to develop bioactive surfactants. A powerful alternative to chemical synthesis is the
expression of recombinant protein surfactants through molecular biology. These proteins
would be monodisperse and have the precise sequence dictated by the cognate gene.
Recombinant protein production would permit the direct incorporation of specific motifs
that mediate protein recognition. We have chosen the naturally occurring plant protein
oleosin as a candidate. Oleosins are a family of plant proteins whose biological role is to
stabilize oil bodies. They have two hydrophilic arms and a central hydrophobic domain.
In this thesis, we have designed many variants of oleosin to self-assemble and/or stabilize
interfaces. First we created a family of truncation mutants that assemble into sheets,
fibers, or vesicles depending on the geometry of the protein and the solution chemistry.
We further truncated this family to create protein variants that assembled into spherical
micelles. All protein variants were confirmed using mass spectroscopy and the
secondary structure was analyzed through circular dichroism. Protein aggregate size and
!
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shape were analyzed through light and X-ray scattering and directly visualized through
cryogenic transmission electron microscopy. Oleosin variants were employed to stabilize
interfaces in two applications. The first was the stabilization of microbubbles generated
in a microfluidic device for ultrasound contrast and therapy. Bubbles were extremely
stable over time, easily functionalized with an eGFP-oleosin fusion, and were echogenic.
We further applied our variants to stabilize an oil-in-water emulsion for the creation of
iron oxide nanoclusters as contrast agents for magnetic resonance imaging. Particles size
was measured using light scattering and directly measured using electron microscopy.
Oleosin stabilized iron oxide clusters were non-toxic and simple targeting to Her2/neu+
cells was achieved by blending a Her2/neu affibody-Oleosin fusion protein into the shell.
These results set the foundation to further engineer oleosin for self-assembly and
interface stabilization and functionalization.
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Chapter!1!
Introduction!
!
Surfactants are molecules of key importance in the food, chemical and pharmaceutical
industries.1,2 Certain families of surfactants can be exploited for their ability to selfassemble due to the asymmetric polarity of the molecules. When the chemistry and
geometry of the surfactants are controlled, precise and complex self-assembly can be
achieved. If these structures are assembled from biologically relevant materials, the
resulting structures can be considered part of the expansive field of biomaterials.
!
Biomaterials!are!materials!that!are!engineered!for!medial!or!biological!
applications.!!The!research!field!covering!biomaterial!is!expansive!and!includes!
tissue!engineering,!implants,!and!drug!delivery!to!name!a!few.!!Biomaterials!are!
used!in!applications!such!as!joint!replacements,!bone!cements,!artificial!ligaments,!
and!heart!valve!replacements.3A6!!!Biomaterials!must!possess!important!properties!
in!order!to!be!effectively!used!in!the!body.!!One!must!consider!the!host!response!to!
the!material,!materials!biocompatibility!and!toxicity,!and!mechanical!properties!

!
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when!engineering!new!materials.!!With!the!current!technology,!designer!
biomaterials!are!being!developed!with!specific!biological!functionality.!
!
Biological!functionality!is!a!broad!term!implying!that!the!material!or!
structure!directly!interacts!with!biology!such!as!controlling!cell!fate,!adhesion,!or!
targeting.!!At!a!high!level,!these!interactions!are!typically!mediated!through!specific!
proteins!but!when!meticulously!investigated,!it!is!found!that!many!interactions!are!
typically!arbitrated!by!only!a!few!amino!acids!in!the!protein!structure.!!This!can!be!
thought!of!as!a!lock!and!key!interaction!where!the!key!is!an!initiator!molecule!or!
ligand!and!the!lock!is!a!docking!station!or!receptor.!!These!interactions!have!evolved!
over!time!to!control!many!biological!functions.!!Therefore,!understanding!and!
incorporating!functional!domains!into!selfAassembled!biomaterials!is!a!promising!
method!to!directly!interact!with!biology.!
!
The!task!of!assembling!functional!biomaterials!from!surfactants!can!be!
approached!in!two!ways.!!The!first!method!uses!chemical!synthesis!to!create!
surfactant!molecules.!!This!method!is!robust!and!well!characterized!and!has!laid!the!
groundwork!for!decades!of!future!surfactant!research.!!But,!due!to!the!syntheses!
methods,!functionalization!of!these!materials!can!be!difficult.!!In!many!cases,!the!
surfactant!is!synthesized!and!the!ligand!or!key!is!added!to!the!material!in!a!separate!
step.!!This!twoAstep!process!can!lead!to!heterogeneous!functionalization.!!Instead,!
one!can!exploit!the!precision!of!nature’s!synthesis!methods!through!recombinant!
biotechnology!by!using!a!host!organism!to!create!the!desired!surfactants.!!In!this!
!
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method,!surfactants!would!be!monodisperse!in!molecular!weight!and!
functionalization!of!these!sequences!can!be!can!be!completed!by!altering!the!
cognate!gene!in!the!organism.!!In!simple!terms,!if!it!is!desired!to!create!biomaterials!
that!directly!interact!with!biology,!a!logical!route!is!to!assemble!the!materials!from!
the!same!building!blocks!used!in!nature,!amino!acids,!and!to!use!the!tools!that!
nature!has!evolved!to!synthesize!the!materials.!
!!
This!work!addresses!the!need!for!a!robust!recombinant!surfactant!for!the!
assembly!of!functional!biomaterials.!!For!these!needs,!we!are!inspired!by!the!
naturally!occurring!plant!protein!oleosin.7!!The!geometry!and!architecture!of!oleosin!
are!unique!and!rarely!observed!in!nature.!!The!structure!of!oleosin!mimics!a!chainA
like!surfactant!making!it!an!ideal!candidate!for!engineered!selfAassembly.!!In!this!
work,!we!attempt!to!apply!the!theory!of!polymer!and!lipid!assembly!to!design!
variants!of!oleosin!that!assemble!into!desired!structures.!!!The!specific!aims!of!this!
work!are!as!follows:!!
1. Develop!a!recombinant!protein!system!that!selfAassembles!into!bilayer!
vesicles!
2. Engineer!soluble!recombinant!surfactants!from!the!base!protein!oleosin!
3. Develop!oleosin!mutants!to!stabilize!and!target!clinically!relevant!
biomaterials!
!
This!work!is!composed!of!seven!chapters.!!Chapter(2!describes!background!
work!and!our!perspective!on!creating!recombinant!surfactants.!!This!chapter!
!
3!

provides!an!overview!on!selfAassembly,!surfactants,!oleosin,!current!progress!in!the!
field,!and!the!techniques!used!to!complete!this!work.!!Chapter!2!is!intended!to!
provide!suffieiencet!information!so!that!the!reader!has!a!context!to!understand!the!
research!described!in!this!thesis.!!
!
Chapter(3!of!this!work!explores!the!selfAassembly!behavior!of!oleosin!truncation!
mutants.!!Families!of!mutants!with!varying!molecular!weight!and!hydrophilic!
fraction!were!designed!and!expressed.!!A!specific!family!of!mutants!was!found!to!
selfAassembled!through!an!emulsions!template!into!fibers,!sheets,!and!vesicles!
depending!on!the!geometry!of!the!protein!and!the!solution!chemistry.!!To!our!
knowledge,!this!was!the!first!report!of!a!bilayer!vesicles!assembled!from!
recombinant!protein.!!!
!
Chapter(4!of!this!work!looks!to!create!soluble!surfactants!from!oleosin.!!To!
achieve!this!goal,!the!hydrophobic!domain!of!oleosin!was!heavily!truncated!
eliminating!the!majority!of!the!secondary!structure!in!the!protein.!!These!protein!
mutants!assemble!into!spherical!micelles!above!a!critical!concentration!and!were!
functionalized!with!a!cellAbinding!motif!for!targeted!internalization.!!!
!
Chapters(5(and(6!of!this!work!focus!on!using!oleosin!as!a!surfactant!to!stabilize!
interfaces.!!In!Chapter(5,!we!use!oleosin!to!stabilize!monodisperse!microbubbles!for!
ultrasound!imaging!and!therapy.!!!In!this!study,!the!bubble!size!and!stability!were!
monitored!over!time.!!Functionalization!and!ultrasound!response!was!investigated.!!!
!
4!

In!Chapter(6,!we!utilized!an!ionic!mutant!developed!in!Chapter!4!for!the!
stabilization!of!superparamagnetic!iron!oxide!nanoparticles!for!magnetic!resonance!
imaging.!!Particle!stability!and!magnetic!properties!are!measured!and!the!particles!
are!targeted!to!cancer!cells!overexpressing!a!specific!receptor.!!!
!
Chapter(7!of!this!work!comprises!concluding!statements!and!extensive!future!
work.!!Preliminary!results!are!included!for!future!projects.!!!
!
!
!
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Chapter 2
Background

2.1 Self-assembly
Self-assembly is the process in which molecules align and orient themselves into a higher
order structure without the guidance from an outside source.1 Assembly can be
controlled through various interactions including hydrogen bonding, hydrophobic forces,
electrostatic interactions, Van der Waals forces, and coordination bonds over many
length scales.2 At the nanoscale, assembly is based on the information in the individual
molecules such as shape, charge, and polarity. Self-assembly is considered a bottom-up
approach because the ordered structures are assembled from random, disordered
monomers opposed to a top-down approach, where particles are manufactured from
larger bulk materials.3 The bottom-up approach allows for the manufacture of large
quantities of assembled particles but lacks the ability to create all shapes and sizes
accessible to top-down assembly methods. Bottom-up assembly is very well understood
and can be precisely controlled allowing for the fine-tuning of functional properties in
!
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nanomaterials. By engineering the structure, chemistry, and function of molecules, we
can exploit the tools of molecular self-assembly to develop aggregates with desired sizes,
geometries, and functional motifs.

2.2 Surfactants
Any molecule that adsorbs to an interface and lowers the surface pressure between the
two phases is considered a surfactant. Common surfactants include lipids, polymers,
dendrimers, polypeptides, proteins, or combinations therein.4 Traditionally, a surfactant
has a hydrophilic head group and a hydrophobic tail. This asymmetric polarity leads to
molecular assembly driven by the hydrophobic effect; the entropic aggregation of
nonpolar domains in aqueous solution and the exclusion of water from these domains.5
The most common surfactant self-assembly is that of non-ionic chain surfactants such as
lipids or polymers. The assembly of these systems is dictated by their geometry. The
ratio of the effective volume of the hydrophilic head group to the hydrophobic tail is
defined as the packing parameter:
!

!=!

!!

(2.1)

where v is the volume of the hydrophobic tail, ao is the effective head group area, and l is
the length of the hydrophobic tail.6 The value of the packing parameter can be used to
predict the aggregate morphology of surfactants in aqueous environments (Figure 2.1). A
value of p<1/3 implies a cone shaped surfactant leading to the formation of high
curvature spherical micelles. As the head group volume becomes comparable to the tail
!
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external stimulus does not change the molecular structure of involved polymers. These phenomena have been well documented for pH or temperature
responsive systems (micelles and vesicles for instance). In other cases, chemical changes are involved during assembling/disassembling course. This has
been exemplified by some pH or photo-sensitive assemblies.
This scheme was constructed according to the literature [9,11].

amphiphile is a triblock copolymer of poly(acrylic acid)b-poly(methyl acrylate)-b-polystyrene (PAA99 -b-PMA73 b-PS66 ), as shown in Table 1a. In the solvent mixture
of water/THF with a volume ratio of 1:1, self-assembly
of PAA99 -b-PMA73 -b-PS66 alone led to spherical micelles.
In contrast, toroidal assemblies formed when assembling was performed in a solvent mixture of water/THF
(v/v = 2:1) containing an organic counterion, i.e., 2,2′ (ethylenedioxy)diethylamine (EDDA). In this case, EDDA
serves as a chemical stimulus that triggered the startup
of like-charged attraction of cylindrical micelles, resulting

3.2.1. Morphological transformation via electrostatic
forces
Structural remodeling of polymer assemblies by
introducing multivalent organic counterions has been
intensively investigated by Wooley, Pochan, and coworkers [22,24,36,101–104]. Assemblies with different
packing geometries, such as disk, toroid, Y-shaped and
periodically striped cylinder, and helix, were thus produced. As a decent example, the transition of spherical
micelle into toroidal structure was attained in the presence of a divalent amine (Fig. 8) [22]. The employed

volume, p increases allowing for the formation of lower curvature structures such as
cylindrical micelles (p=1/3-1/2), vesicles (p=1/2-1), and bilayers (p~1).
!

!

!

!
!

!
!

Fig. 7. The effect of the packing parameter on the structures of assemblies formed.
!
was made according
to the Ref. [87].
This schematic
Figure
2.1:cartoon
Schematic
depiction
of the packing parameter (p). p defines the ratio of the
volume of the hydrophobic tail to the volume of the hydrophilic head group. The packing
parameter can be used to engineer surfactants to assemble into the desired morphologies
in solution. Reprinted from Progress in Polymers Science, 37, Zhang, J. X., Li, X. D. &
Li, X. H., Stimuli-triggered structural engineering of synthetic and biological polymeric
assemblies, 1130-1176, Copyright 2012, with permission from Elsevier.7

2.3 Nanoparticles
A nanoparticle can be defined as a particle or assembly with at least one length scale
between 1 and 100 nm. This unique size range offers a bridge between classical and
quantum material behaviors presenting new properties compared to the properties
observed in the bulk material. Nanoparticles can be assembled from wide range of
materials including polymers, lipids, dendrimers, proteins, silica, metals, carbon, and
Quantum Dots.8-10
!
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The field of nanotechnology has had a major impact into medicine and biology
over the past few decades.11 Nanoparticles have been employed as biological sensors in
various applications with detection based on optics, magnetic fields, or electrochemical
reactions.3 A common approach for optical sensing is the use of gold nanoparticles
functionalized with ligands to directly interact with biology.9,12 The optical properties of
gold is highly tunable and is controlled by the surface ligand as well as the size of the
nanoparticles.9 Fluorescent nanoparticles represent another major optical sensor.
Traditional organic dyes and fluorescent proteins offer a simple, non-destructive sensing
methods. However, these particles have short fluorescent lifetimes and show low
absorption coefficients.8 Fluorescent nanoparticles provide advantages over organic dyes
due to their sensitivity and stability.10 The size of nanoparticles allows for a high signal
to noise ratio and signal amplification and minimizes physical interactions in biological
systems.8

Self-assembled organic nanoparticles are commonly assembled from surfactants.
Lipids represent the most common material used for nanoparticle self-assembly due to
their versatility as depicted in Figure 2.2. Lipids offer an advantage over many other
materials due to the low cost and the large library of chemistries available. Lipid
vesicles, or liposomes, have been used extensively in drug delivery and imaging
applications.13-17 Liposomes can be functionalized by embedding proteins into the lipid
bilayer18 including ion channel proteins19,20, pore forming proteins21,22, and active
enzymes such as tissue factor.23 Native liposomes have low circulation times due to
clearance by the reticuloendothelial system24 leading to the use of polymer coatings,
!
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specifically polyethyleneglycol, to provide stealth capabilities to the nanoparticle.25,26
Although liposomes are one of the most popular drug delivery vehicles, they are unstable
in serum and mechanically weak, but certain chemistries allow for covalent cross-linking
of the membrane potentially mitigate these issues.25,26

Figure 2.2: Schematic depiction of liposome versatility. a) Standard liposomes are
vesicles with a lipid bilayer membrane. Hydrophilic molecules can be encapsulated in
the lumen (green star) and hydrophobic molecules can be trapped in the membrane (red
spheres). b) Stealth liposomes are created by grafting an inert PEG chain to the outside
of the vesicle. c) Cationic lipids can be used to create “onion” liposomes and encapsulate
DNA (purple cylinders) for gene therapy. d) Vase shaped lipids have been shown to
form vesicles demonstrating the diversity of chemistries possible in lipid system.
Reprinted by permission from Macmillan Publishers Ltd: Nature27, copyright 2012.
!
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To overcome the mechanical weakness of liposomes, diblock copolymer vesicles,
or polymersomes, were invented.28 Polymersomes are bilayer vesicles assembled from
diblock copolymers with blocks of opposing polarities. Polymer vesicle membrane
thickness is dictated by the hydrophobic block molecular weight allowing for controlled
mechanical properties (Figure 2.3 A-C).29 Polymersomes have been developed for
various applications including drug delivery30-33, advanced imaging34-36, controlled
release37-39, and sensing40,41. Polymer vesicles have been decorated with adhesion
ligands42,43, but these proteins were cross-linked to the membrane using biotin/avidin
interactions potentially leading heterogeneous functionalization and additional
purification steps post assembly (Figure 2.3 D). Polymer vesicles are inherently
polydisperse in size likely stemming from the molecular weight distribution observed for
the single polymer chains. Vesicle size is typically controlled post assembly with
extrusion.44 Advances in polymer synthesis have lead to fine control over the polymer
molecular weight distributions, which has been shown in polymersomes to correlate with
a predicted average diameter based on the preferred curvature of the molecule.45
Diblock copolymers have been used for a variety of other applications including
emulsification46-48 and lithography49,50.

!
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Figure 1. Cryo-TEM images of a 1.0 wt % aqueous solution of copolymer in water: (a) OB2, (b) OB18, and (c) OB19. The
hydrophobic cores of polybutadiene are the darker areas. Scale bars are 100 nm. Polymorphism is common in cryo-TEM preparations
but does not pose any difficulties to analysis since vesicles can be clearly identified from their concentric-ring structure.

D"

of the present diblocks into membranes requires such
proportions, as it is well-documented theoretically19,20
and experimentally21 that a larger f leads to wormlike
and spherical micelles while smaller values of f yield
inverted phases. Another shared feature of lipid membranes is their narrow range of hydrophobic core thickness d. Thus, connections between molecular conformations and mass, as well as the interplay between these
factors in determining and limiting membrane selfassembly, have not been thoroughly studied. Direct
imaging of our vesicles by cryo-TEM demonstrates a
systematic increase in d with M
h n (Table 1 and Figure
1).
It is important to note that the depth of field for cryoTEM is comparable to the sample film thickness used.
As such, the resulting image is effectively the projection
of a sample’s density into a plane. Assuming a membrane core of homogeneous density and spherical vesicles,
the projected density has a maximum in the intensity I
at the vesicle inner radius r ) Ri. At r ) Ri + d, the
intensity will go to zero or, in our case, to the background intensity I0. This simple model for the intensity
is shown in Figure 2a, where d / Ri is used as a free
parameter. For d / Ri < 0.25, the model is in excellent
agreement with the measured profile (circumferentially
averaged). The dark and light rings seen in Figure 1
are Fresnel interference fringes corresponding to the
Figure 2.3: Polymersome membrane control and functionalization. Cryo-TEM
abrupt changes in the projected density at the inner and
micrographs
showingrespectively.
polymersomes
assembled from various molecular weights.
outer edges
of the membrane,
The fringes
can alsoMembrane
be seen in Figure
2a atisr dictated
) Ri and by
r )the
Ri +molecular
d,
thickness
weight of the polymer, specifically the
thus providing a simple means for determining the
hydrophobic block. A) OB2 (EO spherical
-BD46), 3600 g/mol. B) OB18 (EO80-BD115), 10,400
membrane thickness d. Similar analysis of 20
Figure 2. (a) Experimental intensity profile of a vesicle
C) OB19
(EO
-BD
),
20,000
g/mol.
Scale
are 100Best
nm.fit Reprinted
with
micellesg/mol.
via cryo-TEM
gives
very
comparable
results
to
150
250
imaged bars
by cryo-TEM.
of the data corresponds
to d/Ri
12,21
corresponding
SANS
measurements.
Based
on
either
)
0.25.
Direct
experimental
estimation
gives
permission from Macromolecules, 35, 8203-8208, Bermudez, H., Brannan, A. K., d/Ri ) 0.27,
fitting experimental profiles or edge detection (Figure
which gives a difference of less than 1 nm. Dash-dot and
Hammer,
A., Bates,
F. S. & Discher,
D. E., Molecular
weightfitsdependence
ofand 0.3, respectively.
dashed lines indicate
using d/Ri ) 0.2
2b), measures
of dD.seem
to be independent
of vesicle
Note
the
Fresnel
interference
fringe
at
r / Ri ∼1.3. (b) Depenmembrane
structure,
and stability. Copyright 2002 American
radius polymersome
even though contrast
is reduced
for elasticity,
smaller
dence of measured hydrophobic thickness d on inner radius
29
vesicles.
Chemical Society. D) Polymersomes can be functionalized
through
biotin-avidin
Ri of vesicles imaged
by cryo-TEM
for OB2, OB18, and OB19.
Glassy diblock copolymers of PEO-polystyrene and
Solid
and dashedReproduced
lines are mean values
(
S.D. Data are shown
bridges
to
link
specific
biological
motifs
to
the
membrane.
from
reference
poly(acrylic acid)-polystyrene have previously been
using spherical
vesicles (O) and nonspherical vesicles (4) with
43
out-of-plane curvature estimates.
permission
of shells
The Royal
Society
of Chemistry.
shown with
to generate
vesicular
in organic
mixtures
with added water.22 Although the effects of chain length
h h)a leads to an exponent
and solvent
! have been studied in terms of morphological 13! experimental scaling of d ∼ ( M
20,22
a ∼ 0.5 (Figure 3). In theory, fully stretched chains
effects,
no clear trend between copolymer molecular
would give a ) 1 and ideal random coils would give a )
weight and membrane thickness has yet been estab1/ . Our copolymers are expected to be in the strong
lished. The thickness measurements here for our self2
assembling copolymers suggest a scaling relationship
segregation limit (SSL), where a balance of interfacial
between d and Mn. Noting that the mean hydrophobic
tension and chain entropy yield a scaling of a ) 2/3.19
The best-fit scaling exponent obtained surprisingly
molecular weight is given by M
hh ∼ M
h n(1 - f), the

Dendrimers have been developed as synthetic surfactants with precise molecular
weight. A dendrimer is a molecular that is constructed from branched monomer units.
Dendrimer amphiphiles have been shown to self-assemble into helical pores51, micelles52,
and vesicles, called dendrimersomes53. Dendrimersome diameter size has been shown to
be dependent on the bulk material d-spacing and the concentration of the dendrimer in
solution.54 Controlling the size of the aggregated structure poses a major advantage over
polymersome systems. Recently, a family of amphiphilic glycodendrimers was
synthesized with monosaccharides D-mannose and D-galactose and the disaccharide Dlactose in their hydrophilic head group. These amphiphilic glycodendrimers selfassembled into vesicles, worm-like micelles, and cubosomes and the self-assembled
structures were shown to directly interact with sugar binding proteins.55 Recently,
dendrimers have been developed to control the size and number of bilayers in each
assembled dendrimersome. These “onion” like vesicles offer the possibility of kinetically
controlling extended release with each layer providing a sequential release.56
Dendrimersomes are an interesting platform for drug delivery and imaging because the
synthesis methods allow for complete control over the chemistry and molecular weight of
the amphiphilic dendrimer, and simple methods can be used to control the
dendrimersome diameter, a major advantage for controlled in biodistribution and
circulation time.57
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2.4 Peptide and Protein Nanoparticles
A common limitation of many nanoparticles is their inability to directly interact with
biology without the addition of a peptide or protein. Biological interactions are highly
specific. For example, it is well know that the integrin binding sequence RGDS loses its
binding affinity when just two of the amino acids are scrambled.58 It is therefore
advantageous to create nanoparticles from naturally occurring biological molecules such
as polypeptides or proteins. Proteins and polypeptides are polymers assembled from the
twenty naturally occurring amino acids arranged in a specific order. What separates
proteins from polypeptides is structure. Proteins have local secondary structure such as
alpha helical or beta sheet domains. These local domains fold into a molecular structure
called the tertiary structure dictating the overall shape and size of the protein and, in
many cases, biological function. Polypeptides are linear polymer chains of amino acids
that can display local secondary structure but do not fold into higher order structures.

Polypeptides have been of great interest for creating self assembled nanoparticles.
Seminal work has shown block-copolypeptides can assemble into various structures, such
as vesicles59,60 and micelles61. Stupp and coworkers have created various peptide
amphiphiles that assemble similar to traditional surfactants.62 Additionally, very short
peptide amphiphiles have been shown to assemble into nanotube or nanovesicles
depending on the peptide sequence (Figure 2.4 A).63 Fletcher and coworkers have
developed coiled-coil peptides that can be engineered to form cages, mimicking viruses.64
Deming and coworkers have produced libraries of diblock copolypeptides comprising of
!
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two amino acids, a charged amino acid repeated for the head group and a nonpolar amino
acid for the tail group (Figure 2.4 B).59,61 Different amino acids have been blended into
each block with set average composition, but the precise sequence of amino acids in each
block could not be controlled.65 The diblock copolypeptides have been used to stabilized
nano-emulsions66 and engineered to assembled into hydrogels for tissue engineering and
prolonged drug delivery67-70. Lecommandoux and coworkers invented a zwitterionic pH
switchable polypeptide system with poly(L-glutamic acid)- b-poly(L-lysine) (PGA-bPlys) (Figure 2.4 C).71 Like polymers, most polypeptides are chemically synthesized,
which can lead to polydispersity in the surfactant molecular weight and limits the ability
to incorporate biologically active domains within the sequence.
An alternative is the expression of recombinant surfactants by molecular biology.
These surfactants would be monodisperse and have the precise sequence dictated by the
cognate gene. Unlike synthetic methods, recombinant production permits the direct
incorporation of specific motifs that mediate protein recognition. Embedding recognition
sequences, either at the ends of proteins or deep within the sequence, is straightforward.
Mastrobattista and coworkers have invented small self-assembling recombinant
oligopeptides with the defined sequence Ac-Ala-Ala-Val-Val-Leu-Leu-Leu-Trp-GluGlu-COOH.72 The oligopeptides vesicles are assembled through relatively weak
forces73, but the mechanical stability can be improved with intermolecular crosslinking
through disulfide bonds.74 The assembled vesicles have been used as passive cellular
delivery vehicles75 but the small sizes of these peptides preclude the incorporation of
biologically relevant motifs within the assemblies.

!
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Abstract: We report the preparation and characterization of charged, amphiphilic block copolypeptides
that form stable vesicles and micelles in aqueous solution. Specifically, we prepared and studied the aqueous
self-assembly of a series of poly(L-lysine)-b-poly(L-leucine) block copolypeptides, KxLy, where x ranged
from 20 to 80 and y ranged from 10 to 30 residues, as well as the poly(L-glutamatic acid)-b-poly(L-leucine)
block copolypeptide, E60L20. Furthermore, the vesicular assemblies show dynamic properties, indicating a
high degree of membrane fluidity. This characteristic provides stimuli-responsive properties to the vesicles
and allows fine adjustment of vesicle size using liposome-based extrusion techniques. Vesicle extrusion
also provides a straightforward means to trap solutes, making the vesicles promising biomimetic
encapsulants.

A"

Introduction

B"

There has been an abundance of research in recent years on
the preparation and characterization of polypeptide based
materials.1 Since these polymers employ the building blocks of
proteins, they begin to allow incorporation of the structures and
functions of proteins into synthetic materials. These features
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Upon dissolution
of the diblock copolymer in aqueous basic and
a zwitterionic diblock copolymer poly(L-glutamic acid)acid solutions, self-assembly occurred spontaneously as demonL-lysine) (PGA-b-PLys) has never been studied. As an
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ive properties. Polybutadiene-b-poly(L-glutamic acid) (PBstandard homopolymers. At acidic pH, the poly(L-glutamic acid)
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which the polypeptide precipitates out of solution (Figure 2.5 B). Diblock elastin-like
polypeptides (ELPs) remain the main building block for the formation of nanoparticles
from recombinantly produced polypeptides.76-79 ELP diblocks are commonly created by
fusing two blocks together with varying LCSTs. Manipulating the chemistry and length
of the blocks creates a temperature window where one block precipitates out of solution
while the other remains soluble leading to the formation of nanoparticles. Recent work
has shown that assembly can be controlled through the conjugation of hydrophobic
moieties to an asymmetric ELP diblock.80 In this work, molecules with varying
hydrophobicity were linked to the C-terminus of the ELP chain. It was found that a
minimum hydrophobicity was needed to assemble these asymmetric surfactants into
spherical micelles(Figure 2.5 C).80 In many cases, the core of ELP micelles is highly
solvated potentially limiting the hydrophobicity of the cargo.81 The specific repeat
sequence in ELP diblocks and the cloning methods used to create them79,82 make it
difficult to incorporate biological functionality into the core of the peptide sequence.
Self assembled protein nanoparticles are found in nature in various systems. The
milk protein casein forms spherical micelles to encapsulate hydrophobic components in
solution.83 These micelles are considered associated colloids, which are formed by
highly phosphorylated caseins interacting with calcium phosphate. Micelles have an
average diameter of 200 nm in milk but can be engineered to form much smaller
structures.84,85 Casein micelles have been used extensively for oral drug delivery but
must be cross-linked for stability.86-89
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of ELP fusion proteins provides a simple and convenient
methodology for protein purification that has many advantages over current chromatographic techniques used to isolate recombinant proteins. These advantages are the low cost

of purification, its technological simp
laboratory centrifuge or filter that is r
molecular biology and biochemistry
multiplexing, and high yield.

Another common scaffold for new materials is the self-assembling shell from
protein capsids termed virus-like particles.90 Protein capsids form a single layer of
protein able to entrap hydrophilic compounds inside but unable to store hydrophobic
compounds. These structures offer uniform sizes and can be created recombinately.91
They are assembled from many copies of the same protein monomer. This allows for
highly controlled assembly but limits functionalization due to the precise sequence
needed for assembly. Therefore, much of the functionalization on the interior or exterior
of the shell is done through chemical methods.91,92

There are very few naturally occurring protein surfactants. For stability purposes,
proteins generally embed their hydrophobic amino acids in the core of the molecular and
expose polar and charged amino acids at their surface. A few commonly used proteins
have been shown to lower the surface pressure at interfaces such as lysozyme93 and
bovine serum albumin (BSA)94. These proteins are thought to adsorb to the interface,
which induces stress on the protein structure causing slow denaturation. This
denaturation allows for hydrophobic amino acids to partition into the nonpolar phase,
lowering the surface pressure. The majority of surfactant proteins display a hydrophobic
patch such as hydrophobin95, or they rearrange at an interface to expose a hydrophobic
domain such as latherin96 and ranaspumin97. Although these proteins display surfactant
characteristics, they are not ideal to engineer for self-assembly due to their globular
shape. Ideally, a chain like protein would be desired to mimic the well-studied
assemblies of lipid and polymers. The only known chain like natural surfactant protein is
oleosin98.
!
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2.5 Oleosin
Oleosin is a naturally occurring plant protein that stabilizes oil bodies in seeds.98 The
native structure is defined in three domains: an N-terminal hydrophilic arm, a central
hydrophobic domain, and a C-terminal hydrophilic arm (Figure 2.6).99,100 A proline knot
in the core of the hydrophobic domain forces a 180° turn leading to a hairpin like
structure.98,101-103 The secondary structure of oleosin has been contradictory in
literature.99,101,104-107 Modeling has shown the hydrophobic domain to fold into a coiledcoil domain101, but recent work suggests that oleosin maintains a beta sheet structure in
oil bodies.105 It is unclear what structure oleosin takes in aqueous environments due to its
low solubility.

The surfactant nature of oleosin has been exploited in many applications. Oleosin
has been expressed recombinantly and utilized for its surfactant behavior,108-113 but little
engineering has been completed to optimize the protein for self-assembly. The main
application for oleosin variants has been the stabilization of emulsions, termed artificial
oil bodies.98,113-115 Their ability to stabilize oil-in-water emulsions has led to the
development of oleosin fusions for protein purification.109 Additionally, targeted oil
bodies have been established as hydrophobic drug delivery agents by fusing a Her2
affibody to oleosin and stabilizing artificial oil bodies with the fusions.110,111 Oleosin has
not been exploited as a stabilizing agent for various other interfaces, an area that this
work looks to explore. Also, few studies have explored engineering oleosin into a
!
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surfactant protein for self-assembly. Tzen and coworkers have created truncation
mutants of oleosin by eliminating portions of the hydrophobic domain from the N- and/or
the C-termini but focused on the mutant’s ability to stabilize artificial oil bodies.116
Oleosin is a prime candidate for engineered self-assembly due to its native
hydrophobicity, block-like structure, and known expression in bacterial hosts.

Hsieh and Huang

A"

B"
B"

Figure 2.6: Schematic depictions of oleosin. A) Block primary structure of oleosin shows
the hairpin-like structure of the protein. The cartoon indicates that the two hydrophilic
arms directly interact with the phospholipid membrane while the hydrophobic block
could be in a beta-sheet structure into the TAG matrix. Reproduced from Huang, A. H. C.
Oil Bodies and Oleosins in Seeds.98 B) Cartoon depiction of the proline knot and oil
body membrane. Oil bodies are 1-3 µm emulsions found in seeds. Oleosin is thought to
stabilize these emulsions and protect from aggregation and ripening. Reproduced from
indicated source.100 Copyright 2004, American Society of Plant Biologists.
Figure 1. Models of an oleosin molecule, a seed oil body, and the
synthesis of an oil body on the endoplasmic reticulum. A, The three
portions of an oleosin molecule (yellow), showing the N-terminal
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There are two families of characterization techniques that were employed in this work:
protein and nanoparticle. Protein characterization assessed the purity, identity, molecular
!
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weight, and secondary structure of the molecules. Nanoparticle characterization
primarily focused on shape and size of the particles either through scattering techniques
or direct imaging using electron microscopy.

2.6.1 Protein Characterization
SDS-PAGE is used to access the purity and estimated molecular weight of a protein. A
gel stained with Coomassie Blue will indicate all protein in the sample. Using image
analysis software, the intensity of a lane can be plotted and the area under curve can be
calculated. By calculating the relative area under the curve, the individual bands can be
assessed for percent purity (>95% purity is expected from recombinant purification
methods). Protein identify can be confirmed through western blotting. In western
blotting, a specific antibody is bound to the protein entrapped in a membrane. This
antibody is fluoresenectly identified through the binding of a secondary antibody. The
confirmation of protein identity is of utmost importance because of the heterogeneous
mixture in the cell lysate from which the target protein is purified. Protein molecular
weight can be confirmed using matrix-assisted laser desorption/ionization time-of-flight
mass spectroscopy (MALDI-TOF). This tequnique ionized a dried spot of protein that is
entraped in a host matrix using a high power laser and the time it takes the ionized
protein to travel from the plate to the detector is measured.117 The time is coorelated to
standards and a mass spectra is generated. MALDI-TOF provides the molecular weight
of the entire protein compared to other mass spectroscopy methods where enzyme
cleavage is needed to obtain a specta. Finally, the overall secondary structure of the
!
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proteins can elucidated through circular dichroism118,119. Due to the chirallity of the
peptide bond, proteins adsorb circuallarly polarized light. Pluses of left- and righthanded circularrly polarized light are alternated through an aqueous solution over a range
of wavelengths. The difference between the absorbance of the left and right handed
polarized light is plotted as a function of wavelength. Standard CD spectra for an alpha
helix, beta sheet, or unordered strcuture are shown in (Figure 2.7). It should be noted
that CD provides the secondary structure of the entire protein. For this reason, CD is
useful for examining how mutantions affect the overall secondary structure but can not be
used to determine specific regions of secondary structure.118,119 CD can also elucidate
changes in the secondary structure as a function of concentration or temperature during
self-assembly.

Figure 2.7: CD spectra of pure secondary structure domains. The red curve is indicative
of a random coil, the green curve an alpha helis, and the blue curve a beta sheet.
Reproduced from the Univeristy of Leeds, CD facility.
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2.6.2 Nanoparticle characterization
The nanoparticle characterization techniques employed in this work were scattering
methods and direct imaing through electron micrscopy. Scattering methods provide
population averages for size whereas direct imaging can confirm size and provides direct
evidence of the shape and size of the particle through a visual micrograph. Two types of
scattering were employed in this work, light and X-ray. Dynamic light scattering is used
to measure the hydrodynamic diameter and the distribution of the diameter in
nanoparticle solutions.119 The Brownian motion of particles causes laser light to be
scattered at different intensities and the fluctuations in intensity can yeild the particle
velocity. Employing the Stokes-Einstein equation, the particle size can be determined.
For protein solutions, the raw intensity data were analyzed because an accurate reading
for the refractive index and absorbance, which is needed to convert to percent number or
percent volume, was not availible. Small angle X-ray scattering can be used to meausre
characteristic lengths in a nanostrcutured material. In this technique, concentrated
solutions of protein are subjected to the bombardment of X-rays at a known wavelength.
X-rays are elastically scattered and the 2-D scattering profile is detected at a known
distane from the sample.119 The profile is integrated as a function of the scattering angle.
The spectra can be fit to known fucntions to determine the size and shape of the
nanostructures.

Cryogenic transmission electron microsocpy (Cryo-TEM) is used to directly
image soft matter nanoparticles in solution. Cryo-TEM is the superior method for soft
matter imaging120-122 because unwanted rearrangement of solution structure is avoided
!
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Fig. 1. Schematic of the sample preparation for cryo-TEM. (a) The solution containing self-assembled structures is (b) deposited on a TEM grid. (c) The grid is blotted wit
paper to remove excess solution and plunged into a cryogen. (d) The electron transparent ﬁlm is supported by a carbon support and (e) imaged with the electron beam.

Figure 2.8: Cryo-TEM sample preparation. Sample in the form of a liquid drop (a) is
deposited on a carbon coated TEM grid (b). The grid is blotted and plunged into liquid
ethane (c). (d and e) Cartoon depictions of the grids after blotting. Reprinted from
Current Opinion in Colloid & Interface Science, 17, Newcomb, C. J., Moyer, T. J., Lee,
S. S. & Stupp, S. I., Advances in cryogenic transmission electron microscopy for the
characterization of dynamic self-assembling nanostructures, 350-359, Copyright 2012,
with permission from Elsevier.125
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American Chemical Society.
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architecture of the assemblies. Figure 2.9 shows the projection of structures in the grid
onto the 2-D micrograph. Vesicles show distinct membranes at the edges of the

structures but can easily be confused with disks or circular worm-like micelles if carful

analysis is not taken. Worm like micelles are long strands with equal intensity from enter
to edge. Spherical micelles are shown as single circular dots on the micrograph.
Examples of representative images are shown in Figure 2.9.
Fig. 2. A schematic section through aqueous film, containing
vesicles, spanning the holes of a HPF. Note the size sorting,
and the protruding vesicle in the right hand hole.

A"

B"

Fig. 3. A schematic indication of the 2-D projection in the
imaging of vesicles and disks.

C"

D"

Figure 2.9: A) A schematic of the 2-D projections of various structures in micrographs.
Reprinted from Colloids and Surfaces A: Physicochemical and Engineering Aspects, 174,
Mats Almgren, Katarina Edwards, Göran Karlsson, Cryo transmission electron
microscopy of liposomes and related structures, 3-21., Copyright 2000, with permission
from Elsevier.124 B) Diblock copolymer vesicles. C) Diblock copolymer worm-like
micelles. D) Protein spherical micelles.80 All scale bars are 200 nm.
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Artifacts observed in cryo-TEM arise from various sources such as strong sheer
forces from blotting, the confinement of structures into the film, and solvent
freezing.120,126-128 The main artifacts observed are from the formation of ice crystals
within the film or on the film surface. Ice contamination can look like vesicles or
micelles in many cases but can be distinguished by melting with the electron beam.
Figure 2.10 shows typical ice contaminates.

Figure 2.10: Cryo-TEM ice artifacts. A) Large ice crystals. B) Hexagonal ice crystals. C)
Porous dry film likely caused by over blotting. When a film is over blotted, the sample is
very prone to evaporation during the plunging step. D) Polygonal ice crystals formed
from thawing of the film. Scale bars: 200nm. Reproduced from reference with
permission of The Royal Society of Chemistry.120
!
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!
Chapter!3!
Protein!self2assembly!through!
emulsion!templating!
The work presented in this chapter can be found in the following publication: K. B.
Vargo, R. Parthasarathy, & D. A. Hammer, Self-assembly of tunable protein
suprastructures from recombinant oleosin. Proc. Natl. Acad. Sci. U. S. A. 2012, 109,
11657-11662. The work is protected under the international patent WO 2012/097220.

!
Abstract!
The self-assembly of suprastructures from recombinant amphiphilic proteins would allow
precise control over surfactant chemistry and the facile incorporation of biological
functionality. We used cryo-TEM to confirm self-assembled structures from
recombinantly produced mutants of the naturally occurring sunflower protein, oleosin.
We studied the phase behavior of protein self-assembly as a function of solution ionic
strength and protein hydrophilic fraction, observing nanometric fibers, sheets, and
!
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vesicles. Vesicle membrane thickness correlated with increasing hydrophilic fraction for
a fixed hydrophobic domain length. The existence of a bilayer membrane was
corroborated in giant vesicles through the localized encapsulation of hydrophobic Nile
red and hydrophilic calcein. Circular dichroism spectra revealed that changes in
nanostructure morphology in this family of mutants was unrelated to changes in
secondary structure. Ultimately, we envision the use of recombinant techniques to
introduce novel functionality into these materials for biological applications.
!
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3.1 Introduction
Self-assembled vesicles are of great interest in drug delivery and imaging, given their
ability to sequester large payloads of hydrophilic or hydrophobic agents. Vesicles made
from biologically-relevant phospholipids1 are currently employed for drug delivery2, but
they are mechanically weak and difficult to functionalize. These limitations have
prompted an extensive effort to make vesicles from other macromolecular surfactants
including block co-polymers3,4 and Janus amphiphilic dendrimers5, but these materials
remain difficult to functionalize and are often not biocompatible.

An alternative is the assembly of materials purely from polypeptides. Seminal
work has shown that block-copolypeptides can assemble into various structures, such as
vesicles.6,7 However, these surfactants consist of amino acids polymerized into
polydisperse blocks and then appended to make copolymers. Different amino acids have
been blended into each block with set average composition, but the precise sequence of
amino acids in each block could not be controlled.8 Amino acid copolymerization
prevents the direct incorporation of specific peptide sequences, which are required for
recognition and targeting in biology. Incorporation of such motifs would be limited to the
ends or between these peptide blocks.

A powerful alternative is the expression of recombinant surfactant proteins by
molecular biology. These proteins would be monodisperse and have the precise sequence
dictated by the cognate gene. Unlike synthetic methods, recombinant protein production
!
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would permit the direct incorporation of specific motifs that mediate protein recognition.
Embedding recognition sequences, either at the ends of proteins or deep within the
sequence, is straightforward. Smaller self-assembling oligopeptides can be produced
recombinantly9 but the small sizes of these peptides preclude the incorporation of
biologically relevant motifs. Elastin-like polypeptides10 have been assembled into
various structures including micelles11 and vesicles12, although the direct visualization of
a bilayer membrane or vesicular encapsulation has not been explicitly shown12.

While a number of naturally occurring proteins, such as hydrophobins13,
oleosins14, latherin15, and ranaspumin16, are known to stabilize interfaces, only oleosins
are structurally reminiscent of a chain surfactant. Oleosins are a family of plant proteins
whose biological role is to stabilize oil bodies.14 They have an N-terminal hydrophilic
segment, followed by a hydrophobic core (among the longest natural hydrophobic
stretches17) and another hydrophilic segment at the C-terminus.18,19 Although the crystal
structure is unknown, the molecule is believed to resemble a hairpin with the
hydrophobic domain bifurcated by a proline knot, a stretch containing three prolines that
induce a 180° turn in the chain.14,17,20,21 The two legs of the hairpin are helical, possibly
forming a coiled-coil.17,20 Recently, oleosin has been shown to stabilize artificial oil
bodies and emulsions.22-26 We postulated that the surfactant-like block architecture of
oleosin would make it a logical starting point for the creation of tunable self-assembled
protein suprastructures.
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We describe the expression of sunflower oleosin mutants in bacteria, their
purification, characterization, and assembly into supramolecular structures at the nanoand micro- scales. Depending on hydrophilicity and the ionic strength of the buffer, these
proteins assemble into sheet, fibers, or vesicles. Self-assembly of the proteins was
investigated with cryo-transmission electron microscopy (cryo-TEM) and laser scanning
confocal microscopy (LSCM).
!
!

3.2 Materials and Methods
Oleosin Gene Creation and Expression
The sunflower seed oleosin gene was provided as a gift by Dr. Beaudoin at Rothamsted
Research, Hampshire, England. Standard molecular biology techniques were used to
create the modified genes in the expression vector pBamUK, a pET series derivative, that
was constructed by the van Duyne laboratory (SOM, Penn). PCR primers 42S (5’ -AGA
TAT ACC CAT ATG GCC ACC ACA ACC TAC GAC C) and 63AS (5’ - TTT CTC
ACC CTC GAG TTT CCC CCC TTC TTT TCG CCC TTC) were used to amplify the
gene and add NdeI and XhoI restriction sites to the ends creating 42-87-63 (Oleo-WT).
The P=65 family was cloned into Avi-pBamUK. A gene for a biotin binding site was
created with the primers Avi S (5’ - TAT GGG TCT GAA CGA CAT CTT CGA GGC
TCA GAA AAT CGA ATG GCA CGA AG) and Avi AS (5’ - GAT CCT TCG TGC
CAT TCG ATT TTC TGA GCC TCG AAG ATG TCG TTC AGA CCC A). This gene
was digested with NdeI and BamHI and ligated into pBamUK to create Avi-pBamUK.
!
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43-65-33 was created with the primers 43S (5’ - AAG GAG ATA GGA TCC TAC CGC
CAT GAT CAA CAC ACC) and 33AS (5’ - TAT ATG AAT CTC GAG CTG GCC
CAA GTC CTT CG); 33-65-23 was created with the primers 33S (5 ‘ - AAG GAG ATA
GGA TCC CTC ACC CAC CCA CAG C) and 23AS (5’ - TAT ATG AAT CTC GAG
ATA CTC CCC CAC ATC C); 28-65-18 was created with the primers 28S (5’ - AAG
GAG ATA GGA TCC CGC CAG CAA CAA GG) and 18AS (5’ - AAG GAG ATA
GGA TCC CGC CAG CAA CAA GG); 23-65-13 was created with the primers 23S (5’ AAG GAG ATA GGA TCC CCC TCA ACC GGC AAG ATA ATG G) and 13AS (5’ TAT ATG AAT CTC GAG CAC ATA ATC CCT CTG G). The P=65 family was
digested with BamHI and XhoI and ligated into Avi-pBamUK. Mutants were confirmed
through DNA sequencing prior to expression. pBamUK adds a 6-Histidine tag to the Cterminus of the protein for IMAC purification if needed. The E. coli strain BL21 DE3
(Stratagene) was used with induction controlled by the lac promoter. Cultures were
grown at 37°C in Luria Bertani (LB) Broth with kanamycin at a final concentration of 50
µg/ml until OD600≈0.4. Expression of the protein was induced by the addition of
isopropyl β-D-thiogalactopyranoside (IPTG) to a final concentration of 1.0 mM. Cells
were harvested by centrifugation; cell pellets were frozen at -20°C prior to purification.

Extraction and Purification of Oleosin Proteins
B-PER Protein Extraction Agent (Thermo Scientific) was used to lyse the cells using a
modified protocol for inclusion bodies. A 500 ml culture cell pellet was resuspended
with 10 ml B-PER. DNase was added to a final concentration of 0.5 µg/ml and incubated
at room temperature for 20 minutes. The solution was centrifuged at 15,000 g for 15
!
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minutes and the supernatant was discarded. The resulting pellet was resuspended in 10
ml B-PER. Lysozyme was added at a final concentration of 0.2 mg/ml and incubated at
room temperature for 5 minutes. The suspension was diluted with 25 ml of 1:10 B-PER
in water and centrifuged at 15,000 g for 15 minutes and the supernatant was discarded.
The resulting pellet was washed three times with 25 ml of 1:10 B-PER resulting in a
purified inclusion body pellet. The resulting inclusion body pellet was washed three
times with 10 ml 200 mM Na2CO3 (pH 11). Oleosin was extracted from the inclusion
bodies using an organic solvent mixture.27,28 The pellet was resuspended in 10 ml 200
mM Na2CO3 (pH 11). Chloroform:methanol mixtures were added to the suspension
yielding monophasic solutions of Na2CO3:chloroform:methanol with compositions
corresponding to 1:1:8 (v/v/v) (organic solution A) or 1:2:7 (v/v/v) (organic solution B).
The solutions were centrifuged and the protein rich supernatant was retained.

SDS-PAGE
Protein samples in organic solution A were dried overnight under vacuum. The protein
was suspended in 8M urea, 50 mM phosphate and used for electrophoresis. SDS-PAGE
gels were run on NuPAGE Novex 4-12% Bis-Tris Mini Gels (Invitrogen). Following
electrophoresis, the gel was stained with SimplyBlue SafeStain (Invitrogen). The gel was
destained and imaged with a Kodak Gel Logic 100 Imaging System.

Western Blot Analysis
Western blot analysis was completed according to Li-Cor Biosciences Western Blot
Analysis protocol. Specifically, after SDS-Page electrophoresis, the samples were
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electroblotted onto a PVDF membrane. The membrane was washed overnight with
blocking buffer at 4°C. The membrane was then washed with wash buffer (PBS +0.01%
Tween 20) five times and incubated with anti-6xHis anti-mouse antibody for 1 hour at
room temperature (Antibody dilution of 1:2000). The washing step was repeated and the
membrane was incubated with the secondary antibody IRDye 700x conjugated goat
polyclonal anti-mouse (Bio-Rad) for 1 hour at room temperature (Antibody dilution
1:5000). The washing step was repeated and the membrane imaged on an Odyssey
Infared Imager (Li-Cor Biosciences, Lincoln, NE).

Mass Spectroscopy
Protein pellets were solubilized in 50:50 (v/v) TFE in water. Protein samples were sent
to The Wistar Institute Proteomics Facility (Philadelphia, PA) for mass analysis using
matrix-assisted laser desorption/ionization (MALDI) mass spectroscopy.

Nano-vesicle preparation
Protein solutions in organic solution A ranged from 0.25 to 0.35 mg/ml measured using a
Nanodrop 100 (Thermo Scientific). Solutions were injected (10% volume fraction) into
various buffers created from dilutions of 1X PBS pH 7.4 (0.01 M Phosphate buffered
saline, 0.138 M NaCl, 0.0027 M KCl, Fisher Scientific). Ionic strength of dilutions: 1X
PBS-140 mM ionic strength, 0.5X-70 mM, 0.25X-35 mM, and 0.1X-14 mM. Solutions
were sonicated in a Branson 3510 bath sonicator for 10 seconds and gently swirled by
hand until the solution turned clear. Solutions were open to atmosphere for >6 hours to
allow for organic evaporation and stored for >12 hour at 4°C prior to imaging.
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Cryo-TEM
Vesicle samples were deposited on lacey formvar/carbon mesh grid (Ted Pella) and
added to a cryoplunger (Gatan Cp3, Gatan, Pleasanton, CA). The sample was blotted by
hand and plunged into liquid ethane. Samples were transferred to the cryoholder (Gatan
CT3500TR, Gatan, Pleasanton, CA) and the cryoholder was immediately inserted into a
JEOL 2010 TEM (JEOL, Tokyo, Japan) operating at 200kV. Micrographs were imaged
with an Orius SC200 digital camera.

Cryo-TEM: Membrane Thickness
Vesicles appear on the micrographs as circles with a darker membrane. The inside of the
vesicles will be darker compared to the bulk solution. This is due to electron scattering
through the vesicle shell. The edges of the vesicles are darker due to the increased
number of protein molecules that the electrons must transmit through. The membrane
thickness is measured in ImageJ.29 Ten measurements were made on each vesicle and
averaged to get an overall vesicle membrane thickness. Six vesicle membrane
thicknesses were then averaged to get the membrane thickness for a specific mutant and
plotted in Figure 2G.

Circular dichroism
Far-UV CD spectra were collected at 25° C on an AVIV 410 spectrometer (AVIV
Biomedical Inc, Lakewood, NJ) using a 1 mm quartz cell. Protein concentrations ranged
from 9-12 µM in 50:50 (v/v) TFE in water. Data was analyzed using DichroWeb
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software30 using the CDSSTR method31 and Reference Set 7 containing 48 known protein
structures32.

Giant vesicle preparation
Protein concentrations in organic solution B ranged from 0.25 to 0.5 mg/ml measured
using a Nanodrop 100 (Thermo Scientific). The monophasic solutions were injected (510% volume fraction) into 1X PBS, which resulted in phase separated aqueous in oil in
aqueous double emulsions. The excess organic solvent was allowed to evaporate at room
temperature yielding stable vesicles. Giant vesicles were dyed by adding Nile Red
(Sigma) and calcein (Invitrogen) to the injection mixture.

Confocal Microscopy
Laser scanning confocal microscopy (LSCM) was used to expose giant protein bilayer
vesicles to light at 488 nm. An Olympus Fluoview FV1000 confocal microscope (Center
Valley, PA) with a UPLFLN 40x objective lens was used to image the vesicles with a
scan speed of 4.0 µs pixel-1 (4.426 s frame-1). Nile Red signal was collected between
600-650 nm and calcein was collected between 500-520 nm.
!

3.3 Results and Discussion
3.3.1!Protein!Modifications!
Structurally, oleosin is comprised of three connected segments – a hydrophilic block at
the N-terminus, a center hydrophobic block with a proline turn, and a second hydrophilic
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block at the C-terminus. We use the nomenclature N-P-C to describe the variants in this
chapter, where N is the number of amino acids in the hydrophilic N-terminus, P is the
number of amino acids in the hydrophobic core, and C is the number of residues in the
hydrophilic C-terminus (Figure 3.1). Wild type oleosin is denoted 42-87-63. A library of
mutant proteins with variable hydrophobicities and molecular weights was created by
deleting amino acids from either hydrophilic arm or the hydrophobic segment. Without a
defined crystal structure, we could not truncate based on secondary structure motifs.
Although we ultimately have the potential to introduce point mutations anywhere within
the protein, in this work we chose to simply truncate the hydrophobic block and
hydrophilic arms creating families of various hydrophilic fractions; future publications
will describe point mutations and replacements. We created two families of mutants,
with two different sized hydrophobic blocks – that of the wild type (P = 87), and one in
which the hydrophobic block was truncated at the hydrophobic-hydrophilic junction by
removing a total of 22 amino acids, decreasing the hydrophobic block size by 25%
(P=65). Using the P=87 and P=65 hydrophobic blocks as templates, the hydrophilic arms
were systematically truncated by 5 amino acids creating a large family of proteins.
Members of the P=65 family included 43-65-33, 33-65-23, 28-65-18, and 23-65-13 selfassembled into a variety of nanostructures in aqueous solution. Members of the P=87
family remained very surface active but were not found to self-assemble. These proteins
could be useful for surfactant stabilization at interfaces but pose difficulty due to their
limited solubility in common buffers.
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!
Figure!3.1:!Schematic representing protein vesicle formation. a) Oleosin protein mutants
were expressed recombinantly in E coli. An organic solution was used to extract and
purify protein from the inclusion bodies. Purified protein was injected into aqueous
solutions yielding self-assembled protein suprastructures. b) The P=65 family of mutants
was found to self-assemble upon solvent injection. This family contains identical
hydrophobic blocks and the length of the hydrophilic arms varies as indicated. Protein
variants are named by N-P-C, where N is the number of amino acids in the hydrophilic
N-terminus (blue N-terminal arm), P is the number of amino acids in the hydrophobic
core (red), and C is the number of residues in the hydrophilic C-terminus (blue Cterminal arm). Proteins are drawn to scale based on the number of amino acids in each
domain.
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3.3.2!Protein!expression,!purification,!and!identification!
Oleosin genes were created using standard recombinant techniques and cloned into the
expression vector, pBamUK for expression in the BL21 (DE3) strain of Escherichia coli
following induction with IPTG. Recombinant protein was found in inclusion bodies,
which were isolated using standard extraction techniques and repeatedly washed with a
high pH buffer to remove bound DNA from the positively charged hydrophilic arms.
Protein was extracted using monophasic mixtures of sodium carbonate (pH 11),
chloroform, and methanol as previously reported 27,28. Decreasing the size of the
hydrophobic core to P=65 amino acids from P=87 amino acids increased protein
expression 10-fold, and we obtained between 35-100 mg purified protein per liter of
culture, with yield increasing when N and C were longer. Protein purity exceeded 95%,
as assessed by SDS-PAGE followed by Coomassie staining (Figure 3.1a). Protein
homogeneity was examined by Western blotting using an anti- 6x-His tag antibody
(Figure 3.1b) and in all cases the bands displayed the expected molecular weight.
Molecular weights were confirmed by MALDI-TOF (Figure 3.2 C-G). The dual peaks
observed in mass spectroscopy were due to incomplete loss of the initiation methionine.33
Expression of oleosin in inclusion bodies presumably inhibits methionine aminopeptidase
from accessing the initiation methionine within the aggregated protein leading to partial
removal. Expected molecular weights with and without the methionine are compared to
the mass spectroscopy peaks in Table 3.1. In all cases, the expected protein mass with
and without the methionine matches very closely with the two peaks in the MALDI-TOF
spectra. No contamination peaks were observed in the spectra.
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!
Figure!3.2: Protein identification and MALDI-TOF spectra. a) Protein purity was
measured after organic solvent purification to be >95% with SDS-PAGE. b) Oleosin
mutant identity was confirmed through Western blotting using an anti-6-His antibody.
The lanes for both gels are (1) 42-87-57 (wild-type oleosin), (2) 43-65-33, (3) 33-65-23,
(4) 28-65-18, (5) 23-65-13. c-g) MALDI-TOF confirmed the molecular weights of the
protein mutants: c) 42-87-63 (wild-type oleosin), d) 43-65-33, e) 33-65-23, f) 28-65-18,
g) 23-65-13. Peak closely match expected weights of the protein mutants as seen in Table
3.1.
!
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Table!3.1:!Protein mutant properties and mass spectroscopy information!

!
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3.3.3 Surfactant protein self-assembly
The large hydrophobic core of oleosin limits its solubility in water, but since it is a
surfactant, the protein can stabilize emulsions. Following published procedures27,28, we
solubilized the recombinant proteins in an organic phase, choosing chloroform for its
volatility and consequent ease of removal. Injection of the protein in
Na2CO3:chloroform:methanol (1:1:8 v/v/v) into phosphate buffered saline (PBS) created
an oil-in-water single emulsion stabilized by the oleosin mutants. Brief sonication was
used to reduce the emulsion droplet size. As the chloroform phase in the emulsion
diffuses through the aqueous phase and evaporates, the local concentration of protein in
the emulsion increases forcing spontaneous protein budding and assembly similar to
polymer systems34,35. Cryo-TEM provided conclusive evidence of the morphology in
solution due to the instant vitrification of the sample (Figure 3.3). The buds self-assemble
to form higher surface area structures determined by protein sequence and solution
composition. By controlling the solvent ratios, buffer solution, and protein chemistry, we
were able to assemble nearly water-insoluble compounds into various self-assembled
structures in an aqueous environment through kinetic pathways. We found protein
!
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concentrations in the organic injection mixture exceeding 0.4 mg/ml led to aggregation of
the protein rather than self-assembly -- possibly because protein-protein interactions at
these concentrations overwhelmed the surface instabilities that initiate budding.

!
Figure!3.3:!Cryo-TEM micrographs of protein membrane formation. a) Cryo-TEM
micrograph of 23-65-13 emulsion droplet with vesicular buds on the surface in PBS. b)
Cryo-TEM micrograph of 33-65-23 showing budding from dried bulk protein in PBS.
Scale bars are 200 nm.

3.3.4!Morphology!control!
The morphology of the structures in solution was investigated using cryo-TEM. CryoTEM is a superior method for soft matter imaging 36-38, because unwanted rearrangement
of solution structure is avoided through rapid vitrification; whereas, freeze fracture TEM
fails to identify membranes and TEM with negative staining is associated with potential
staining artifacts 39. Protein suprastructures were observed in phosphate buffered saline
(PBS), a physiological buffer with an ionic strength of 140 mM. The cryo-TEM
!
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micrographs in Figure 3.4 (a-d) show a dark membrane and a lumen that is darker than
the surrounding solution representative of a bilayer vesicle 4. The smallest and most
hydrophobic mutant, 23-65-13, as well as a slightly less hydrophobic variant, 28-65-18,
were found to form both sheets and vesicles upon injection. The small size of the
hydrophilic head groups of these molecules lead to planar and curved lamellar packing
enabling the coexistence of sheets and vesicles. Increasing the head group size by an
additional five amino acids in each hydrophilic arm (33-65-23) led to the formation of
only vesicles, suggesting that the larger head group induced sufficient curvature to
prevent the formation of planar bilayers. The addition of ten more amino acids to each
hydrophilic arm, 43-65-33, also yielded vesicles; the increased hydrophilic head group
maintained curvature and did not hinder vesicle formation.

!
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Figure!3.4:!Cryo-TEM micrographs indicate vesicle formation across the entire P=65
family. All scale bars are 200 nm. a) 23-65-13 and b) 28-65-18 coexist as sheets (Figure
7) and vesicles in PBS (140 mM) after injection. c) 33-65-23 and d) 43-65-13 form
vesicles in PBS (140 mM).
The membrane thickness of vesicles formed by the proteins injected into PBS was
measured by cryo-TEM4. We found that the membrane thickness increases as a function
of the total molecular weight of the surfactant (Figure 3.5), even though the length of the
hydrophobic block remained unchanged. This effect is different than increasing
membrane thickness by increasing the hydrophobic block, which has been seen
previously in polymer systems40. In the absence of a crystal structure, modeling suggests
that the length of the hydrophobic domain of the wild type protein is ~6.0 nm20; the
hydrophobic block of the P=65 family may be estimated to be ~5.2 nm long. The
measured membrane thickness of 23-65-13 is 6.2 ± 0.1 nm, implying that the two
hydrophobic domains are highly interdigitated, similar to a zipper. A further increase in
!
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the size of the hydrophilic arms (43-65-33) increased the membrane thickness to 8.6 ± 0.4
nm. In various macromolecular amphiphilic systems, the hydrophilic arms are wellsolvated and are not directly visible in cryo-TEM due to the lack of contrast37. Our
system, however, is composed of protein hydrophilic arms possessing secondary
structure, which potentially provides contrast through phase-contrast mechanisms in
cryo-TEM37. Further, the hydrophilic arms contain multiple electron-dense Tyr and Met
residues, which could enhance mass-thickness contrast. It is unclear if the electron-dense
amino acids combined with secondary structure in the hydrophilic arms contribute visible
contrast in the micrographs or if the hydrophilic arms are well-solvated and not visible in
the micrographs. If the hydrophilic arms contribute contrast, an increase in membrane
thickness with increasing hydrophilic block size is easily rationalized. If the hydrophilic
arm is well-solvated and diffuse, it is conceivable that the hydrophobic core becomes less
interdigitated (i.e., expands) as the hydrophilic arms increase in size. Either or both of
these explanations could lead to increased apparent total membrane thickness.
Distinguishing the relative contributions of these two possibilities would need further
work, perhaps using scattering methods.
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!

!
Figure!3.5:!Increasing the molecular weight of protein at constant hydrophobic block
length increases the hydrophilic block fraction and leads to thicker vesicle membranes as
measured through Cryo-TEM. Protein hydrophilic fraction: 23-65-13: 35.4%, 28-65-18:
41.4%, 33-65-23: 46.3%, and 43-65-33: 53.9%. Error bars represent one standard
deviation (N=6).
The phase behavior of the protein surfactants likely depends on the total molecular
weight, hydrophilic block fraction, ionic strength and pH of the buffer, secondary
structure of the protein, specific amino acid interactions, and protein concentration. The
hydrophilic block fraction of each protein was estimated by the number of amino acids in
the hydrophilic arms divided by the total number of amino acids in the molecule.
Increasing ionic strength of the solution will screen electrostatic interactions. Since the
hydrophilic arms contain distributed positive and negative amino acids throughout the
sequence, it is difficult to predict the effectiveness of charge shielding, but the phase
!
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behavior can be readily assessed by experiment. We detected a general trend in the
structural transition of self-assembled oleosin structures from lamellar phases to vesicles
as the ionic strength of the surrounding solution was increased (Figure 3.6). In deionized
water, 23-65-13 and 28-65-18 formed exclusively sheets while 33-65-23 and 43-65-33
formed only fiber-like structures. The fiber structures were >20 nm in thickness
indicating that the packing was similar to the previously reported lamellar packing in
block copolypeptide fibers 41 rather than that in high-curvature worm-like micelles. 4365-23 and 33-65-23 display a coexistence of fibers and vesicles when the ionic strength is
increased to 35 mM and a single vesicle phase in 70-140 mM ionic strength solutions.
For the smaller head group sized proteins, 23-65-13 and 28-65-18, it was not until the
ionic strength reached 140 mM that vesicles were seen. This finding reasonably suggests
that proteins with smaller head groups prefer to pack into lower curvature sheets.
Representative micrographs of the three phases are shown in Figure 3.6 (b-d). Cryo-TEM
micrographs for each point in Figure 3.6 (a) can be found in Figure 3.7. The large
regions of coexistence between phases suggest the multiple effects of the many
parameters that affect assembly such as molecular weight, hydrophilic fraction,
isoelectric point, pH, and protein concentration. We have shown how hydrophilic block
fraction and ionic strength can be varied to systematically alter the structure of the
assemblies.
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!
Figure!3.6:!!a) The phase behavior of the P=65 family was explored as a function of
hydrophilic fraction and ionic strength of the buffer. The diagram shows three phases,
vesicles, sheets, and fibers, as well as coexistence phases. Figure 3.7 shows cryo-TEM
micrographs for each phase point on the diagram. b,c,d) Representative micrographs of
fibers (43-65-33 in DI water), sheets (23-65-13 in 1x PBS), and vesicles (43-65-33 1x
PBS) are shown. All scale bars are 200 nm.
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!
Figure!3.7:!Phase behavior of the -65- family in various ionic strength buffers. a-f) 4365-33 and g-l) 33-65-23 shift from fibers in DI water and 14 mM ionic strength solution
to fibers and vesicles in 35 mM ionic strength solution to only vesicles in 70-140 mM
ionic strength solutions. m-r) 28-65-18 and s-x) 23-65-13 exist as sheets in 0 mM, 14
mM, 35 mM, and 70 mM ionic strength solutions and coexist as sheets and vesicles in
140 mM ionic strength solutions. Background colors match phase mapping in Figure
3.6. Scale bars are all 200 nm.
!
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3.3.5!Protein!secondary!structure!
Modeling has suggested that the hydrophobic block of oleosin is helical, possibly a
coiled-coil20. Helical polypeptides prefer to align along the helical axes42, creating rigid
chain conformations. The resulting rigid packing of the hydrophobic block as well as
interactions between chains leads to the formation of low curvature structures explaining
the lack of higher curvature spherical and worm-like micelles43. This suggests that
increases in ionic strength would decrease the rigidity of the helical blocks by softening
interactions in the hydrophilic arms, allowing proteins to shift from planar lamellar
alignments in the fibers and sheets to curved lamellar alignments in vesicles.

Given the variety of assemblies formed by the mutant oleosins, we investigated
whether the structure of the assembly could be related to the secondary structure of the
constituent proteins. We analyzed secondary structure using CD spectroscopy. Since
the proteins are insoluble in a pure aqueous phase, and chloroform could not be used as a
co-solvent because of its absorption at far-UV wavelengths (thus interfering with the
spectroscopy) protein samples were resuspended in 50/50 trifluoroethanol:water (v/v).
CD data were fit to a reference set of 48 proteins31 using Dichroweb30 software and the
CDSSTR analysis method32 (Figure 3.8 a). The fits to the spectra were very good and
provided an estimate of the relative contributions of different characteristic secondary
structural motifs (Figure 3.8 b). Spectral curves show that all mutant proteins studied
exhibited secondary structure after exposure to organic solvents during purification.
Decreasing the length of the hydrophilic arms and the hydrophobic core leads to
!
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increasing alpha-helical structure compared to the wild-type protein, but all the members
of the P = 65 family retained similar secondary structure. Since members of this family
exhibited widely variable self-assembly, this suggests that changes in secondary structure
are not responsible for the changes in the structure of the corresponding suprastructures
in this family of molecules.

!
Figure!3.8:!a) Far-UV circular dichroism spectra of wild-type oleosin and the P=65
mutants. Solid lines represent fits calculated with DichroWeb software. The fits match
experimental data very well allowing for prediction of overall secondary structure. b)
Estimation of secondary structure of wild type oleosin and the P=65 mutants. The P=65
family show similar secondary structure, although mutants show increased alpha-helical
structure compared to wild-type oleosin. Morphological differences seen between
protein mutants are not attributable to changes in the secondary structure of the proteins
across the P=65 family.

3.3.6 Giant oleosin vesicles
In order to visualize the membrane better and to investigate the ability of the
vesicles to sequester solutes, giant vesicles (> 1 µm in diameter) were created with
recombinant 33-65-23 using phase-separated double emulsions. Protein solubilized in
Na2CO3:chloroform:methanol (1:2:7 v/v/v) was injected into PBS, resulting in
!
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spontaneous water-in-oil-in-water (W/O/W) double emulsions confirmed by dual
encapsulation of Nile Red and calcein that were added to the injection mixture (Figure
3.9 a,b). As organic solvent evaporated from the double emulsion, the hydrophobic dye
Nile Red sequestered into the hydrophobic core of the membrane whereas the hydrophilic
calcein remained in the hydrophilic lumen (Figure 3.9 c,d). Laser scanning confocal
microscopy was used to image the original double emulsions and the vesicles created
after solvent evaporation. The ability to encapsulate hydrophobic dye in the membrane
and hydrophilic dye in the lumen suggests the assembly of bilayer vesicles on the micron
scale, consistent with the formation of vesicles on the nanometer scale.

Figure!3.9: a,b) Giant bilayer vesicles evolve from phase separated double emulsions.
Protein solutions in organic mixture B (see Methods) were injected into PBS resulting in
a phase separated water-in-oil-in-water (W/O/W) double emulsion. Nile Red and calcein
are loaded into the organic injection mixture and partition into the appropriate phases.
Scale bars = 50 µm. c,d). The organic middle phase evaporates leading to sequestering of
Nile Red into the hydrophobic membrane and calcein into the hydrophilic lumen. Scale
bars = 5 µm.
!
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3.4!Conclusions!
Recombinant proteins hold the promise of making designer surfactants with precise
chemical sequences. We employed emulsions of tailored composition to self-assembly
largely water-insoluble amphiphilic proteins through kinetic pathways. Such a strategy
could be used to assembly other low solubility surfactants. Using recombinant oleosins,
we have demonstrated that engineered recombinant surfactant proteins can yield a
fascinating variety of self-assembled structures in solution, including vesicles, at both the
nano- and micro- scales. In making vesicles, we found that increasing the length of the
hydrophilic arms while keeping the length of the central hydrophobic block constant
altered the membrane thickness of the vesicles. By varying both the ionic strength of
solution and the molecular weight (hydrophilic fraction) of the protein, we could control
the phase behavior of the assemblies. The oleosin mutants possess helical hydrophobic
blocks which likely drive lamellar membrane packing. However, significant changes in
suprastructure morphology are seen without changes in the protein secondary structure.
Giant vesicles were also made, creating a platform for macroscopic measurements in
future studies, such as micropipette aspiration to assess membrane material properties.
We envision using oleosin and its mutants to a make a wide variety of materials with
biological activity: examples include adding terminal adhesive domains that bind to cell
surface receptors for vesicle targeting; protease recognition sites that could mediate
protease-induced disintegration; and self-assembly motifs driven by coiled-coil assembly
and ionic concentration. Therefore, recombinant oleosin has significant potential for
making assembled structures of designer biofunctionality.
!
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Chapter 4
Spherical Micelles Assembled from
Soluble Recombinant Oleosin
Mutants
The work presented in this chapter is submitted for publication with the following
reference: K. B. Vargo, N. Sood, T. D. Moeller, P. A. Heiney, & D. A. Hammer,
Spherical micelles assembled from soluble recombinant oleosin mutants. Submitted for
Publication 2014,.

The work is protected under the international patent WO

2012/097220.

Abstract
An emerging field in biomaterials is the creation and engineering of protein surfactants
made by recombinant biotechnology. Biomaterials made from self-assembled
recombinant proteins allow for complete control of the surfactant chemistry. The proteins
are uniform and monodisperse in molecular weight and functionalization with amino acid
77

sequences is straightforwardly achieved by genetic engineering. We modified the
naturally occurring amphiphilic plant protein oleosin by truncating a large portion of its
central hydrophobic block creating a soluble triblock surfactant. Additional mutants were
constructed to eliminate secondary structure and create ionic surfactants. Oleosin
surfactant mutants assembled into spherical micelles with a diameter ~21 nm above a
critical micelle concentration. We found that the critical micelle concentration could be
manipulated through changes in the protein backbone and were correlated with changes
in the protein secondary structure. Micelle size and shape is characterized with dynamic
light scattering (DLS), small angle X-ray scattering (SAXS), and cryogenic transmission
electron microscopy (cryo-TEM). Micelles were functionalized with the integrin-binding
domain, RGDS, leading to a 2.9 fold increase in uptake in Ovcar-5 cells after 12 hours.
Oleosin surfactants present a promising platform for micellar assembly because of the
ability to precisely modify the protein backbone through molecular biology allowing for
control over the CMC and addition of functional domains into the material.
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4.1 Introduction
Surfactants are molecules of key importance in the food, chemical and pharmaceutical
industries. Some families of surfactants are known to self-assemble into various
structures in solution as a function of molecular weight, chemistry, and solvent. One
such structure, the spherical micelle, provides an ideal system for the entrapment of
hydrophobic compounds in their hydrophobic core, which is surrounded by a solvated
corona. Micelles are traditionally assembled from amphiphilic surfactants such as lipids
or diblock copolymers, but herein we describe an approach of assembling spherical
micelles from protein amphiphiles made by recombinant biotechnology.1,2

Molecular biology provides the ability to control the precise sequence of amino
acids in the surfactant. Such precision is tantamount to control of the type and position of
monomers in a polymer chain, while simultaneously ensuring that each polymer is the
same molecular weight. Also, the sequence of amino acids is a unique identification
sequence for lock and key binding, and recombinant methods allow for direct
incorporation of biological motifs at any point in the protein backbone.

Diblock elastin-like polypeptides (ELPs) have been used as building blocks for
the formation of nanoparticles from recombinantly produced polypeptide.3-6 ELPs display
a lower critical solution temperature (LCST), above which the polypeptide precipitates
out of solution. ELP diblocks are created by fusing two blocks together with differing
LCSTs. Manipulating the chemistry and length of the blocks can yield a material that
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when exposed to an intermediate temperature, one block precipitates out of solution
while the other remains soluble, leading to the formation of nanoparticles. Recent work
has shown that assembly can be controlled through the conjugation of hydrophobic
moieties to an asymmetric ELP diblock.7 In many cases, the core of the ELP micelle is
highly solvated, as shown by a pyrene assay, potentially limiting the hydrophobicity of
the cargo.8

Here we present an alternative, using nature as a template we engineered the
natural surfactant protein oleosin to self-assemble in solution. Oleosin is a protein from
plants that stabilizes oil bodies in seeds.9 Oleosin has been expressed recombinantly and
used as a surfactant,10-16 but little engineering has been completed to optimize it for selfassembly. The native structure is defined in three domains: an N-terminal hydrophilic
arm, a central hydrophobic domain, and a C-terminal hydrophilic arm.17,18 A proline knot
in the core of the hydrophobic domain forces a 180° turn leading to a hairpin like
structure.9,19-21 Models have estimated the hydrophobic core to have significant helical
structure19. Previously, we have shown that a family of oleosin mutants produced by
recombinant methods, where the center block was truncated, and the hydrophilic arms
varied in length will self-assemble from the surface of an emulsion into fibers, sheets, or
vesicles, based on the hydrophilic fraction of the protein and the solution ionic strength.16
Thus, oleosin has proven a versatile surfactant that can be expressed recombinantly and is
amenable to engineering.
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Our goal in the current work was to remove the secondary structure of oleosin to
create a surfactant that possesses the structure of a random coil and is capable of selfassembly in solution. Previous work has shown that oleosin remains surface active at
oil/water interfaces when large portions of the hydrophobic domain are removed.22 In
order to abolish the secondary structure of the protein, we removed a large portion of the
hydrophobic domain including the elimination of cross chain hydrogen bonds through
threonines, which have been hypothesized to generate secondary structure in previous
models.19 Three additional mutants were made from the base protein to explore the
function of secondary structure and charge on the self-assembly behavior. The soluble
mutants self-assemble into spherical micelles as a function of concentration, and pyrene
was used to determine the critical micelle concentration. Micelle size was determined
with dynamic light scattering and small angle X-ray scattering. Assemblies were directly
visualized with cryogenic transmission electron microscopy. We demonstrate the
simplicity of functionalizing the micelles by adding the integrin binding peptide, RGDS,
to the C-terminus. This peptide increased the uptake of micelles three fold in Ovcar-5
cells after a 12 hour incubation. These studies demonstrate the potential for oleosin
mutants to have a major impact in the design of functional protein micelles.

4.2 Materials and Methods
Gene creation and expression
The sunflower seed oleosin gene was provided as a gift from Dr. Beaudoin at Rothamsted
Research, Hampshire, England. Sequential rounds of PCR were used to create the
mutated genes. Mutants were created using sequential PCRs. Primers can be found in
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Appendix 1. Oleosin-30 was created using 42-87-63 as a template. Oleosin-30G and
oleosin-30-RGDS was created using oleosin-30 as a template. The five glycines were
added in using the following oligo as a PCR template: 5’ –
CTCGCTCTCGGTGCGACTCCGCTGTTTGGTGTTATAGGTTTCAGCCCTGTTATT
GTTCCAGCGATGGGTATAGCGATTGGGCTTGCGGGTGTTACCGGGTTTCAG –
3’. Oleosin-30 and oleosin-30G were created by combining individual PCR products for
each domain: the N- and C-terminal arms and the hydrophobic core. The charged
mutants were created using Oleosin-30G as a template. The charged mutants and
oleosin-30-RGDS were created using extending sequential PCRs. The genes for were
inserted into the expression vector pBamUK, a pET series derivative constructed by the
Duyne Laboratory (SOM, Penn). Mutants were confirmed through DNA sequencing prior
to protein expression. pBamUK adds a 6-Histidine tag to the C-terminus of the protein
for IMAC purification. Protein was expressed in the E. Coli strain BL21 DE3
(Stratagene) controlled by the lac promoter. Cultures were grown at 37°C in Luria
Bertani (LB) with kanamycin at a final concentration of 50 µg/ml until OD600≈0.7.
Protein expression was induced with isopropyl β-D-thiogalactoside (IPTG) to a final
concentration of 1.0 mM. Cells were harvested by centrifugation; cell pellets were frozen
at −20 °C prior to purification.

Protein Purification
Oleosin-30G(-) was the only mutant expressed solubly; Oleosin-30, Oleosin-30G,
Oleosin-30G(+), and Oleosin-30-RGDS were all expressed in inclusion bodies. B-PER
protein extraction agent (Fisher Scientific) was used for protein purification following the
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manufactures’ protocol for soluble or inclusion body purification respectively. Briefly,
pellets were resuspended in B-PER (30 ml B-PER per liter of culture) and DNAse was
added to a final concentration of 0.7 µg/ml. The resuspended pellets were centrifuged at
15,000 g for 15 minutes. The supernatant of Oleosin-30G(-) was collected and added to
an equilibrated Ni-NTA column (Hispur Ni-NTA resin, Thermo Scientific) and allowed
to bind for >1 hour while the supernatant of the other mutants was discarded. Inclusion
body purification only: The remaining inclusion body pellet was suspended in denaturing
buffer (8M urea, 50 mM phosphate buffer, 300 mM NaCl). The solution was centrifuged
at 15,000 g for 15 minutes and the supernatant was added to an equilibrated Ni-NTA
column. Protein was allowed to bind to the column for >1 hour and washed three times
with denaturing wash buffer (denaturing buffer with 20 mM imidazole). Protein
refolding was accomplished by diluting the column 50 times with refolding buffer (50
mM phosphate buffer, 300 mM NaCl, 5% by volume glycerol, 4°C) and rocked at 4°C
for >1 hour. All mutants: Ni-NTA columns were washed extensively with wash buffer
(50 mM phosphate buffer, 300 mM NaCl, 20 mM imadzole) and eluted in fractions with
elution buffer (50 mM phosphate buffer, 300 mM NaCl, 300 mM imidazole). The
concentration of each elution fraction was measured with a Nano-Drop 1000 (Thermo
Scientific). Buffer exchanges were completed with dialysis or using centrifugal filters
(Amicon Ultra, 3 kDa, Millipore). All analysis was completed in 50 mM phosphate,
140mM NaCl unless otherwise noted.

SDS-PAGE
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SDS/PAGE gels were run on NuPAGE Novex 4–12% Bis-Tris mini gels (Invitrogen) in
MES buffer. Following electrophoresis, the gel was stained with SimplyBlue SafeStain
(Invitrogen). The gel was destained and imaged with a Kodak Gel Logic 100 Imaging
System.

Matrix Assisted laser desorption/ionization time of flight mass spectroscopy (MALDITOF)
Protein molecular weight was confirmed with MALDI-TOF. Sample spots were created
with 0.5 µl protein in 1x PBS and 0.5 µl saturated sinapinic acid solution (50/50
acetonitrile/water + 0.1% TFE). Spectra were collected on an Ultraflextreme MALDITOF (Bruker, Billerica, MA).

Circular Dichroism (CD)
Far-UV CD spectra were collected at 25 °C on an AVIV 410 spectrometer (AVIV
Biomedical Inc.) using a 1 mm quartz cell. Protein concentration was 15 µM in 50 mM
phosphate, 140 mM NaF. NaF was used to replace NaCl due to the strong absorbance of
the Cl- ion.

Dynamic Light scattering (DLS)
Dynamic light scattering of protein solutions was performed on samples at 30 µM using a
Malvern Zetasizer Nano ZS (Westborough, Massachusetts). Each sample was run in
triplicate.
Small Angle X-Ray Scattering (SAXS)
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Protein micelle solutions were loaded into 1 mm glass capillaries (Charles Supper
Company, Natick, MA) at a concentration of 15 mg/ml and sealed on both ends. The Xray scattering setup uses Cu Kα X-rays from a Nonius FR-591 rotating-anode generator
operating at 40 kV and 85 mA. Osmic Max-Flux optics and triple pinhole collimation
were used to obtain a highly collimated beam under vacuum. Data were collected using a
Bruker Hi-Star multiwire detector with a sample detector distance of 150 cm for 2.5
hours each. The data reduction and analysis were performed using Datasqueeze
software.23 Background scattering from a capillary filled with pure buffer was subtracted
from the sample scattering.

Pyrene Assay (CMC)
The fluorescence probe pyrene was used to determine the critical micelle concentration
(CMC). 7 µl of a 12 mM pyrene (Sigma-Aldrich; St. Louis, MO) in ethanol was added to
20 ml of 50 mM phosphate, 140 mM NaCl. 100 µl of the phosphate pyrene solution was
added to low volume cuvettes. High concentration protein stock solutions were used to
create a dilution series. Pure buffer was added to each cuvette to bring the total volume
to 700 µl maintaining an equal pyrene concentration in each cuvette. Cuvettes were
scanned with an excitation of 334 nm and an emission of 360-400 nm (excitation slit: 3
nm, emission slit: 3 nm) using a Fluoromax-4 spectrophotometer (Horiba Jobin Yvon).
The intensity of the first and third peak, I1 and I3, was determined as the maximum from
369-374 nm and 380-384 respectively. The ratio I1/I3 was plotted as a function of oleosin
concentration. The CMC was determined as the inflection point of the best-fit sigmoidal
curve.
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Cryogenic Transmission Electron Microscopy (Cryo-TEM)
Cryogenic transmission electron microscopy was performed at the University of
Pennsylvania in the Nanoscale Characterization Facility (Philadelphia, PA). Lacey
formvar/carbon grids (Ted Pella) were washed in chloroform to remove the formvar
template and carbon coated with a Quorum Q150T ES carbon coater (Quorum
Technologies, United Kingdom). Grids were cleaned with hydrogen/oxygen plasma for
15 seconds using the Solarus Advanced Plasma System 950 (Gatan, Pleasanton, CA). A
sample in the form of a 2 µl drop was deposited onto the grid and added to a Gatan Cp3
cryoplunger (Gatan, Pleasanton, CA). The samples were blotted by hand and plunged
into liquid ethane. Grids were transferred to a Gatan CT3500TR cryoholder (Gatan,
Pleasanton, CA) and immediately inserted into a JEOL 2100 HRTEM (JEOL, Tokyo,
Japan) operating at 80 keV. Micrographs were imaged with an Orius SC200 digital
camera.

Protein labeling and calibration curve
Protein was directly labeled with the amine reactive fluorophore Dylight 488 NHS-ester
(Pierce/Thermo Scientific) using the manufacturer’s protocol. Excess dye was removed
using centrifugal filters (Amicon Ultra, 3 kDa, Millipore) until the flow through
fluorescence was undetectable. Labeled protein concentration was calculated according
to the labeling protocol. A calibration curve was generated to correlate the fluorescent
signal from Oleosin-30 and Oleosin-30-RGDS to protein concentration to account for
differences in the degree of labeling. A dilution series was created in 50 mM phosphate,
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140 mM NaCl. Fluorescent spectra were taken (λex = 493 nm, λem = 500 – 600 nm) and
the peak intensity was plotted as a function of concentration. The calibration curves were
used to correlate fluorescence measurements taken of the lysed cells to the amount of
protein in each cell.

Cell Line
NIH:OVCAR-5 (OVCAR-5) cells were obtained from the NIH and maintained in
RPMI 1640 media (Invitrogen) supplemented with 10% fetal bovine serum (Sigma) and
1% penicillin/streptomycin (Invitrogen).

In vitro cell internalization
OVCAR-5 cells were plated in RPMI 1640 media (10% FBS, 1% Pen/Strep) and
grown until they reached 60% confluence. Once confluent, the cells were rinsed with
RPMI 1640 media (no serum) and treatment media containing either no micelles, 8 µM
of Oleosin-30, or 8 µM Oleosin-30-RGDS in low serum RPMI 1640 media (5% FBS, 1%
Pen/Strep) was added. Following the internalization period (3 or 12 hours), the cells were
rinsed three times with RPMI 1640 media (no serum), trypsinized (0.05% trypsin,
Invitrogen), and counted using a Z1Coulter Particle Counter (Beckman Coulter). The
trypsinized cells were transferred to a conical tube and centrifuged at 1200 RPM for 5
minutes to pellet the cells. The cell pellet was collected and resuspended in 1mL of 50
mM phosphate, 140 mM NaCl. In order to obtain the complete unquenched fluorescent
signal from internalized micelles, the cells were lysed by freezing in liquid nitrogen.
After thawing the lysed cells, the fluorescent signal from the micelles was detected via
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fluorescence (λex = 493 nm, λem = 500 – 600 nm) using a Fluoromax-4 spectrophotometer
(Horiba Jobin Yvon). The internalization study was performed in triplicate.

4.3 Results and Discussion
4.3.1 Gene design and expression
The naturally occurring 20-kDa wild-type sunflower seed oleosin has 87 amino acids in
the hydrophobic block. The hydrophobic block was truncated by 57 amino acids leaving
30 amino acids in the hydrophobic core, creating a variant we designate as oleosin-30
(Figure 4.1). This family of molecules can be thought of as a triblock N-P-C surfactant
protein, where N and C are hydrophilic and P is hydrophobic. Five glycines were added
into the hydrophobic block of oleosin-30 creating oleosin-30G. The glycines were
positioned such that a proline or glycine was present every four amino acids providing
increased flexibility to the hydrophobic domain (Figure 4.1). Cationic and anionic
mutants of oleosin-30G were cloned by mutating the hydrophilic arms to contain only
positive or negative charges creating oleosin-30G(+) and oleosin-30G(-) respectively
(Figure 4.1). The mutants were created such that the naturally charged amino acids were
replaced to create all positive or all negative mutants. Tyrosines were also removed from
the hydrophilic arms and replaced with Asn or Gln removing all aromatic groups from
the hydrophilic portions of the protein. Charge was distributed throughout the
hydrophilic arms with an average charged residue every six amino acids.
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Genes were cloned into the expression vector pBamUK for expression in the
BL21 (DE3) strain of Escherichia coli. pBamUK adds a 6-histine tag on the C-terminus
for purification through immobilized metal affinity chromatography (IMAC). All mutants
were expressed in inclusion bodies, except for oleosin-30G(-), which was expressed
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solubly. Protein mutants were purified using IMAC. Protein yields were ~15 mg
(oleosin-30), ~25 mg (oleosin-30G), ~18 mg (oleosin-30G(+)), and ~80 mg (oleosin30G(-)) of purified protein per liter of culture. Mutants were highly soluble in buffered
solutions (pH 7.4) and the charged mutants were extremely stable at high concentrations
(>100 mg/ml). Protein purity was >95% as assessed by SDS-PAGE electrophoresis with
Coomassie Blue staining (Figure 4.3 A). Molecular weights were confirmed with
MALDI-TOF (Figure 4.2) (oleosin-30 expected: 14677 Da, measured: 14667 Da,
oleosin-30G expected: 15025 Da, measured: 15022 Da, oleosin-30G(-) expected: 14995
Da, measured: 14954 Da, oleosin-30G(+) expected: 14977 Da, measured 14979 Da).
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Figure 4.2: Mass spectra of A) Oleosin-30, B) Oleosin-30G, C) Oleosin-30G(-), and D)
Oleosin-30G(+). Expected and measured masses can be found in Table 4.1.

90

4.3.2 Protein secondary structure
Reports on the secondary structure of oleosin have been contradictory.16,17,19,24-26
Modeling has shown the hydrophobic domain to fold into a coiled-coil domain.19 Recent
work suggests that oleosin maintains a beta sheet structure in oil bodies.24 It is unclear
what structure oleosin adopts in aqueous environments due to its low solubility.
Previously, we demonstrated that truncating the hydrophobic block of oleosin from 87
amino acids to 65 amino acids creates a structure with high alpha-helical content in a
buffer of 50:50 TFE:water, a buffer that promotes alpha helical structure. The role of the
oleosin secondary structure in self-assembly is unclear, although it is hypothesized that
strong helical character limited self-assembly to low curvature structures due to strong
helix-helix interactions.16,27

One goal of our work was to eliminate the secondary structure of oleosin to create
a protein surfactant that acts as a random coil in solution removing the unknown effects
of the secondary structure on assembly. The hairpin in oleosin has been hypothesized to
fold due to hydrogen bonding between the two arms of the molecule.19 By significantly
truncating the hydrophobic domain, we eliminated the hypothesized cross-chain
hydrogen bonding (bridges T63-T104-T108 and T67-T97-T101) (Figure .41). Protein
secondary structure was elucidated using circular dichroism (Figure 4.3 B). The spectra
were fit with the CDSSTR analysis method using Dichroweb (Figure 4.3 C).28-30
Analysis of the CD spectra shows almost no helical character in the variants. The
removal of 65% of the hydrophobic domain in oleosin-30 leads to ~50% unordered
91

structure with ~20% beta sheet remaining in the protein. The addition of five glycines
into the hydrophobic block in oleosin-30G creates a random coil polypeptide with ~65%
of the backbone in an unordered structure. Surprisingly, the cationic and anionic mutants
show drastically different secondary structure. oleosin-30G(+) is ~60% unordered
whereas oleosin-30G(-) has a large portion of its backbone committed to turns in the
protein. The proline knot remains in all mutants, but it is unclear if a full 180° turn exists
in the molecule. It is likely that without the hydrogen bonds in the hydrophobic core to
stabilize the turn, the molecule exists in a more flexible form, rather than a hairpin seen in
the naturally occurring protein, allowing for the high curvature assemblies.
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Figure 4.3: A) SDS-PAGE gel shows >95% purity after IMAC purification for all
mutants. Lane 1: oleosin-30, lane 2: oleosin-30G, lane 3: oleosin-30G(-), lane 4: oleosin30G(+). B) CD spectra of the four oleosin mutants at 15 μM. C) CDSSTR analysis of
the CD spectra show that oleosin-30 and oleosin-30G(-) display more confined structures
compared to the nearly unordered structures of oleosin-30G and oleosin-30G(+).

4.3.3 Pyrene Assay
The critical micelle concentration (CMC) for protein assemblies was determined using
the fluorescent probe pyrene.31 Pyrene preferentially partitions into non-polar
environments and the ratio of the first and third emission peaks (I1/I3) incrementally
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decreases as a function of the local polarity.31,32 The I1/I3 ratio decreased as a function of
concentration for oleosin solutions indicating the formation of a hydrophobic core
(Figure 4.4). The profiles were fit with a Sigmoidal-Boltzmann equation (SBE),
!!
!!

= !!exp

!! !!!
!!!! /∆!

+ !!

(4.1)

where ai and af are the initial and final asymptotes of the sigmoid respectively, x0 is the
inflection point of the curve, and Δx is the independent variable interval x.33 It has been
shown that this method can yield two CMCs, one at x0 and one at x0+2Δx depending on
the ratio of x0/Δx. For all curves, the ratio x0/Δx<10, therefore the CMC is the
concentration at the inflection point.34 oleosin-30 micelles display high thermodynamic
stability with a CMC of 5.7 µM.

The oleosin-30G mutant displays two aggregation concentrations. The lower
concentration is thought to be a nucleation concentration where multimers assemble but
do not pack efficiently enough to expel all of the water. This can be seen as the shoulder
in the I1/I3 curve for oleosin-30G (Figure 4.4 A). We hypothesize that the presence of the
nucleation concentration is due to the increased disorder in the hydrophobic block from
the glycine additions. As concentration is increased, the protein surfactants pack in a way
to expel the majority of the water leading to the second aggregation concentration, termed
the micelles maturation concentration.
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Figure 4.4: Pyrene fluorescence is used to calculate the CMC for surfactant selfassembly. The ratio of the first and third fluorescence peaks (inset) is plotted as a
function of concentration and the inflection point is the CMC. A) oleosin-30 (blue) shows
a single inflection point whereas oleosin-30G (red) displays two inflection points, a
nucleation point at a low concentration and a micellar maturation point at higher
concentration. The addition of the five glycines is hypothesized to provide increased
flexibility to the hydrophobic domain allowing for assembly at lower concentrations. B)
As expected, the charged arms of oleosin-30G(+) (red) increase the concentration at
which the micelle hydrophobic core matures as indicated by the broad shoulder in the
curve. Surprisingly, the shoulder for oleosin-30G(-) (blue) is narrower than oleosin-30G
indicating that the hydrophobic core develops at lower concentrations as seen by the shift
in the second inflection point.

By charging the hydrophilic arms, it was anticipated that the maturation
concentration would increase due to the electrostatic repulsions opposing the
hydrophobic forces driving assembly. The ionic mutants show similar nucleation
concentrations and as expected the maturation concentration of oleosin-30G(+) increased
by 6-fold compared to oleosin-30G. Surprisingly, oleosin-30G(-) displayed a lower
maturation concentration than oleosin-30G. The values for each inflection point can be
found in Table 4.1.
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Table 4.1: Protein mutant and micelle characterization
Protein
Expected-MW-(g/mol) Measured-MW-(g/mol) Inflection-point-1-(μM) Inflection-point-2-(μM) Hydrodynamic-Diameter-(nm)
42B30B63
14677
14667
B
4.1
21.52
42B30GB63
15026
15022
0.09
11.3
20.77
42B30GB63-(B)
14955
14954
0.15
7.2
20.68
42B30GB63-(+)
14977
14979
0.1
61.3
18.9

PDI
0.086
0.139
0.165
0.289

To investigate the discrepancy between oleosin-30G(-) and oleosin-30G, we
studied the protein secondary structure as a function of concentration. The secondary
structure of oleosin-30G(-) does not significantly change between 3-20 µM whereas the
secondary structure of oleosin-30G becomes restricted losing much of its unordered
character as the concentration is increased from 5 µM to 25 µM (Figure 4.5). Mutants
that display restricted structure at low concentration, oleosin-30 and oleosin-30G(-), will
mature into micelles at lower concentrations compared to proteins that display pure
random coil structure at low concentrations, oleosin-30G and oleosin-30G(+), due to the
additional conformation entropy in the random coil mutants. This indicates that the
protein must conform to a more restricted structure to proceed through the maturation
aggregation concentration and fully assemble into a micelle.
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Figure 4.5: Concentration dependent CD spectra. A) CD spectra of oleosin-30G(-) at
various concentrations. B) CDSSTR analysis of the CD spectra of oleosin-30G(-)
indicates no change in structure as a function of concentration. C) CD spectra of oleosin30G at various concentrations. D) CDSSTR analysis of the CD spectra of oleosin-30G
indicates that the protein transitions from an unordered polypeptide to a more confided
structure with increasing concentration. It is hypothesized that the confined structure is
needed to mature the hydrophobic core of the micelles and is directly related to the
pyrene data discussed in Figure 4.4.

The I1/I3 ratio is a direct indication of the polarity of the environment inside the
micelle.32,33 The lower the I1/I3 ratio, the more hydrophobic the micellar core. Pure
hydrocarbon solvents have an I1/I3 ratio of about 0.6, polar solvents vary between 1.252.00, and micellar systems have an I1/I3 ratio that range from 1.1-1.5.32,33 ELP spherical
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micelles have an I1/I3 minimum of about 1.55 indicating a very polar core.8 The oleosin
spherical micelles’ I1/I3 ratio falls to 1.05 indicating an extremely hydrophobic core
creating a more stable environment for nonpolar encapsulates. The I1/I3 ratio minima
difference between ELP and oleosin micelles can be attributed to the head group size.32,35
Diblock ELPs have much larger head groups than oleosin, which leads to lower
interfacial compactness allowing for water to penetrate more deeply within the micelle.
The oleosin head group is much smaller and composed of two arms likely leading to a
more compact interface limiting water penetration.

4.3.4 Micelle characterization
Micelle size was measured with small angle X-ray scattering. The scattering profile of
concentrated solutions of oleosin-30 micelles were fit to a Rayleigh function, which
assumes spherical particles with uniform electron density. Datasqueeze was used to
calculate the fits for the SAXS profiles.23 Good agreement was found with a model
consisting of the sum of a polynomial (representing a smooth background) and a
Rayleigh function36 (which models spherical particles with uniform electron density).
The momentum parameter Q=(4π/λ)sin θ was used as the independent parameter for the
least squares fits. Fit parameters can be found in Tables 4.2 and 4.3. The fit yielded an
average diameter of 23.0 nm (Figure 4.6 A). Oleosin-30 micelles were directly
visualized with cryogenic transmission electron microscopy (Cryo-TEM). Proteins
inherently have low electron density due to the lack of high atomic number elements
leading to low contrast in TEM. Therefore, samples were imaged at 80 keV to increase
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contrast between the protein micelles and the external buffer solution at the expense of
resolution. In agreement with X-ray scattering, micrographs show monodisperse spheres
in solution with an average core diameter of 18.4±1.6 nm (standard deviation of the
mean, n=30) (Figure 4.6 B). We expect the diameter measured from cryo-TEM
micrographs to be slightly smaller due to any hydration of the shell and the resolution
sacrifice from operating at 80 keV.

Table 4.2: Datasqueeze fit parameters for Oleosin-30
Oleosin-30!

Function!

Variable!

One0Parameter!

Multi!Parameter!Error!Bars!

Error!Bars!

Lower!Limit!

Upper!Limit!

Value!

Polynomial!

Constant!

5.85E002!

1.04E003!

5.21E002!

6.49E002!

Polynomial!

Linear!

0.15041!

9.50E003!

9.56E002!

0.20644!

Rayleigh!

Amplitude! 17.15808!

4.34E002!

17.04304!

17.27421!

Rayleigh!

Radius!

110.69351!

112.37035!

Rayleigh!

Dispersion! 30.07388!

29.43669!

30.72938!

111.52148! 8.36E002!
7.32E002!
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Table 4.3: Datasqueeze fit parameters for Oleosin-30-RGDS
Oleosin-30-RGDS!

Function!

Variable!

One0Parameter!

Multi!Parameter!Error!Bars!

Error!Bars!

Lower!Limit!

Upper!Limit!

Value!

Polynomial!

Constant!

07.80E002!

1.42E003!

09.03E002!

06.60E002!

Polynomial!

Linear!

1.57573!

1.51E002!

1.45862!

1.69435!

Rayleigh!

Amplitude! 20.97314!

5.34E002!

20.80748!

21.14014!

Rayleigh!

Radius!

123.46862! 8.76E002!

122.3563!

124.61596!

Rayleigh!

Dispersion! 38.61803!

37.71027!

39.55709!

7.83E002!

Dynamic light scattering was used to confirm micellar populations in all mutants.
Scattering spectra show monodisperse populations with an average hydrodynamic
diameter of 21.5 nm (PDI=0.086) for oleosin-30 and 20.8 nm (PDI=0.139) for oleosin30G. DLS confirmed similar sizes for the ionic mutants of 20.68 nm (PDI=0.165) and
18.9 (PDI=.289) for oleosin-30G(-) and oleosin-30G(+) respectively (Figure 4.6 C).
Measurements were taken at 30 µM, above the maturation concentration of all mutants
except for oleosin-30G(+). The hydrodynamic diameter of the oleosin-30G(+)
aggregates were undistinguishable above and below the maturation concentration.
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Figure 4.6: A) Oleosin-30 micelle size is measured with small angle X-ray scattering.
Data were fit with a Rayleigh function and a first order polynomial to account for
background scattering. Fits resulted in a diameter of 23.0 nm. B) Cryo-TEM micrograph
of oleosin-30 micelles shows uniform, spherical particles in solution. C) Dynamic light
scattering was used to confirm micellar structures in all mutants. Spectra show
monodisperse peaks of ~20 nm indicative of micelle assembly. Curves are shifted for
clarity.
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4.3.5 Micelle functionalization
Targeted protein mutants were created by appending the integrin binding motif RGDS to
the C-terminus of oleosin-30 creating oleosin-30-RGDS. The RGDS tag was appending
after the 6-histidine tag allowing for terminal display of the peptide. oleosin-30-RGD
was expressed and purified using the same method as oleosin-30; purity and MW were
confirmed (Figure 4.7 A-B).

The addition of the tag had no affect on the CMC or

secondary structure of the protein (Figure 4.7 B-C). The addition of the RGD sequence
has been shown to alter the morphology of certain block copolymer assemblies in
aqueous environments.37 Light and X-ray results indicate that the addition of the integrinbinding domain, RGDS, does not affect the size of the oleosin micelles (Figure 4.7 D-E).
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Figure 4.7: Conformation of Oleosin-30-RGDS. A) SDS-PAGE shows >95% purity for
Oleosin-30 (lane 1) and Oleosin-30-RGDS (lane 2). B) A pyrene assay indicates no
change in the CMS with the addition of the RGDS tag. C) MALDI-TOF confirms the
molecular weight of the mutant. Expected: 14924 Da, measured: 14915 Da. D) CD
spectra shows no change in secondary structure with the addition of the peptide.
Dynamic light scattering (E) and SAXS (F) show no change in size of the micelles.
Analysis indicates that the addition of RGDS does not affect micelle assembly.
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curve correlating the fluorescence intensity to the protein concentration (Figure 4.9).
This example shows the simplicity of precisely controlling the chemistry of the protein
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Figure 4.8: Top: Block diagram of the primary sequence of oleosin-30 and oleosin-30RGDS. The 6-histidine tag is cloned before the RGDS ligand to allow for terminal
display of the peptide. Bottom: The addition of the RGDS tag resulted in an increase in
cellular uptake by 2.4 times after 3 hours and 2.9 times after 12 hours of incubation.
Fluorescence is directly correlated to protein concentration through a calibration curve.
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Figure 4.9: Calibration curves used to correlate the fluorescence intensity of the lysed
Ovcar-5 cells to the amount of protein per cell. Both curves showed linear behavior at
low concentration.

4.4 Conclusions
We report the creation of a soluble protein surfactant by mutating the naturally occurring
protein oleosin. The oleosin variants are expressed in high quantity and are simply
purified. By removing 65% of the hydrophobic domain, the helical secondary structure
has effectively been abolished and the addition of five glycines into the hydrophobic
block creates a random coil tri-block surfactant protein. These mutants self-assembles
into spherical micelles in solution above a critical concentration. Mutating multiple
103

charges into the hydrophilic arms can create ionic assemblies. It was found that the
secondary structure of the protein directly affected the concentration at which assemblies
form. This finding could lead to structure driven assembly at controlled concentrations.
The base protein was functionalized through molecular biology to add the integrinbinding domain, RGDS, to the C-terminus. This addition did not affect the CMC or the
morphology of the micelles. The RGDS mutant displayed a significant increase in uptake
after 12 hours of incubation with Ovcar-5 cells. Oleosin surfactants present a promising
platform for micellar assembly because of the ability to precisely modify the protein
backbone through molecular biology allowing for the control over CMC and addition of
functional domains into the material.
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Chapter 5
Oleosin Stabilized Microbubbles
The work presented in this chapter is submitted for publication with the following
reference: F. E. Angilè, K. B. Vargo, C. M. Sehgal, D. A. Hammer, & D. Lee,
Recombinant Protein-Stabilized Monodisperse Microbubbles With Tunable Size Using a
Valve-based Microfluidic Device. Submitted for Publication 2014. A patent application
on this technology is submitted.

Abstract
Microbubbles are used as contrast enhancing agents in ultrasound sonography and
more recently have shown great potential as theranostic agents that enable both
diagnostics and therapy. Conventional production methods lead to highly polydisperse
microbubbles, which compromise the effectiveness of ultrasound imaging as well as of
novel therapeutic approaches such as antivascular ultrasound therapy (AVUST). The
inefficacy of polydisperse microbubbles in these applications is due to their inability to
uniformly resonate under a given ultrasound frequency. In addition to the polydispersity
of microbubbles, surfactants that are used to stabilize microbubbles have been limited to
!
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biological molecules or synthetic materials that offer limited possibilities in modifying
the shell properties of microbubbles and functionalizing microbubbles for therapeutic
applications. In this work, we generate monodisperse gas microbubbles by using a
microfluidic flow focusing method. This microfluidic device uses an air-actuated
membrane valve that enables production of highly monodisperse sub–10 µm
microbubbles with narrow size distribution. The size of microbubbles can be precisely
tuned by dynamically changing the dimension of the channel using the valve. The
microbubbles are stabilized by an amphiphilic protein, oleosin, which provides versatility
in controlling the mechanical properties of the microbubble shell and adding specific
ligands for targeted drug delivery applications via recombinant protein technology. We
show that it is critical to control the composition of the stabilizing agents to enable
formation of highly stable and monodisperse microbubbles that are echogenic under
ultrasound insonation. Our protein-shelled microbubbles based on the combination of
microfluidic generation and recombinant protein technology provide a promising
platform for ultrasound theranostic applications.

!
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5.1 Introduction
Ultrasound imaging is inexpensive, safe, and commonly used for diagnosis in soft tissue
and vasculature.1 Microbubbles have been used as ultrasound contrast agents; their
gaseous core is highly compressible, which greatly enhances the scattering of ultrasound
increasing the signal.2 Commercially available microbubble contrast agents have a broad
size distribution. Tuning the size distribution to a specific imaging application can
enhance the effectiveness of these bubbles. Previous methods have been developed to
created monodisperse microbubbles but these techniques lead to significant loss of
bubbles limiting their commercial relevance.3,4 In addition to having broad size
distributions, most microbubbles that are currently being developed use phospholipids,
proteins, or polymers. Due to the synthesis methods, these materials are not easily
modified to have targeting ligands on the microbubble surface or to enable the
modulation of the rheological properties of the stabilizing shells. The current materials
compromise the effectiveness of microbubbles in ultrasound imaging and novel
theranostic approaches such as targeted drug delivery and antivascular ultrasound therapy
(AVUST).5-11

In this work, we present a method to create stable protein-shelled microbubbles
using a microfluidic device. The Lee lab at the University of Pennsylvania has fabricated
a flow focusing device that uses an air-actuated membrane valve. This valve enables the
production of highly monodisperse sub–10 µm microbubbles. Although other studies
have shown that monodispserse bubbles can be generated based on microfluidic
!
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techniques,12-14 the size range of microbubbles that can be generated from such devices is
somewhat limited. The air-actuated membrane valve enables precise control over the size
of microbubbles while producing highly monodisperse microbubbles. To stabilize the
microbubbles generated by the microfluidic technique, we developed a novel soluble
mutant of the amphiphilic protein oleosin, oleosin-30G, discussed in Chapter 4. Unlike
common proteins that have been used to stabilize microbubbles,15 oleosin provides
versatility in controlling the mechanical properties of the microbubble shell and adding
specific ligands for targeted drug delivery applications via recombinant protein
technology.16 We demonstrate an example of such modularity by expressing and
incorporating a eGFP-oleosin fusion into the microbubble shell. The Lee lab has
demonstrated that careful tuning of the composition of the stabilizing agents is critical in
the formation of highly stable and monodisperse microbubbles that are echogenic under
ultrasound insonation.

The bubble work has been completed in collaboration with Francesco E. Angliè in
Daeyeon Lee’s research group in the Department of Chemical and Biomolecular
Engineering, University of Pennsylvania and Chandra M. Sehgal in the Department of
Radiology, University of Pennsylvania School of Medicine. This work was a true
collaboration where my contributions included engineering oleosin to stabilize the
bubbles, creating fluorescent oleosin mutants, and imaging the bubbles under confocal
microscopy. The Lee lab created the microfluidic devices, manufactured the bubbles,
and characterized the bubbles over time. Dr. Sehgal was instrumental in measuring the
echogenicity of the bubbles. The entire work will be presented for clarity and to dictate
!
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the wide variety of applications of oleosin mutants but it should be clearly noted the
contribution related to this thesis was the design, production, purification, and
characterization of the oleosin surfactants used to stabilize the microbubbles.

5.2 Materials and Methods
Microfluidic Device Fabrication
Microfluidic flow focusing devices with expanding nozzle design (Figure 5.1) are
fabricated using single layer soft lithography in poly(dimethylsiloxane) (PDMS).17,18
Negative photoresist SU-8 2010 (Microchem, Newton, MA), thinned to a 3:1 ratio with
SU-8 developer, is spin coated onto a clean silicon wafers to a thickness of 5 µm and
patterned to UV light through a transparency photomask (CAD/Art Service, Bandon, OR)
using a Karl Suss MA4 Mask Aligner (SUSS MicroTec Inc., Sunnyvale, CA). To
incorporate an air-actuated valve, we use single-layer membrane valves,19 which exist in
the same plane as the microfluidic channel, allowing us to fabricate the entire
microfluidic device in a single layer mold. Sylgard 184 poly(dimethylsiloxane) (Dow
Corning, Midland, MI) is mixed with crosslinker (ratio 12:1), degassed thoroughly and
poured onto the photoresist pattern, and cured for 1 hr at 65 ◦C to make the membrane
highly compliant. The PDMS replica are peeled off the wafer and bonded to a PDMS
membrane fabricated by spin coating PDMS on a glass slide after oxygen-plasma
activation of both surfaces. Having a microchannel fully-enclosed in PDMS allows for
more efficient use of the valve-membrane.

!
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Gene creation and protein expression
The sunflower seed oleosin gene is provided as a gift from Dr. Beaudoin at Rothamsted
Research, Hampshire, England. Multiple rounds of PCR are used to create the Oleosin30G and eGFP-oleosin-30G. The following PCR primers were used to create the three
domains, which were combined in a single PCR step: N-terminal hydrophilic S 5’ –
AAGGAGATAGGATCCACCACAACCTACGACC – 3’, N-terminal hydrophilic AS 5’
– GCACCGAGAGCGAGCTTGCCGGTTGAGG – 3’, hydrophobic S 5’ –
CCTCAACCGGCAAG CTCGCTCTCGGTGC – 3’, hydrophobic AS 5’ –
CCTTCACATAATCCCTCTGAAACCCGGTAACACC – 3’, C-terminal hydrophilic S
5’ – GGTGTTACCGGGTTTCAG AGGGATTATGTGAAGG – 3’, C-terminal
hydrophilic AS 5’ – TATATGAATCTCGAGTTTCCCCCCTTCTTTTCG – 3’. The
PCRs to create the hydrophilic portions were run with oleosin-30 as the template and the
hydrophobic domain PRC was run with the following oligo as the template: 5’ –
CTCGCTCTCGGTGCGACTCCGCTGTTTGGTGTTATAGGTTTCAGCCCTGTTATT
GTTCCAGCGATGGGTATAGCGATTGGGCTTGCGGGTGTTACCGGGTTTCAG –
3’. PCR was used to create the eGFP mutants using the following primers: eGFP S 5’ –
ATCGGTATACATATGGTGAGCAAGGGCGAGG – 3’ and eGFP AS 5’ –
ATCTAAAATGGATCCCTTGTACAGCTCG – 3’ with pBamUK-eGFP as a template
(see SI for sequences). The genes are inserted into the expression vector pBamUK, a
pET series derivative constructed by the Duyne Laboratory (SOM, Penn). Mutants are
confirmed through DNA sequencing prior to protein expression. pBamUK adds a 6Histidine tag to the C-terminus of the protein for IMAC purification. Protein is expressed
in the E. Coli strain BL21 DE3 (Stratagene) controlled by the lac promoter. Cultures are
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grown at 37 ◦C in Luria Bertani (LB) withkanamycin (50µgml−1) until OD600 ≈ 0.7 – 0.9.
Protein expression is induced with isopropyl-D-thiogalactopyranoside (IPTG) to a final
concentration of 1.0 mM. Cells are harvested by centrifugation and cell pellets are frozen
at −20 ◦C prior to purification.

Protein Purification and Characterization
B-PER protein extraction agent (Fisher Scientific) is used for protein purification.
Oleosin-30G is expressed in inclusion bodies whereas eGFP-oleosin-30G is expressed in
the soluble fraction of the cell. Oleosin-30G is purified according to the B-PER protocol
for inclusion bodies and eGFP-oleosin-30G is purified according to the protocol for
soluble proteins. Briefly, pellets were resuspended in B-PER (30 ml B-PER per liter of
culture) and DNAse was added to a final concentration of 1 µg/ml. The resuspended
pellets were centrifuged at 15,000 g for 15 minutes. The oleosin-30G supernatant was
discarded and the eGFP-oleosin-30G supernatant was applied to an equilibrated column
and allowed to bind for >1 hour. The remaining inclusion body pellet of oleosin-30G
was suspended in denaturing buffer (8M urea, 50 mM phosphate buffer, 300 mM NaCl).
The solution was centrifuged at 15,000 g for 15 minutes and the supernatant was added to
an equilibrated Ni-NTA column (Hispur Ni-NTA resin, Thermo Scientific). The
denatured oleosin-30G was allowed to bind to the column for >1 hours and washed three
times with denaturing wash buffer (denaturing buffer with 20 mM imidazole). Oleosin30G refolding was accomplished by diluting the column 50 times with refolding buffer
(50 mM phosphate buffer, 300 mM NaCl, 5% by volume glycerol, 4°C) and rocked at
4°C for >1hr. Both mutants was washed extensively with wash buffer (50 mM phosphate
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buffer, 300 mM NaCl, 20 mM imadzole) and eluted in fractions with elution buffer (50
mM phosphate buffer, 300 mM NaCl, 300 mM imidazole). The concentration of purified
protein is measured with a Nano-Drop 1000 (Thermo Scientific). Buffer exchange is
completed with dialysis. All analysis is completed in PBS unless otherwise noted.

To establish the purity of the proteins, SDS/PAGE gels are run on NuPAGE
Novex 4–12 % Bis-Tris mini gels (Invitrogen) in MES buffer. The gel is stained with
SimplyBlue SafeStain (Invitrogen) following electrophoresis. The gel is destained
overnight in water and imaged with a Kodak Gel Logic 100 Imaging System. Protein
molecular weight is confirmed with MALDI-TOF. Sample spots are created with 0.5 µl
protein in 1x PBS and 0.5 µl saturated sinapinic acid solution (50/50 acetonitrile/water +
0.1 % TFE). Spectra are collected on an Ultraflextreme MALDI-TOF (Bruker, Billerica,
MA) (see Figure S4 for eGFP spectra). To confirm the proteins structural composition,
far-UV CD spectra are collected at 25 ◦C on an AVIV 410 spectrometer (AVIV
Biomedical Inc.) using a 1 mm quartz cell. Protein concentration is 15 µM in 50 mM
phosphate, 140 mM NaF. NaF is used to replace NaCl due to the strong absorbance of the
Cl− ion.

Microbubbles production and characterization
The liquid phase containing the shell material consists of oleosin-30G or a solution
containing oleosin-30G and (PEO)78–(PPO)30–(PEO)78 or (PEO)100–(PPO)65–(PEO)100
diluted in phosphate buffered saline (PBS) (pH 7.2, Sigma-Aldrich, St Luis, MO, USA).
The components were mixed together to the desired concentration. Microbubbles were
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generated using liquid phases containing different combinations of the three components.
The liquid phase consisting of oleosin and (PEO)n-(PPO)m-(PEO)n triblock copolymers,
at the optimal concentration dispersed in PBS was supplied to the device using a syringe
pump (Harvard Apparatus PHD Ultra) at flow rates between 500 µL h−1 to 1000 µL h−1.
To connect the channels to syringes, polyethylene tubing with an inner diameter of 0.38
mm and an outer diameter of 1.09 mm (BB31695-PE/2, Scientific Commodities Inc,
Lake Havasu City, AZ) was used. The gas phase consists of 99.999 % pure nitrogen gas
(N2, GTS Welco, Richmond, VA) or octafluorocyclobutane (C4F8) (SynQuest
Laboratories, Alachua, FL) supplied to the device using a pressure regulator (Type 700,
ControlAir Inc., Amhrest, NH) at pressures between 15 and 20 psi. Polyethylene tubing
with an inner diameter of 0.86 mm and an outer diameter of 1.32 mm (BB31695-PE/5,
Scientific Commodities Inc, Lake Havasu City, AZ) was used connect the channel to the
pressure regulator. The membrane valve was actuated using a dual-valve pressure
controller (PCD-100PSIG-D-PCV10, Alicat Scientific, Tucson, AZ) at pressure between
0 and 40 psi.

Microbubbles were produced by first applying a small pressure to the gas inlet (2–4
psi) immediately followed by injecting the liquid phase at the desired flow rate (500-1000
µl h-1). The gas phase was increased slowly until steady state of bubble generation is
reached. Images of microbubbles production were captured using an inverted microscope
(Nikon Diaphot 300) connected to a high speed Phantom V7 camera. For microbubbles
that remain stable during generation and collection, long term stability was characterized
by collecting microbubbles at the air-water interface in 35 mm petri dishes, acquiring
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images under an upright microscope (Carl Zeiss Axio Plan II) connected to a QImaging
Retiga 2000R camera. Microbubbles diameter variation over time was measured and
images are analyzed using ImageJ (v 1.47v, NIH, USA).

Ultrasound Imaging
Microbubbles for ultrasonic imaging were collected and imaged directly in 16 mm
membrane dialysis bag, which is pre–filled with buffer solution and sealed at one end.
After a desired amount of bubbles is collected, the tube was sealed at the other end
carefully avoiding formations of air pockets. The collected microbubbles were imaged
using a clinical ultrasound scanner HDI 5000 (Phillips/ATL, Bothell, WA, USA) which
is equipped with a broadband high-frequency ultrasound transducer at 7–15 MHz. Gray
scale B-mode images are acquired with a mechanical index (MI) of 0.37 and 0.47 with
focus between 0.5–1.5 cm and 1–2 cm, respectively. Time gain compensation (TGC) was
fixed throughout the experiments.

5.3 Results and Discussion
5.3.1 Creation and optimization of the microfluidic device
For a variety of applications that involve microbubbles and ultrasound, the size
distribution of microbubble agents drastically influences the efficacy of the image
contrast enhancement and therapeutic methods. To enable formation of microbubbles
with highly monodisperse and tunable size, the Lee lab developed an expanding nozzle
flow-focusing microfluidic device with a single-layer membrane valve at the orifice as
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schematically illustrated in Figure 5.1. This design provides the flexibility to tune the
size of the microbubbles in the same chip without changing the continuous phase or gas
flow rates, by only changing the size of the orifice through the application of pressure to
the valve. Furthermore, the use of the single-layer membrane valve overcomes the low
resolution that is typically achieved by using polymeric photomasks20 (smallest feature ~
10 µm).
Inner phase
(N2, CO2, C4F8)
Continuous
phase inlet

50 µm

AIR

Continuous phase
(Proteins solution)

Inner phase
Inlet (GAS)

1.
1
m
m

Collection

Valve actuation
inlet

(a)

(b)

Figure 1: (a) Schematic illustration of a PDMS microfluidic device used to generate monodisperse microbubbles of
different
(b) Schematic of
a microbubble of
stabilized
with a mixture
of oleosin and
(PEO)nused
–(PPO)to
m –(PEO)
n triblock
Figure
5.1:sizes.
a) Schematic
illustration
a PDMS
microfluidic
device
generate
copolymer.

monodisperse microbubbles of different sizes. b) Schematic of a microbubble stabilized
with a mixture of oleosin-30G and (PEO)n-(PPO)m-(PEO)n triblock copolymer.
Nitrogen gas and a common surfactant, sodium dodecyl sulfate (SDS, SigmaAldrich, St Luis, MO, USA), were used for the initial testing of the microfluidic device.
Monodisperse microbubbles with radius ranging from approximately 2 to 10 µm are
produced for several hours without changes in the bubble size. The advantage of this
microfluidic device over previous flow-focusing devices is that a wide size distribution of
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microbubbles can be generated from a single device.20,21 Increasing the applied pressure
to the single-layer value restricts the area of the valve opening reducing the resulting
bubble size. By altering the pressure, the size of the microbubbles can be controlled
(Figure 5.2). It was found that the bubble size is linearly correlated to the width of the
nozzle. Although SDS enables the investigation of microfluidic device performance,
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the size of the nozzle, which is controlled by an air- actuated valve placed at the orifice, it is possible to generate uniform
microbubbles.
By changing the size of the nozzle, which is controlled by an air- actuated
microbubbles of different sizes. (b) Effect of orifice width on the size of microbubbles.
valve placed at the orifice, it is possible to generate uniform microbubbles of different
sizes. (b) Effect of orifice width on the size of microbubbles.

5.3.2 Oleosin stabilized bubbles
To produce stable microbubbles with high monodispersity, size tunability and structural
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modularity, we turn our attention to oleosin as the bubble shell material. Oleosin is a
plant protein that stabilizes oil bodies in seeds.22 The protein has a natural amphiphilic
structure with N- and C- terminal hydrophilic arms and a central hydrophobic core
containing a proline knot forcing the protein into a hairpin structure.22-27 Oleosin has been
used in various biotechnology and biomedical applications exploiting its amphiphilic
properties.28-32 Eliminating a large portion of the hydrophobic domain and removing the
majority of the secondary structure in the protein backbone has been shown to yield a
soluble oleosin mutant that naturally self-assembles into micelles19. The soluble oleosin
mutant is named oleosin-30 defining the number of amino acids in the hydrophobic
block. The oleosin-30 mutant was modified by inserting five glycines into the
hydrophobic core (see Chapter 4 for addition information) creating oleosin-30G. The
addition of the five glycines increased the protein expression, stability, and solubility
while completely abolishing the secondary structure as shown by circular dichroism
(Figure 5.3). Protein is expressed in the Escherichia coli strain BL21 (DE3) with
isopropyl β-D-1-thiogalactopyranoside (IPTG) induction. Protein is purified using
immobilized metal affinity chromatography through a 6-histidine tag on the C-terminus
of the protein leading to highly purified products (Figure 5.3). Protein molecular weight
is confirmed with matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF)
mass spectroscopy (Figure 5.3).
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30G indicates a random coil structure. The addition of the five glycines in the
hydrophobic block significantly increases the unstructured nature of the protein compared
to the previously reported oleosin-30 (Chapter 4).

When microbubbles are produced with only oleosin at concentrations between 1–2
mg mL-1, we can only stabilize bubbles with radius above 10 µm. During the generation
of microbubbles with radii smaller than 10 µm, bubbles are observed to coalesce. In
addition, the relatively high surface tension between the liquid and the gas phases makes
the generations of such microbubbles challenging, often resulting in unsteady formation
of microbubbles in the microfluidic device.
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A number of microbubble systems that are currently being investigated (e.g.,
phospholipid-stabilized microbubbles) often have an extra component such as the
amphiphilic triblock copolymer Pluronic to provide stability to the microbubbles and to
aid in the bubble generation process. We tested two different types of Pluronic triblock
copolymers that have been studied: (PEO)100–(PPO)65–(PEO)100 and (PEO)78–(PPO)30–
(PEO)78. When a mixture containing 1–2 mg mL−1 oleosin and 5–20 mg mL−1
(PEO)100–(PPO)65–(PEO)100 (average molecular weight 12600) was used, a consistent
stream of monodisperse microbubbles were formed at the nozzle; however, these
microbubbles undergo coalescence upon collection. In contrast, when (PEO)78–(PPO)30–
(PEO)78 (average molecular weight 8400) is added to oleosin solutions, monodisperse
microbubbles were generated at the nozzle and very limited coalescence was observed
upon collection. The optimal concentration for stable microbubble formation was found
to be an aqueous phase containing 1 mg mL−1 of oleosin and 10 mg mL−1 of (PEO)78–
(PPO)30–(PEO)78 (Figure 5.4).
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5.3.3 Microbubble stability
Microbubbles generated using the mixture of oleosin and (PEO)78–(PPO)30–(PEO)78
(molar ratio of oleosin:triblock copolymer = 1:18) were stable once collected.
Microbubbles were collected and stored in water (microbubbles reside at the air-water
interface due to their buoyancy). Microbubble radius decreases by about 13 % during the
first four days and eventually ceases to shrink further. These microbubbles remained
stable for at least for 4 weeks (Figure 5.5). The stability of these microbubbles did not
depend on whether N2 or C4F8 is used as the gas phase. In contrast, microbubbles
generated solely with (PEO)78–(PPO)30–(PEO)78 did not exhibit such excellent stability.
These results indicate that oleosin plays a critical role in stabilizing the shell of
microbubbles, which likely consists of a mixture of oleosin and (PEO)78–(PPO)30–
(PEO)78, to prevent complete dissolution or coalescence of microbubbles upon their
!
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collection. Similar examples, in which shells suppresses the dissolution of microbubbles,
have been observed in microbubbles that have been stabilized with other types of proteins,
nanoparticles or synthetic polymers18,33-52.
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5.3.4 Functional microbubbles
As discussed briefly above, one of the unique aspects of oleosin is that the molecular
structure and thus the properties of the monolayer that contains this molecule can be
engineered using recombinant protein technology. Recombinant protein technology
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allows for precise molecular engineering of proteins generated from microorganisms such
as bacteria and thus can be used to generate oleosin species with different functionality
and properties.16 To demonstrate proof-of-principle that this molecule has such
modularity, we expressed a green fluorescent protein mutant oleosin by fusing enhanced
green fluorescent protein (eGFP) to the N-terminus of the oleosin-30G. The modified
oleosin genes were constructed using standard molecular biology techniques and cloned
into the expression vector pBamUK. eGFP-functionalized oleosin was added to the
aqueous phase during microbubble generation. It is evident that the microbubbles
produced with the blend of the two oleosin species (pure at 1 mg mL−1, mutant at 0.05
mg mL−1) along with 10 mg mL−1 (PEO)78–(PPO)30–(PEO)78 had the eGFP mutant
species incorporated in the bubble shell, whereas the microbubbles generated without the
eGFP mutant species did not show any fluorescence (Figure 5.6). Fluorescence intensity
was observed to be fairly uniform on the surface of the bubbles with no signs of phase
separation, which had been observed on microbubbles that were stabilized with mixture
of phospholipids.33-35 Our results clearly indicate that that oleosin with different
functionalities can be generated and incorporated into the microbubble shell and that
oleosin distributes uniformly on the surface of microbubbles.
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5.3.5 Bubble Echogenicity
Echogenicity measurements were carried out using microbubbles generated with a
solution containing 1 mg mL−1 oleosin and 10 mg mL−1 (PEO)78–(PPO)30–(PEO)78. We
collected microbubbles directly in a ∼3 cm long dialysis tubing with a diameter of 16
mm, which is sealed at one end and pre-filled with PBS solution containing 10 mg mL−1
(PEO)78–(PPO)30–(PEO)78. Microbubbles were flown directly into the dialysis tube from
the PDMS device outlet using polyethylene tubing, which was submerged in the PBS
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solution. After collecting a desired amount of microbubbles, the tube was sealed on the
other end to avoid introducing any air pockets and is stored in 50 mL centrifuge tubes
filled with PBS solution containing 10 mg mL−1 (PEO)78–(PPO)30–(PEO)78. The tube
was rotated at 60 rpm to induce continuous motions of the microbubbles and more
importantly to remove large bubbles that may have been collected. The echogenicity of
these microbubbles was tested using a broadband high-frequency ultrasound transducer at
7–15 MHz in brightness mode (B-mode). The microbubbles, with a radius of about 4 µm
are acoustically active along the entire length of the dialysis tube as shown in Figure 5.7.
In contrast, a PBS solution containing 10 mg mL−1 (PEO)78–(PPO)30–(PEO)78 without
any microbubbles did not show any acoustic activity, indicating that the oleosinstabilized microbubbles are echogenic. Microbubbles remain acoustically responsive 30
min after the initial measurement and even one week after the first measurement,
showing non-detectable changes in the signal brightness. These results clearly indicate
that these microbubbles stabilized with oleosin are highly stable and echogenic and have
large potential for theranostic applications.

!

129!

Cross section
a

Side view

GEL

b

T=0

Dialysis tube
contours

Operator
hand

d

e

f

g

h

Control

T = + 168 hr

T = +30 minutes

c

Scale Bars: 500 µm

Figure
5.7: Ultrasound sonography images of C4F8 microbubbles generated with a
Figure 8: Ultrasound sonography images of C4 F8 microbubbles generated with a solution containing 1 mg mL 1 and
1
1 (PEO) –(PPO) –(PEO)1 . Ultrasound images of microbubbles
10
mg
(a and
b) 1-2 hours
after generation,
(c and
solution mL
containing
1mg
–(PPO)
78
30 mL 78 and 10 mg mL (PEO)78
30–(PEO)
78. Ultrasound
d) 30 minutes and (e and f) 7 days after initial imaging. Ultrasound images of control samples are reported in panels g
images
of microbubbles (a and b) 1-2 hours16after generation, (c and d) 30 minutes and (e
and h.
and f) 7 days after initial imaging. Ultrasound images of control samples are reported in
panels g and h.
!

130!

5.4 Conclusions
We have shown that a recombinant mutant oleosin in combination with a triblock
copolymer, (PEO)78–(PPO)30–(PEO)78, can be used to successfully produce stable and
monodisperse microbubbles with high echogenicity. The Lee lab demonstrated that the
use of a PDMS microfluidic device with an air-actuated valve is an effective method to
control the size of microbubbles while maintaining narrow size distribution.
Microbubbles incorporating oleosin show high stability and can be further functionalized
using recombinant protein technology, which we demonstrated by the incorporation of an
eGFP-oleosin fusion mutant into microbubbles. We envisage that the combination of
microfluidic generation and oleosin-based stabilization of microbubbles will represent a
promising platform for ultrasound theranostic applications. In particular, by
functionalizing oleosin with specific targeting ligands via recombinant protein
techniques,31,32 it will be possible to enable localized antivascular ultrasound therapy.
Also by varying the molecular structure of oleosin (e.g., controlling the structure of
hydrophobic domain), microbubble shells with different rheological properties could be
generated.
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Chapter 6
Oleosin stabilized and targeted
superparamagnetic iron oxide
nanoparticles
The work presented in this chapter is submitted for publication with the following
reference: K. B. Vargo, A. Al Zaki, R. Warden-Rothman, A. Tsourkas, & D. A. Hammer,
Superparamagnetic Iron Oxide Nanoparticle-Loaded Micelles Stabilized by Recombinant
Oleosin for Targeted Magnetic Resonance Imaging Submitted for Publication 2014. The
technology has been disclosed to the University of Pennsylvania Center for Technology
Transfer and is being evaluated for a patent application.

Abstract
Superparamagnetic iron oxide (SPIO) nanoparticles are used as magnetic resonance
contrast agents in many research applications providing strong T2 weighted contrast. The
nanoparticles are typically clustered and stabilized by a polymer or lipid membrane to
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increase circulation time. These systems offer little flexibility when engineering the
particle surface for biological targeting or controlled degradation. In this work, we
engineered the naturally occurring plant protein oleosin to stabilize SPIO nanoparticle
emulsions, which eventually dry to packed nanocluster micelles. Oleosin was engineered
to be soluble and highly anionic providing electrostatic repulsion between the particles
and limited non-specific cellular uptake. The particles are monodisperse after
purification, display high relaxivity, and show no toxicity to cells after 4 hours of
incubation. The Her2/neu affibody was fused to the N-terminus of the oleosin variant and
blended into the structures to provide cell specific targeting. Targeted micelles show
increased uptake in Her2/neu+ cells and can be blocked through competitive inhibition
with free affibody indicating targeting through the Her2/neu receptor. Including
functionality into the shell occurs during particle formation negating the need for
additional functionalization steps. The use of recombinant oleosin as a stabilizing shell
for SPIO is a encouraging platform for targeted magnetic resonance imaging.
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6.1 Introduction
Superparamagnetic iron oxide (SPIO) nanoparticles have gained interest for use as
magnetic resonance contrast agents, with the ability to provide T2 weighted contrast
enhancement on MR imaging applications.1-4 Their strong contrast enhancing capabilities
have rendered them useful for molecular imaging applications with various targeting
molecules being conjugated to the surfaces of SPIO nanoparticles.5-8 These strategies
have the potential to increase tumor accumulation, specificity, and therapeutic efficacy.
The prerequisite for any targeted nanoparticle is the successful bioconjugation of ligands
onto the nanoparticle surface. Many techniques to do so have low reaction efficiencies,
require multiple conjugation steps, and often create products with poorly oriented
antibodies. Developing recombinant proteins that can stabilize SPIO nanoparticles would
allow for the functionalization of particles in the formulation step by directly modifying
the protein through molecular biology.

We chose to engineer the naturally occurring surfactant protein oleosin.9 Oleosin
is expressed in plant seeds with the native function of stabilizing fat reservoirs called oil
bodies. The protein consists of three domains, a central hydrophobic domain flanked by
two hydrophilic arms on the C- and N- termini.9,10 The protein resembles a hairpin
structure with a proline knot embedded in the central hydrophobic domain that forces a
180° turn.11 Recombinant oleosin has been exploited for it surfactant nature in many
biotechnology applications.12-17
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We have previously engineered oleosin to self-assembly into vesicles, fibers, or
sheets by creating a family of truncation mutants thereby varying the
hydrophilic/hydrophobic ratio of the surfactant protein.18 Further truncations of the
hydrophobic block have led to soluble oleosin mutants that spontaneously self-assemble
in aqueous solution as a function of concentration.19 These proteins can be highly
engineered for specific applications. We present here the engineering of oleosin mutants
to stabilize and target iron oxide protein micelles for enhanced magnetic resonance
imaging (Figure 6.1 A).

This work was in collaboration with Ajlan Al Zaki and Robert Warden-Rothman
in Dr. Andrew Tsourkas’ lab. Ajlan synthesized the SPIO nanoparticles and completed
the targeting studies. Rob helped with all the cell culture work and plating for all
experiments. This has been a fascinating collaboration with both sides equally
contributing to the final result.

6.2 Materials and Methods
Gene synthesis
Oleosin-30G(-)was created from the template Oleosin-30G20 using sequential PCR steps
with the following primers: 1S 5’ –
GATCAGCATGATCAACACACCGGTGACCAGCTCACCCACCCACAGGACCAGC
AACAAGGCCCCTCAACCGGCGAACTCGCTCTCGGTGCGACTCC -3’, 2S 5’ –
AATTCAATAGGATCCGAAGCCACCACAACCAACGACCAGCACCATGTCACCA
!
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CCACCCAACCCCAAGATCAGCATGATCAACACACC – 3’, 1AS 5’ –
TATCTGCTGGCCCAAGTCGTTCGTGTTCTGGCCCGTCTGCTCCCCCACATCCT
GCAATTCCCCGTTCACGTTATCCTGCCACTGAAACCCGGTAACACC – 3’, 2AS
5’ –
TTCTGCCCTTCGTTCCCACCACCCTGACCCTGACCCTGGCCCTGGTCACCCAT
TTCATGGGCCGTATGCTGTATCTGCTGGCCCAAGTCG – 3’, 3AS 5’ –
TTTATGAATCTCGAGTCAGTCATCGTGGTGGTGGTGGTGGTGGTTCCCCCCTT
CGTTCTGCCCTTCGTTCCCACC – 3’. The Oleosin-30G(-) PCR product was cloned
in the expression vector pBamUK. The Her2 affibody was amplified using the primers
Her2 1S 5’ – GATGCGCAGGCGCCGAAAGGCGGCGGTGGCGGTAGC – 3’, and
Her2 fusion AS 5’ – GGTTGTGGTGGATCCTTTCGGCGCCTGC – 3’ and cloned into
the vector pBamUK-Oleosin-30G to create pBamUK-Her2-Oleosin-30G. The gene for
the expression of the Her2 affibody alone was created using the following primers: Her2
1S 5’ - GATGCGCAGGCGCCGAAAGGCGGCGGTGGCGGTAGC – 3’, and Her2 AS
5’ – TAGATAATTCTCGAGTTTCGGCGCCTGCGCATCG – 3’ and cloned into
pBamUK. pBamUK adds a 6-histidine tag onto the C-terminus of the protein to allow for
immobilized metal affinity chromatography (IMAC).

Protein production and purification
Mutants were expressed under the control of the lac promoter in E. Coli (BL21 DE3,
Stratagene). Cultures were grown until OD600~0.7 and induced with isopropyl β-D-1thiogalactopyranoside to a final concentration of 1.0 mM (Fisher Scientific). Cells were
pelleted at 5,000 rpm and frozen at -20 °C prior to purification. Oleosin-30G(-) and the
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Her2 affibody were expressed solubly, whereas the fusion Her2-Oleosin-30G was
expressed in inclusion bodies. The protein mutants were solubilized according to the BPER protocol for soluble or insoluble proteins respectively. Unpurified protein solutions
were added to Ni-NTA beds (Hispur Ni-NTA resin, Thermo Scientific) and allowed to
bind to the column for 1 hour at room temperature. Protein was washed and eluted in
fractions according to the Hispur protocol. Protein concentration was measured using a
Nanodrop-1000 (Fisher Scientific). Buffer exchanges were completed with dialysis or
with centrifugal filters (Amicon Ultra, 3 kDa, Millipore).

SDS-PAGE
SDS-PAGE gels were run in MES buffer with NuPAGE Novex 4–12% Bis-Tris mini
gels (Invitrogen). After electrophoresis, the gels were stained with SimplyBlue Safestain
(Invitrogen) and destained in water overnight. The resulting gel was imaged with a
Kodak Gel Logic 100 Imaging station.

Matrix Assisted laser desorption/ionization time of flight mass spectroscopy (MALDITOF)
MALDI-TOF spectra were used to confirm the molecular weights of the mutants.
Sample spots were created with 0.5 µl protein in 1x PBS and 0.5 µl saturated sinapinic
acid solution (50/50 acetonitrile/water + 0.1% TFE).
Ultraflextreme MALDI-TOF (Bruker, Billerica, MA).

Circular Dichroism (CD)
!

142!

Spectra were collected on an

Far-UV CD spectra were collected on an AVIV 410 spectrometer (AVIV Biomedical
Inc.) at 25 °C in 1 mm quartz cuvettes. Protein concentration was 10 µM in 10 mM
phosphate, 140 mM NaF due to the high signal from the Cl- ion in PBS.

SPIO synthesis
Briefly, 0.6 mmol of Fe(CO)5 dissolved in 0.3 mL of ortho-dichlorobenzene (ODCB)
was rapidly injected into a hot solution containing 1.2 mL of ODCB and 0.6 mmol of
dodecylamine (DDA). The resulting mixture was maintained at 180ºC under aerobic
conditions. During this process, the initial orange color of the solution gradually changes
to slightly brownish black. After 9 hr., the resulting solution was cooled to room
temperature and an approximately 3-fold volume excess of toluene was added to adjust
the solubility of the nanocrystals. The nanoparticle solution was then centrifuged to
remove nanoparticle aggregates. After adding ethanol into the remaining solution,
resulting black flocculates were isolated by centrifugation.

Nanoparticle assembly and purification
FeO-oleosin micelles were synthesized using an oil-in-water emulsion and stabilized with
oleosin-30G(-). FeO nanoparticles were dissolved in toluene at a concentration of 80
mg/ml. Protein stocks were diluted into sterile PBS to a concentration of 2 mg/ml. The
FeO nanoparticles in toluene (50 µL) were directly injected to the protein solution and
sonicated until a uniform emulsion was created and no visible iron aggregates existed.
The emulsion was allowed to dry overnight at room temperature. The particles were
purified using sequential centrifugation21. The solution was centrifuged at 380 RCF for
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10 minutes and large aggregates were removed in the pellet. The supernatant was
centrifuged at 4646 RFC for 30 minutes and the resulting supernatant was removed. Two
pellets exist from this spin, a soft soluble pellet, and a hard, insoluble pellet of
aggregates. The soft pellet was removed and used for further studies. The nanoparticles
were concentrated and solution exchanges were completed using centrifugal filters
(Amicon Ultra, 50 kDa, Millipore).

Dynamic light scattering (DLS)
Dynamic light scattering of nanoparticle solutions was performed on samples in PBS
using a Malvern Zetasizer Nano ZS (Westborough, Massachusetts). Each sample was
run in triplicate.

Cryogenic transmission electron microscopy (Cryo-TEM)
Cryogenic transmission electron microscopy was performed at the University of
Pennsylvania in the Nanoscale Characterization Facility (Philadelphia, PA).

Lacey

formvar/carbon grids (Ted Pella) were rinsed in chloroform to remove the formvar
template. The resulting grids were carbon coated with a Quorum Q150T ES carbon
coater (Quorum Technologies, United Kingdom).

Grids were cleaned with

hydrogen/oxygen plasma for 15 seconds using the Solarus Advanced Plasma System 950
(Gatan, Pleasanton, CA). A 2 µl drop of nanoparticles in PBS was deposited onto the
grid and added to a Gatan Cp3 cryoplunger (Gatan, Pleasanton, CA). The samples were
blotted by hand and plunged into liquid ethane. Grids were transferred to a Gatan
CT3500TR cryoholder (Gatan, Pleasanton, CA) and immediately inserted into a JEOL
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2100 HRTEM (JEOL, Tokyo, Japan) operating at 200 keV. Micrographs were imaged
with an Orius SC200 digital camera.

Stability
Particles were incubated at 37°C for 5 days in either PBS or Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum, 1%
penicillin/streptomycin. DLS measurements were taken daily to monitor for particle
degradation or aggregation.

Cell Viability Assay
The viability and proliferation of cells in the presence of Fe-Oleosin nanoparticles were
evaluated by 3-[4,5-dimethylthialzol-2-yl]-2,5-diphenyltetrazolium bromide (MTT,
Sigma) assay. The assay was performed in triplicate in the following manner. NIH3T3
cells were seeded into 96-well plates at a density of 1 x 104 cells per well in 200

L of

media and grown overnight. The cells were then incubated with various concentrations of
Fe-Oleosin (0, 0.025, 0.05, 0.075, 0.1, and 0.15 of Fe/mL) for 4 h. Following incubation,
cells were incubated in media containing 0.1 mg/mL of MTT for 1 h. Thereafter, MTT
solution was removed, and precipitated violet crystals were dissolved in 200

L of

DMSO. The absorbance was measured at 560 nm.

Cell lines
NIH/3T3 and T6-17 cells (i.e., NIH/3T3 cells engineered to stably express the Her2/neu
receptor, kindly provided by Dr. Mark Greene, University of Pennsylvania) were
!
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maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum, 1% penicillin/streptomycin at 37 °C, and 5% CO2.

Her2/neu targeting
T6-17 and NIH/3T3 cells were incubated with 100 µg Fe/mL of Her2/neu-targeted SPIO
micelles for 45 min in full media in triplicate. The media was removed and the cells were
washed with PBS two times to remove any unbound micelles. Cells were trypsinized and
counted. Cell suspensions were diluted to 0.4 × 106 cells/ml and T2 relaxation times were
measured using a bench top relaxometer (Bruker mq60).

6.3 Results and Discussion
6.3.1 Protein design, expression, and characterization
Two oleosin genes were engineered, one to stabilize the FeO micelles and a second to
target the resulting clusters to Her2/neu+ cells. Previously it has been shown that
oleosin can be engineered to stabilize various interfaces such as emulsion droplets and
bubbles.18,20 In order to provide adequate repulsion between the micelles, we mutated the
hydrophilic arms of oleosin-30G to be negatively charged. Negative nanoparticles have
also been shown to limit nonspecific cell targeting.22-24 Specifically, all positive amino
acids as well as any tyrosine residues in the hydrophilic arms were mutated to Q, N, D, or
E depending on the location and local charge. The negative charge was spread evenly
across the hydrophilic arms with an average negative amino acid every six residues. This
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mutant is called Oleosin-30G(-). To directly target Her2/neu+ cancer cells, we have
fused a Her2/neu affibody onto the N-terminus of the oleosin mutant Oleosin-30G.25
This targeted mutant is named Her2/neu-Oleosin-30G. The Her2/neu affibody was
expressed independently as a competitive inhibitor for cell studies. Mutants were made
using standard molecular biology techniques and cloned into the expression vector
pBamUK, which adds a 6-histine tag on the C-terminus of the protein for immobilized
metal affinity chromatography (IMAC). Oleosin variants were confirmed through DNA
sequencing. Vectors were transformed into the Escherichia coli strain BL21 (DE3) for
expression. Her2/neu-Oleosin-30G was insoluble and expressed in inclusion bodies
whereas Oleosin-30G(-) was soluble. Mutants were purified using IMAC.
Protein yields were ~24 mg, ~80 mg, and ~65 mg of purified protein per liter of
culture for Her2/neu-Oleosin-30G, Oleosin-30G(-), and Her2/neu respectively. SDSPAGE indicates highly purified products after IMAC (Figure 6.1 B). The band for
Oleosin-30G(-) runs much higher than expected on the gel, likely due to its highly
negative charge. Molecular weights were confirmed with MALDI-TOF (Figure 6.2)
(Oleosin-30G(-) expected: 14956, measured: 14958, Her2/neu-Oleosin-30G: expected:
21714, measured: 21713, Her2/neu expected: 7771, measured: 7773).
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Figure 6.1: A) Cartoon depiction of Her2/neu targeted iron oxide nanoparticle micelles
stabilized by oleosin. B) Protein purity is accessed to be >95% pure by SDS-PAGE (lane
1: Oleosin-30G(-), lane 2: Her2/neu-Oleosin-30G, lane 3: Her2/neu affibody). C)
Circular dichroism indicates an unordered structure for the charged mutant Oleosin-30G(). D) CD spectra for the fusion Her2/neu-Oleosin-30G show contributions from the
helical Her2/neu affibody and the unordered Oleosin-30G. E) CDSSTR analysis of CD
spectra shows increased helical structure in the fusion compared to Oleosin-30G
indicating that the affibody is likely folded on the N-terminus of the oleosin mutant.
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Figure 6.2: MALDI-TOF confirms molecular weights for A) 45-30G-63(-), B) Her2Oleosin-30G, and C) Her2. Oleosin-30G(-)expected: 14956, measured: 14958, Her2Oleosin-30G: expected: 21714, measured: 21713, Her2 expected: 7771, measured 7773.

Protein secondary structure was elucidated through circular dichroism. The parent
molecule Oleosin-30G is a highly unordered protein.20 CD indicates that Oleosin-30G(-)
remains unordered after the various mutations to they hydrophilic arms (Figure 6.1 C).
The secondary structure of Her2/neu-Oleosin-30G was investigated to ensure correct
affibody folding as a fusion partner. The Her2/neu affibody is a highly helical protein
(Figure 6.1 D) and when fused to oleosin, the Her2/neu-Oleosin fusion displays structure
from the helical affibody and the unordered oleosin backbone (Figure 6.1 D). The
spectra were fit with the CDSSTR analysis method using Dichroweb (Figure 6.1 E).26-28
The analysis shows clear helical structure in the fusion protein indicating that the
affibody is likely folded in the fusion.

6.3.2 SPIO-oleosin assembly and characterization
SPIO-oleosin micelles were assembled through an emulsion method. SPIO nanoparticles
solubilized in toluene were injected into solutions of protein in PBS. The emulsion was
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soincated and the toluene was allowed to evaporate overnight at room temperature. This
led to a heterogeneous mixture of micelles. SPIO-Oleosin micelles were purified using
stepwise centrifugation.21 Cryo-TEM of the various separation fractions indicates large
aggregated particles are removed in pellet after low RCF spins and excess protein and
small particles in the supernatant of the high RCF spins (Figure 6.3).
A"

B"

C"

D"

Figure 6.3: Cryo-TEM micrographs of the various fractions during purification. A) The
hard, insoluble pellet after the high RCF spin shows large aggregates of particles stuck
together. B). The soft, soluble pellet that is extracted and used for further studies shows
individual nanoclusters. C and D) The supernatant after the high RCF contains excess
protein (C) and small nanocluster or individual particles (D). All scale bars are 200 nm.
The mass ratio of the particles to the protein, the oil volume fraction, and the
particle stabilization coat all play an important role in the formation of packed
nanoclusters. The oil volume fraction and mass ratio of protein to iron was optimized.
Previous studies used an oil volume fraction of 4.8% for particle formation and a 4:4 ratio
of nanoparticle to surfactant (mg:mg).21 We found that decreasing the volume fraction of
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toluene in the emulsion to 1.2% and increasing the protein concentration greatly affected
the resulting structures. The optimal particles were created by injecting 50 µl of toluene
containing 4 mg of SPIO-DDA coated nanoparticle into a 4 ml solution of protein in PBS
at a concentration of 2 mg/ml (Figure 6.4).
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Figure 6.4: Optimization of iron-to-protein ratio and oil volume fraction. Increasing the
amount of surfactant and decreasing the volume of toluene used in the emulsification led
to highly packed particles with little to no aggregates present after purification. Scale bars
are all 200 nm.
Dynamic light scattering of the purified particles show a monodisperse population
with an average hydrodynamic diameter of 113 nm (peak: 127 nm, PDI=0.104) (Figure
6.5 A). Purified particles were imaged using cryogenic transmission electron microscopy
(Cryo-TEM) (Figure 6.5 B). The micrograph displays tightly packed iron oxide
nanoparticles and no visible excess protein on the particles. Particles from three
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independent batches were directly measured from micrographs and found to have an
average diameter of 74 ± 33 nm (N=660 particles) (Figure 6.5 C). As expected, the
average diameter measured in micrographs is less than the hydrodynamic diameter
measured by DLS. The DLS data are skewed to higher diameters due to increased
intensity of scattering from larger particles.
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Figure 6.5: A) Dynamic light scattering reveals a monodisperse population of micelles
with an average diameter of 113 nm (PDI=.104). B) Cryo-TEM micrograph of FeO
micelles stabilized by Oleosin-30G(-) in PBS (pH 7.4). C) Particle size distribution
measured directly from cryo-TEM images. The average particle size was found to be 74
± 33 nm (Standard deviation of the mean, N=660 particles). This diameter is
significantly lower than the hydrodynamic diameter from DLS due to the increased
scattering from larger particles. D) Protein stabilized particles are stable over 5 days in
buffer (1xPBS) and serum at 37°C as measured by DLS. E) Particles show high
relaxivity with an R2 value of 407.2 ± 4.0 mM-1 s-1. F) The R1 value was found to be 4.47
± 0.46 mM-1 s-1.
The surface charge of SPIO particles has been shown to have significant impact in the
uptake by cells4. Zeta potential measurements indicated a negative surface charge at of !
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12.5 ± 1.7 mV. The negative charge is needed to provide repulsive electrostatic
interactions between the emulsion droplets during particle formation reducing
aggregation. The particles show long-term stability in buffer (1 x PBS) and serum with
no significant change in the hydrodynamic diameter over 5 days at 37°C (Figure 6.5 D).
The particles display extremely high relaxivity with an R2 value of 407.2 ± 4.0 s-1 mM-1
and an R1 value of 4.47 ± 0.46 s-1 mM-1 (Figure 6.5 E-F). The potential cytotoxicity of
the nanoparticles was assessed using an MTT assay. Over all concentrations, cell
viability remained above 97% for the 4-hour incubation with particles (Figure 6.6). The
physical and magnetic properties of the oleosin-stabilized nanoparticles are summarized
in Table 6.1.
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Figure 6.6: Particles show no toxicity between 25 and 150 µM after 4 hours of incubation
at 37°C with NIH/3T3 cells.
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Table+6.1:+Physical+and+magnetic+properties+of+oleosin+
stablized+nanoparticles
Hydrodynamic+diameter+(nm)
113+±+36
Numer+Diameter+(nm)
74+±+33
Zeta+Potential,+pH+7.4+(mV)
@12.5+±+1.7+
r 2 +(mM @1+s @1 )
407.2+±+4.0
r 1 +(mM @1+s @1 )
4.47+±+0.46
r 2 /r1+
91.1

6.3.3 Her2 targeting
Her2/neu+ targeted micelles were created by blending Her2/neu-Oleosin with Oleosin30G(-) at 10% by weight in the PBS solutions (0.8 mg Her2/neu-Oleosin-30G: 7.2 mg
Oleosin-30G(-)). The micelles were prepared and purified in the same manor. The
blending of the targeted mutant into the micelles did not change the size of the micelles
as measured by DLS (Figure 6.7 A) or the stability of the particles over time (Figure 6.7
B). The surface charge of the particles remains negative but slightly increased to -10.7 ±
0.8 mV.
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Figure 6.7: Characterization of Her2+ functionalized nanoparticles. A) DLS spectra
shows monodisperse particles with a peak at 131 nm (PDI=0.11) indicating that the Her2Oleosin-30G blending into the micelles does not affect the overall size. B)
Functionalized particles are stable in PBS and serum for up to 5 days at 37°C.
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FeO micelles were incubated with Her2/neu- (NIH/3T3) and Her2/neu+ (T6-17)
cells at a concentration of 100 µg/ml for 45 minutes. The T2 relaxation time for the
NIH/3T3 cells showed no difference between negative control particles, targeted
particles, or cells incubated without particles indicating little to no nonspecific binding.
In the Her2/neu+ cell line, the cells incubated with the targeted particles show a
significantly lower T2 relaxation time, consistent with the presence of SPIO, compared to
cells with the negative control particles or cells incubated without particles. A
competitive binding study was completed by adding excess Her2/neu affibody to the T617 cells before and during the incubation with the targeted particles. The affibody
competition led to a significant increase in the T2 time (Figure 6.8). Therefore, these
results provide clear evidence that Her2/neu oleosin micelles provide cell specific
targeting.
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Figure 6.8: Functional evaluation of the Her2/neu SPIO-oleosin micelles conjugates.
SPIO-oleosin and Her2/neu-SPIO-oleosin were incubated with either Her2/neu-positive
and Her2/neu-negative cells in the presence and absence of excess free affibody. Free
affibody served as a competitive inhibitor to confirm specific binding of the Her2/neu
receptor. Relaxivity measurements of cells incubated with SPIO-oleosin micelles or
Her2/neu-SPIO-oleosin micelles were acquired.

6.4 Conclusions
This work demonstrates the engineering of the naturally occurring surfactant protein
oleosin to stabilize and target FeO nanoparticle micelles to Her2/neu+ cells. The
functionalization of these particles is trivial due to the ease of incorporating biologically
relevant motifs into the coat protein through molecular biology. These particles are
extremely stable and display high relaxivity. We envision oleosin stabilized nanoparticle
!
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micelles will represent a promising platform for targeted enhanced imaging applications.
Specifically, varying the surface charge and appending specific stealth ligands29 to the
particles could engineer nanoparticle shells to be nontoxic and maintain long circulation
times.
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!
Chapter!7!!
Conclusions!and!Future!Directions!
!

7.1!Specific!Aims!
The!research!presented!within!this!thesis!shows!that!we!are!able!to!successfully!
engineering!the!surfactant!protein!oleosin!to!selfAassemble!into!desired!higher!
order!structures!and!exploit!its!ability!to!stabilize!interfaces!to!create!novel!
biomaterials.!!The!specific!aims!of!this!work!were!as!follows:!
!
1. Develop!a!recombinant!protein!system!that!selfAassembles!into!bilayer!
vesicles!
2. Engineer!soluble!recombinant!surfactants!from!the!base!protein!oleosin!
3. Develop!oleosin!mutants!to!stabilize!and!target!clinically!relevant!
biomaterials!
!
!

!
!
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7.2!Specific!Findings!
7.2.1!Oleosin!selfAassembly!through!emulsion!templating!
Chapter!3!focuses!on!creating!oleosin!mutants!that!naturally!self!assemble!into!
higher!order!structures,!specifically!bilayer!vesicles.!!To!achieve!this,!families!of!
truncation!mutants!were!created!and!tested!for!assembly.!!A!family!of!truncation!
mutations!where!the!hydrophobic!domain!was!shorted!by!22!amino!acids!and!the!
hydrophilic!armed!were!symmetrically!truncated!created!four!mutants!with!varying!
hydrophilic!fractions!and!molecular!weights!that!were!found!to!assemble.!!Assembly!
was!mediated!through!an!emulsion!template.!!The!morphology!of!the!selfAassembled!
structures!was!a!function!of!the!protein!geometry!and!the!solution!ionic!strength.!!
The!four!mutants!in!the!A65A!family!form!vesicles!at!physiological!ionic!strength!and!
the!membrane!thickness!of!the!vesicles!was!found!to!be!a!function!of!the!overall!
molecular!weight.!!Micron!sized!vesicles!can!be!created!using!double!emulsions!as!a!
template!and!the!resulting!structures!can!be!duel!labeled!to!prove!the!presence!of!a!
hydrophobic!bilayer!membrane.!!Although!the!role!of!secondary!structure!in!the!
assembly!is!unclear,!there!were!no!changes!in!secondary!structure!across!the!
mutants,!indicating!that!it!was!not!a!factor!in!various!morphologies!observed.!!This!
work!completes!Aim!1!of!the!thesis.!!
!

!
!
!
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7.2.2!Creation!of!soluble!oleosin!mutants!
A!major!challenged!faced!in!Chapter!3!of!this!work!was!the!insoluble!nature!of!many!
of!the!oleosin!mutants.!!Thus,!this!work!set!out!to!engineer!the!molecule!into!a!
soluble!form!while!maintaining!the!surfactant!character!needed!for!assembly.!!This!
was!accomplished!by!removing!65%!of!the!hydrophobic!domain!creating!the!
oleosinA30!family.!!This!protein!was!found!to!selfAassemble!into!spherical!micelles!
above!a!critical!micelle!concentration.!!The!micelles!were!monodisperse!with!a!
diameter!of!about!20!nm.!!OleosinA30!micelles!were!trivially!targeted!to!OvcarA5!
cells!displaying!active!integrins!using!the!cell!binding!motif!RGDS.!!Micelles!with!the!
RGDS!peptide!showed!a!2.9!fold!increase!in!internalization!compared!to!the!control!
micelles.!!This!family!of!surfactants!has!been!shown!to!be!highly!modular.!!For!
instance,!mutants!were!created!with!additional!flexibility!in!the!hydrophobic!
backbone!increasing!the!expression!and!stability!of!the!molecule.!!Ionic!surfactant!
were!developed!by!point!mutating!specific!charged!amino!acids!into!the!hydrophilic!
arms.!!These!mutants!also!selfAassemble!into!spherical!micelles.!!It!was!found!that!
the!assembly!is!a!function!of!secondary!structure!and!therefore!could!be!modulated!
based!on!the!structure!of!the!protein!backbone.!!This!work,!described!in!detail!in!
Chapter!4,!accomplishes!the!goal!set!out!in!Aim!2.!!
!

7.2.3!Applications!of!soluble!protein!mutants!
Beyond!selfAassembly,!the!oleosin!mutants!developed!in!Chapter!4!can!be!used!to!
stabilize!various!interfaces!to!create!new!functional!biomaterials.!!In!Chapters!5!and!
!
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6,!we!exploit!the!surfactant!characteristics!of!the!soluble!mutants!to!create!stable!
microbubbles!and!targeted!iron!oxide!nanoparticle!respectively.!!In!the!microbubble!
work,!we!collaborated!with!Daeyeon!Lee’s!lab!at!Penn!to!create!monodisperse,!
stable!microbubbles!with!diameters!<10!μm.!!The!bubbles!were!generated!using!an!
air!actuated!microfluidic!device!and!stabilized!with!a!mixture!of!oleosinA30G!and!
pluronic.!!In!this!work,!oleosins!ability!to!stabilize!the!airAwater!interface!was!
needed!to!provide!longAterm!stability!to!the!bubbles.!!A!demonstration!of!
functionalization!was!completed!by!fusing!enhanced!green!fluorescent!protein!to!
the!oleosin!mutant!and!using!this!molecule!to!label!the!bubbles.!!Bubbles!were!
shown!to!be!echogenic!and!remained!echogenic!for!a!week!after!the!initial!
measurement.!!
!
Chapter!6!of!this!work!used!oleosin!to!stabilize!emulsions,!which!eventually!
dry!to!packed!iron!oxide!nanoparticles.!!This!work!was!completed!in!collaboration!
with!Dr.!Andrew!Tsourkas’!lab.!!!The!emulsion!based!technique!for!creating!these!
particles!is!suited!perfectly!for!oleosin.!!A!negative!mutant!was!created!to!provide!
the!need!electrostatic!repulsion!to!mitigate!coalescence!of!the!emulsion.!!The!size,!
stability,!charge,!and!magnetic!properties!of!the!particles!were!characterized.!!The!
particles!show!no!toxicity!in!cells!after!4!hour!of!incubation.!!A!mutant!was!created!
to!target!cells!that!overexpress!the!Her2!receptor,!a!common!overexpression!in!
various!cancers.1!!Particles!targeted!with!the!Her2AOleosin!mutant!showed!
significant!uptake!in!Her2+!cells!and!the!targeting!could!be!blocked!through!
competitive!inhibition!with!the!free!affibody!indicating!that!the!targeting!is!through!
!
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the!Her2!receptor.!!Chapters!5!and!6!show!just!two!examples!of!the!many!
applications!that!oleosin!surfactants!can!be!used!for.!!This!work!completes!Aim!3.!
!

7.3!Future!Work!
Oleosin’s!unique!architecture!and!robust!ability!to!express!in!bacteria!allows!for!
extensive!future!work!to!be!conducted!on!the!molecule.!!The!number!of!mutations!
that!can!be!imagined!and!created!is!almost!endless.!!This!section!will!outline!specific!
ideas!for!future!work!with!oleosin!and!other!proteins.!!!
!

7.3.1!SelfAAssembly!
In!chapters!3!and!4!oleosin!selfAassembly!was!discussed.!!The!insoluble!mutants!of!
oleosin!hold!promise!for!surfactant!work!due!to!their!large!hydrophobic!domains.!!
The!fullAlength!oleosin!hydrophobic!block!(87!amino!acids)!was!found!to!be!too!
hydrophobic!limiting!expression!in!bacteria!and!making!handling!of!the!surfactant!
difficult.!!Future!work!on!this!family!of!mutants!would!first!need!to!focus!on!
increasing!expression!of!the!surfactant!therefore!the!shorter!A65A!family!of!mutants!
should!be!explored.!!The!A65A!family!discussed!in!Chapter!3!expresses!extremely!
well!and!we!have!shown!that!it!is!amenable!to!mutations.!!In!Chapter!4,!we!explored!
removing!the!secondary!structure!in!oleosin!and!found!that!it!aided!in!assembly.!!
Removing!the!secondary!structure!in!the!hydrophobic!block!of!the!A65A!family!
would!allow!for!increased!flexibility!in!the!protein!backbone,!possibly!increasing!
solubility!and!allowing!for!solution!selfAassembly.!!Replacing!helix!forming!amino!
!
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acids!with!helix!breaking!amino!acids!such!as!glycine!or!alanine!can!complete!this.!!!
Recent!work!has!created!soluble!mutants!from!these!large!hydrophobic!blocks!by!
negatively!charging!the!hydrophilic!arms,!which!will!be!discussed!later!in!this!
section.!
!
The!soluble!mutants!created!(hydrophobic!block!45!and!30)!are!currently!the!
most!promising!mutants!for!future!engineering.!!The!45!mutant!expressed!in!lower!
quantities!and!is!not!as!stable!as!the!30!mutant!therefore!it!was!not!extensively!
studied!in!comparison!to!the!oleosinA30!assembly!work!shown!in!Chapter!4.!!A!
family!of!mutants!from!the!OleosinA30!molecule!was!created!by!truncating!the!
hydrophobic!arms!symmetrically!in!the!hopes!of!decreasing!the!head!group!size!
allowing!for!the!assembly!of!lower!curvature!structures.!!In!all!cases,!the!protein!
mutants!were!not!stable!over!time.!!The!shorter!truncations!(37A30A37!and!27A30A
27)!led!to!potentially!promising!structures!as!visualized!by!light!microscopy!but!the!
structures!would!quickly!aggregate.!!To!mitigate!this,!one!could!add!a!few!charged!
residues!to!the!NA!and!CAtermini!to!provide!electrostatic!repulsion!between!the!
structures.!!!
!
Another!interesting!area!to!explore!is!controlling!the!CMC!of!the!micelles!
assembled!in!Chapter!4.!!Controlling!the!CMC!of!these!surfactants!can!be!extremely!
useful!for!many!applications.!!For!drug!delivery!and!imaging,!lower!CMCs!are!
advantageous!for!stability!when!diluted!into!blood.!!Adding!large!hydrophobic!
amino!acids!(Phe!or!Trp)!into!the!central!core!could!lower!the!CMC!of!the!oleosinA30!
!
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families.!!It!was!found!that!the!CMC!of!the!micelles!directly!correlated!to!the!
proteins!ability!to!adopt!a!specific!secondary!structure!therefore!changes!in!the!
hydrophobic!domain!secondary!structure!could!lead!to!control!over!the!CMC.!!For!
interfacial!work,!it!would!be!advantageous!to!design!molecules!with!high!CMCs.!!
This!would!allow!for!quick!adsorption!to!an!interface!without!the!need!to!deplete!
monomers!from!a!micellar!assembly.!!Increasing!the!disorder!in!the!protein!
backbone!or!decreasing!the!hydrophobic!nature!of!the!central!domain!could!
increase!the!CMC.!!
!
Micelle!forming!oleosin!mutants!can!be!created!with!protease!sites!within.!!
These!sites!will!cleave!the!protein!when!the!specific!protease!is!present.!!This!would!
provide!the!ability!to!control!release!in!the!presence!of!a!specific!protease.!!Mutants!
have!been!created!where!the!NAterminal!arm!of!oleosinA30!was!truncated!from!42!
amino!acids!to!32,!22,!or!11!amino!acids!with!the!protease!site!enterokinase!(Figure!
7.1).!!These!mutants!were!used!to!stabilize!emulsions!and!emulsion!stability!was!
monitored!after!protease!addition.!!It!was!found!that!the!emulsions!remained!stable!
after!the!protein!was!cleaved.!!Addition!of!protease!sites!on!the!CAterminal!arm!and!
in!the!hydrophobic!block!could!help!control!the!stability!of!the!emulsions!in!the!
future.!!Also,!binding!domains!could!be!placed!directly!after!the!protease!site.!!The!
ligand!site!would!be!shielded!from!binding!until!reaction!with!a!protease,!which!
would!expose!the!site!and!allow!the!micelle!to!bind.!!This!could!be!useful!for!
targeted!delivery!in!the!presence!of!a!specific!protease!such!as!thrombin,!which!is!
present!at!the!sites!of!clot!formation.!!!
!
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Figure!7.1:!A)!Cartoon!depiction!of!OleosinA30!mutants!with!enterokinase!domains!
added!into!the!NAterminal!hydrophilic!arm.!!The!enterokinase!sites!were!added!at!
different!points!in!the!arm!to!test!if!steric!hindrances!affect!enzyme!activity.!!B)!SDSA
PAGE!gel!showing!the!three!mutants!before!and!after!cleavage.!!All!mutants!show!
almost!100%!cleavage!after!reacting!with!the!protease.!!!
!
!
A!recent!goal!of!this!work!was!to!create!helical!hydrophobic!blocks!with!
highly!charged!hydrophilic!head!groups!mimicking!work!from!the!Deming!lab!at!
UCLA2A5.!!Deming!and!coworkers!created!polypeptide!vesicles!from!diblock!
amphiphilic!copolypeptides!where!the!hydrophobic!polyAleucine!block!was!alpha!
helical!and!the!hydrophilic!polyAlysine!was!a!random!coil.4!!To!accomplish!this,!a!
family!of!negatively!charged!mutants!was!created!with!where!both!hydrophilic!arms!
were!highly!charged!and!the!hydrophobic!blocks!were!either!87,!65,!45,!or!30!amino!
!
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acids!long.!!In!all!cases,!the!mutants!were!soluble.!!This!family!is!the!first!example!of!
mutants!with!an!87!or!65!hydrophobic!block!that!is!soluble.!!These!mutants!were!
expressed!and!purified!and!preliminary!cryoATEM!studies!show!that!they!remain!
micellar.!!Additional!work!including!CD!should!be!conducted!to!ensure!the!helical!
nature!of!the!87!and!65!blocks!remains!and!CMC!calculations!should!be!completed.!!
!
Blending!of!surfactants!has!lead!to!rich!phase!behavior!in!previous!work.6A8!!
With!the!large!families!of!oleosin!mutants!created,!blending!mutants!with!different!
hydrophobic!fractions!could!lead!to!interesting!selfAassembled!structures.!!
Specifically,!blending!micelles!forming!mutants!with!highly!charged!soluble!mutants!
could!lead!to!various!interesting!assemblies.!!!
!
A!key!feature!of!oleosin!is!the!proline!knot.!!The!three!conserved!prolines!are!
thought!to!allow!the!180°!turn!in!the!peptide!chain!creating!the!hairpin!like!
structure.9,10!!Previous!work!has!looked!at!removing!the!proline!knot!and!focused!on!
the!ability!of!the!protein!to!enter!the!endoplasmic!reticulum!and!target!oil!bodies!
after!the!mutation.11!!Preliminary!work!on!mutation!the!proline!knot!has!consisted!
of!creating!an!oleosinA30!hydrophobic!block!with!the!prolines!mutated!to!alanines!
(P2A!mutants).!!The!P2A!mutant!showed!increased!helical!structure!compared!to!
the!native!30!mutant!(Figure!7.2).!!!It!is!hypothesized!that!the!mutations!of!the!
prolines!will!eliminate!the!kink!in!the!hydrophobic!block!creating!a!linear!triblock!
surfactant.!!Future!work!could!focus!on!replacing!the!prolines!with!various!
!
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hydrophobic!amino!acids!specifically!glycine!for!flexibility!or!more!hydrophobic!
amino!acids!(Leu,!Phe,!or!Trp)!to!increase!the!nonpolar!characteristics!of!the!blocks.!!!
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Figure!7.2:!CD!spectra!of!OleosinA30!and!OleosinA30!P2A.!!The!mutation!of!the!three!
prolines!to!alanines!in!the!proline!knot!increases!in!helical!and!sheet!structure!
compared!to!the!OleosinA30!mutant.!!This!mutant!could!lead!to!interesting!linear!
triblock!surfactants.!!
!
!

7.3.2!Stabilizing!interfaces!
We!have!exploited!oleosin!for!its!ability!to!stabilize!interfaces!in!the!microbubble!
and!SPIO!micelle!work!discussed!earlier.!!The!robust!nature!of!soluble!oleosin!
mutants!to!stabilize!interfaces!leaves!much!future!work!to!be!explored.!!We!have!
!
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been!able!to!engineer!an!oleosin!mutant!to!stabilize!almost!any!interface.!!In!many!
cases,!oleosin!not!only!stabilizes!the!interface!but!it!can!impart!specific!functionality!
to!the!surface!such!as!charge!or!the!presence!of!a!ligand!as!we!have!demonstrated.!!I!
will!specifically!talk!about!future!work!related!to!oleosinAstabilized!microbubbles!
and!SPIO!micelles!but!the!real!limitation!in!this!section!arising!from!the!lack!of!
applications.!!Future!collaborations!with!surface!scientists!will!greatly!move!this!
work!forward!to!find!novel!applications!for!oleosin!mutants.!!
!
The!oleosinAstabilized!microbubbles!in!Chapter!5!were!stabilized!with!a!
mixture!of!pluronic!and!OleosinA30G.!!It!is!hypothesized!that!the!pluronic!was!
needed!to!initially!stabilize!the!bubbles!generated!in!the!microfluidic!device!and!
oleosin!was!needed!for!longAterm!stability.!!The!concentration!of!oleosin!used!in!the!
microfluidic!device!was!much!greater!than!the!CMC!of!the!mutant!meaning!the!
majority!of!the!protein!molecules!were!clustered!into!spherical!micelles.!!The!
soluble!monomers!would!quickly!be!depleted!and!the!micelles!would!begin!to!
disassemble!in!order!maintain!the!equilibrium!between!the!monomers!in!solution!
and!those!residing!in!micelles.!!It!is!imaged!that!this!micelle!disassembly!is!relatively!
slow!leading!to!the!inability!to!quickly!stabilize!the!air!water!interface.!!This!could!
be!improved!by!designing!oleosin!mutants!with!higher!CMCs!to!stabilize!interfaces!
under!flow!such!as!the!OleosinA30G(+)!mutant!discussed!in!Chapter!4.!!!
!
The!obvious!next!step!is!to!replace!the!eGFPAoleosin!fusion!with!a!targeted!
mutant!and!test!if!localized!microbubble!accumulation!can!be!achieved.!!This!is!a!
!
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simple!next!step!and!can!be!completed!with!the!cloning!of!one!fusion.!!Another!
direction!for!this!project!is!the!addition!of!switches!into!the!microbubble!shell,!
specifically!for!degradation.!!To!accomplish!this,!one!could!add!protease!sites!
throughout!the!protein!backbone.!!It!is!hypothesized!that!the!bubbles!could!be!
designed!to!degrade!at!a!controlled!rate!depending!on!the!frequency!of!the!protease!
sites.!!Additionally,!bubbles!have!been!seen!to!stick!to!each!at!the!air/water!
interface!other!implying!some!interaction!between!the!shells.!!The!addition!of!
charge!to!the!surface!of!the!bubbles!could!help!prevent!aggregation.!!
!
It!is!desirable!to!control!the!mechanical!properties!of!the!bubbles!to!optimize!
the!ultrasound!response.!!This!can!be!achieved!through!many!of!the!same!mutations!
discussed!earlier.!!The!addition!of!hydrogen!bonding!amino!acids!or!cysteine!to!
crossAlink!can!be!used!to!strengthen!the!membrane.!!Crosslinking!can!also!be!
completed!through!lysines!by!adding!amineAtoAamine!cross!linkers!post!bubble!
formation.!Another!option!is!to!use!protein!hydrophobic!blocks!with!secondary!
structure.!!The!block!of!the!A65A!family!displays!strong!helical!character,!which!has!
been!known!to!have!strong!lateral!packing.2,4,5!!A!recent!mutant!where!the!
hydrophilic!arms!have!been!negatively!charged,!OleosinA65(A),!would!be!a!good!
starting!point!to!test!this!theory.!!!
!
Current!microbubbles!are!created!in!the!clinic!by!mechanical!shaking.!!
Although!this!technique!produces!a!polydisperse!population!of!microbubbles,!the!
bubbles!perform!well!enough!in!the!clinic!to!remain!the!standard!of!care.!!It!could!be!
!
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desired!to!make!targeted!oleosin!bubbles!through!mechanical!shaking.!!This!would!
allow!for!quicker!entry!into!commercialization!due!to!the!simple!production.!!Many!
oleosin!mutants!will!form!stable!bubbles!upon!shaking.!!The!size!and!longAterm!
stability!of!these!mixtures!has!not!been!explored!but!remains!an!open!area!for!
future!work.!!I!hypothesis!that!a!mixture!of!oleosins!would!work!best!regardless!of!
the!generation!method!used.!!There!is!a!need!for!the!development!of!mutants!that!
quickly!stabilize!the!interface!to!use!in!conjunction!with!longAterm!stability!mutants.!!!
!
SPIOAoleosin!stabilized!micelles!discussed!in!Chapter!6!are!promising!for!
targeting!imaging!agents.!!Many!oleosin!variants!were!cloned!before!OleosinA30G(A)!
was!found!to!stabilize!the!interface!of!the!particles.!!Three!major!improvements!can!
be!made!on!this!system.!!The!first!is!the!stability!of!the!particles!during!purification.!!
The!use!of!sequential!centrifugation!as!a!purification!method!led!to!significant!loss!
of!particles.!!A!mechanically!sensitive!purification!method!should!be!developed!or!
the!protein!shells!should!be!strengthened!through!crosslinking.!!Second,!the!oleosin!
mutants!were!not!able!to!stabilize!oleic!acid!coated!SPIO!particles.!!This!is!a!major!
disadvantage!because!the!oleic!acid!coated!particles!are!highly!monodisperse!and!
much!larger,!which!would!likely!producing!a!micelle!with!higher!relaxivity.!!A!longer!
hydrophobic!block!might!interact!better!with!the!oleic!acid!coated!particles!to!
provide!stable!micelles.!!Finally,!we!showed!targeting!but!felt!that!the!particle!
targeting!could!be!enhanced.!!This!is!likely!due!to!protein!adsorption!to!the!micelle!
shell.12,13!!The!accessibility!and!orientation!of!the!Her2!affibody!could!be!improved!
by!adding!a!peptide!linker!in!between!the!fusion.!!This!would!provide!additional!
!
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freedom!for!the!affibody!on!the!shell!and!shield!it!from!nonAspecific!adsorption!of!
serum!proteins.!!!!
!
Initial!tests!were!completed!to!investigate!mutant!oleosin’s!ability!to!stabilize!
emulsions.!!Some!interesting!results!were!found!for!the!hydrophobic!families!as!well!
as!the!A30A!family.!!The!A87A!and!the!A65A!families!were!only!soluble!in!an!organic!
solvent!mixture!as!discussed!in!Chapter!3.!!When!protein!solutions!in!organic!
solutions!were!injected!in!aqueous!solution!interesting!multilayer!emulsions!formed!
(Figure!7.3!AAC).!!These!emulsions!were!stable!for!short!periods!of!time!due!to!the!
evaporation!of!chloroform!but!in!some!cases,!vesicle!structures!were!formed!in!low!
yields!after!drying!(Figure!7.3!DAE).!!Many!of!the!emulsions!buckled!upon!drying!
indicating!that!the!protein!layer!was!likely!solid.!!High!yield!vesicles!could!be!
created!with!this!method!if!the!protein!layer!was!engineered!to!be!fluid!allowing!for!
the!desorption!of!molecules!upon!drying.!!It!is!hypothesized!that!if!these!protein!
mixtures!were!added!to!a!nonAvolatile!oil!in!water!emulsion,!say!silicone!oil!in!
water,!the!protein!would!stabilize!the!chloroform!emulsion!drops!but!eventually!
transfer!to!the!silicone!oil!as!the!chloroform!evaporated.!!This!could!be!a!reasonable!
means!to!use!these!highly!hydrophobic,!insoluble!proteins!to!stabilize!emulsions!
created!from!nonAvolatile!oils!in!aqueous!solutions.!!!

!
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Figure!7.3:!Solutions!of!the!A87A!and!A65A!family!in!1:2:7!(Na2CO3:!chloroform:!
methanol)!into!PBS!lead!to!multicompartment!emulsions.!!A)!7A87A7.!!B)!17A65A17.!!
C)!17A65A17!with!Nile!red!in!the!injection!solution.!The!dye!partitions!to!the!
hydrophobic!fractions!of!the!emulsions!indicating!an!aqueous!core.!!Once!dried,!a!
small!number!of!the!emulsions!dry!to!become!protein!shells.!!Confocal!microscopy!
shows!a!clear!shell!structure!in!DIC!(D)!and!the!segregation!of!the!hydrophobic!dye!
Nile!red!into!the!shell!in!the!fluorescence!image!(E).!
!
!
The!OleosinA30!family!has!shown!interested!emulsion!behavior!as!well.!!
When!OleosinA30!is!added!into!a!mixture!of!silicone!oil!and!water!and!emulsified!
using!a!high!sheer!emulsifier,!greater!than!50%!of!the!emulsion!drops!are!waterAinA
oilAinAwater!emulsions!(W/O/W)!(Figure!7.4).!!The!emulsions!are!stable!for!hours.!!
In!this!configuration,!OleosinA30!must!stabilize!surfaces!with!inverse!curvature.!!
This!type!of!work!could!be!expanded!to!look!at!protein!mixtures,!possibly!creating!
more!stable!double!emulsions!by!including!a!smaller!head!group!mutant!to!stabilize!
the!interior!and!a!larger!head!group!mutant!to!stabilize!the!exterior.!!!
!
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A"

B"

!
Figure!7.4:!A)!Schematic!of!OleosinA30!stabilized!double!emulsions.!!Note!that!the!
protein!must!stabilize!interfaces!of!inverse!curvature.!B)!DIC!image!of!PBSAinA
Silicone!oilAinAPBS!emulsions!stabilized!by!OleosinA30.!!Emulsions!were!created!
using!a!highAspeed!sheer!emulsifier.!!
!
Another!interesting!field!is!that!of!nanoemulsions.14!!These!could!be!developed!for!
drug!delivery!or!imaging!or!used!in!various!material!applications.!!Nanoemulsions!
are!typically!created!from!highApressure!emulsifiers.!!Future!work!could!focus!on!
creating!nanoemulsions!stabilized!by!oleosin!mutants!for!targeted!therapies!or!
imaging.!!!
!

7.3.3!Interfacial!measurements!
Seeing!as!oleosin!is!a!surfactant,!a!wealth!of!information!can!be!collected!on!its!
surface!behavior.!!Initial!experiments!on!oleosinA30!were!conducted.!!LongAterm!
Wilhelmy!plate!experiments!produced!results!showing!that!as!the!protein!bulk!
concentration!increased,!the!surface!pressure!dropped!until!the!surface!was!
saturated.!!This!occurred!very!close!to!the!CMC!measured!with!the!pyrene!assay.!!
!
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Pendant!drop!measurements!were!conducted!on!oleosinA30!but!issues!with!the!
drop!volume!over!time!precluded!the!collection!of!useful!data.!!Kinetic!and!
equilibrium!surface!pressure!measurements!should!be!calculated!for!olesoinA30!and!
the!various!mutants!in!the!family.!!Modifications!to!these!mutants!can!be!studied!to!
look!at!how!they!affect!the!ability!for!the!surfactant!proteins!to!adsorb!to!the!
interface!and!lower!the!surface!pressure.!!Specifically,!this!work!would!be!useful!
with!microfluidic!applications!where!it!is!unclear!if!the!protein!is!diffusion!limited!
or!adsorption!limited!when!stabilizing!interfaces.!!This!understanding!could!help!
design!optimal!protein!mutants!for!different!interfacial!applications.!!!
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Figure!7.5:!A)!Kinetic!surface!pressure!measurements!of!OleosinA30!as!a!function!of!
bulk!concentration.!!Increasing!the!bulk!concentration!of!protein!increases!the!rate!
at!which!the!surface!pressure!drops.!!B)!Equilibrium!surface!pressure!as!a!function!
of!concentration.!!The!equilibrium!surface!pressure!drops!as!concentration!is!
increased!until!the!surface!is!saturated!above!4!μM.!!This!work!was!completed!in!
collaboration!with!Dr.!Marcello!Cavallaro!in!Dr.!Kathleen!Stebe’s!lab.!!!
!
!
!
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!

7.3.4!Diblock!surfactants!
Creating!protein!diblocks!is!a!promising!design!for!selfAassembly!due!to!the!vast!
literature!available!for!diblock!copolymer!assembly.!!!Using!simple!molecular!
biology!techniques,!oleosin!triblock!structures!can!be!truncated!into!a!diblock!
structure!by!splitting!the!molecule!in!two.!!Every!hydrophobic!block!created!(87,!65,!
45,!and!30)!has!been!further!engineered!into!halfAoleosins.!!Unfortunately,!almost!all!
mutants!do!not!express!in!bacteria!and!the!reason!for!limited!expression!is!unclear.!!
A!single!halfAoleosin!created!from!the!fullAlength!molecule,!designated!halfAoleo3!
(see!Appendix!2!for!sequence),!expressed!but!was!minimally!soluble!in!aqueous!
solutions.!!!Finding!a!family!of!halfAoleosin!molecules!that!expresses!well!could!lead!
to!very!promising!selfAassembling!protein!structures!and!assembly!could!be!
controlled!using!the!same!variables!as!diblock!copolymer!assembly.!!!A!few!ideas!
include!increasing!the!length!of!the!hydrophilic!block!past!the!native!length,!creating!
halfAoleosin!mutants!from!the!proline!mutations!discussed!above,!and!minimizing!
the!length!of!the!hydrophobic!block!but!maximizing!the!hydrophobicity.!!!
!
An!alternate!route!is!creating!fusion!proteins!where!the!hydrophilic!block!is!
a!polypeptide!known!to!express!in!bacteria!and!the!hydrophobic!block!is!taken!from!
the!hydrophobic!domain!of!oleosin.!!We!have!explored!two!hydrophilic!blocks!to!
fuse!to!oleosin!domains,!resilinAlike!polypeptides!(RLP)!and!elastinAlike!
polypeptides!(ELP).15A18!!RLPs!are!15!amino!acid!repeat!unit!based!on!the!naturally!
occurring!insect!protein!resilin.19!!Resilin!is!a!highly!elastic!protein!found!in!the!
!
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joints!of!insects,!specifically!dragonflies!and!grasshoppers!and!has!been!used!
extensively!in!biomedical!applications.20!!We!have!fused!a!trimer!RLP!to!various!
oleosin!blocks!(22!and!34!amino!acids!long!creating!RLP3AOleosin22!and!RLP3A
Oleosin34!respectively)!(Figure!7.6!A).!!!Unlike!the!halfAoleosin!mutants,!RLPAoleosin!
diblock!express!well!and!are!highly!soluble.!!Mutants!are!purified!with!IMAC!and!
display!>95%!purity!measured!by!SDSAPAGE!(Figure!7.6!B).!!!Both!mutants!show!
similar!secondary!structure!to!that!of!RLP!alone,!with!the!longer!oleosin!mutant!
displaying!more!unordered!structure!(Figure!7.6!C).!!!
!
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Figure!7.6:!A)!Schematic!of!the!diblock!protein!surfactant!family!RLPAOleosin.!B)!
SDSAPAGE!showing!highly!purified!fusions!of!RLP3AOleo22!and!RLP3AOleo34.!!C)!CD!
spectra!indicate!relatively!unordered!structures!for!the!diblock!surfactants!similar!
to!RLP!repeats!alone.!
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A!pyrene!assay!indicates!that!a!hydrophobic!domain!is!created!as!the!
concentration!of!the!diblock!protein!surfactants!is!increased!(Figure!7.7!A).!!RLP3A
Oleosin22!has!a!CMC!of!27.3!μM!and!RLP3AOleosin34!has!a!CMC!of!12.5!μM.!!The!CMC!
decreases!as!the!length!of!the!oleosin!block!increases!due!to!larger!hydrophobic!
driving!forces.!!Dynamic!light!scattering!indicated!the!both!RLPAoleosin!mutants!
likely!assemble!into!spherical!micelles!with!diameters!of!18.4!(PDI=0.037)!and!18.8!
(PDI=0.016)!for!RLP3AOleosin22!and!RLP3AOleosin34!respectively!(Figure!7.7!B).!!
CryoATEM!was!used!to!directly!visualize!the!spherical!micelles!as!seen!in!Figure!7.7!
CAD.!!!
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Figure!7.7:!A)!Pyrene!assay!shows!both!RLP3AOleo22!and!RLP3AOleo34!self!assemble!
as!a!function!of!concentration.!!As!the!hydrophobic!block!is!increased,!the!CMC!
decreases.!!B)!Both!mutants!show!monodisperse!populations!of!aggregates!with!
diameter!of!~18!nm.!!C!and!D)!CryoATEM!micrographs!of!the!spherical!micelles!
assembled!from!the!RLPAoleosin!fusions.!!!
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With!the!formation!of!spherical!micelles,!it!is!hypothesized!that!two!
directions!could!be!taken!to!obtain!lower!curvature!assemblies!based!on!the!
packing!parameter:!1)!shorten!the!RLP!block!or!2)!lengthen!the!oleosin!hydrophobic!
domain.!!We!have!tested!RLP1!blocks!and!found!that!the!RLP1Aoleosin!fusions!did!
not!express!well!in!bacteria!likely!due!to!the!large!asymmetric!hydrophobic!domain.!!
RLP2Aoleosin!and!RLP6Aoleosin!mutants!have!been!cloned.!!The!RLP6!mutants!have!
been!found!to!express,!but!large!quantities!were!not!purified!yet!therefore!assembly!
has!not!been!tested.!!Initial!next!steps!should!include!testing!the!expression!of!the!
RLP2Aoleosin!family!and!testing!the!assembly!of!RLP6Aoleosin!mutants.!!Extended!
future!work!should!focus!on!increasing!the!overall!molecular!weight!of!the!protein!
fusions.!!With!such!a!short!RLP!domain!now,!we!are!limited!in!the!ratios!of!RLP!to!
oleosin!that!we!can!create!due!to!expression!issues.!!The!RLP!domain!is!providing!
solubility!to!the!diblock,!therefore!increasing!the!length!of!the!RLP!would!allow!for!
longer,!more!hydrophobic!oleosin!domains!to!be!fused.!!This!could!allow!for!all!
geometries!needed!to!form!various!selfAassembled!structures.!!!
!
Both!blocks!can!also!be!engineered!to!include!specific!amino!acids!or!peptide!
sequences!to!help!dictate!assembly.!!I!will!present!a!few!ideas!that!could!force!and!
control!the!specific!assembly.!!Adding!tyrosines!into!the!junction!between!the!
hydrophilic!and!hydrophobic!block!could!lead!to!a!strong!hydrogen!bond!network!at!
the!junction!point,!possibly!lowering!the!curvature!of!resulting!structures.!!Adding!a!
single!cysteine!at!the!junction!point!and!allowing!fusion!mutants!to!crosslink!into!
dimers!effectively!creating!X!shaped!molecules!could!achieve!a!similar!result.!!Many!
!
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dendrimer!molecules!that!have!been!shown!to!assemble!into!vesicles!have!this!
architecture.21A23!!The!RLP!sequence!is!not!as!amenable!to!mutations!as!the!oleosin!
block.!!The!15!amino!acid!repeats!are!specific!providing!little!control!over!changes!
to!the!chemistry.!!A!specific!tyrosine!in!the!native!protein!found!in!the!repeated!
sequence!YGAP!has!been!mutated.24!!In!our!RLPAoleosin!mutants,!the!Try!has!been!
mutated!to!at!Lys!for!potential!crosslinking.!!The!added!charge!of!the!lysine!could!
cause!electrostatic!repulsion!in!the!head!group!limiting!the!assembly!of!low!
curvature!structures.!!Future!work!should!focus!on!mutating!this!domain!back!to!
Tyr!!as!well!as!exploring!other!possible!amino!acids!such!as!Thr!to!induce!hydrogen!
bonding!in!the!hydrophilic!block.!!!!The!diblock!RLPAoleosin!system!is!a!promising!
family!of!molecules!for!the!selfAassembly!of!a!wide!range!of!suprastructures.!!!
!
Another!hydrophilic!polypeptide!family!that!we!recently!explored!as!a!fusion!
partner!is!elastin!like!polypeptides!(ELP).!!ELPs!are!repeats!of!the!amino!acid!
sequence!VPGXG,!where!X!is!any!guest!residue!other!than!proline.17!!These!
polypeptide!sequences!are!discussed!in!detail!in!the!background!of!Chapter!4.!!We!
have!used!the!ELP!sequence!(VPGAG)x!where!x!=!40,!80,!or!160!repeats.!!We!have!
fused!these!to!three!different!oleosin!hydrophobic!domains:!a!halfAoleosin!domain,!
the!hydrophobic!domain!of!OleosinA30G,!and!the!OleosinA30G!domain!with!a!6AHis!
tag!on!the!end.!!These!mutants!were!purified!using!inverse!transition!cycling!and!
lyophilized.17!!Interestingly,!we!found!that!the!ELP40AOleoAhis!assembled!into!high!
aspect!ratio!worm!like!micelles!(Figure!7.8).!!The!remaining!mutants!remain!to!be!
characterized.!!These!fusions!have!major!impact!due!to!the!high!expression,!simple!
!
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purification,!and!temperature!switching.!!Future!work!should!focus!on!fusing!longer!
hydrophobic!domains!to!the!ELPs!and!experimenting!with!secondary!structure!in!
the!hydrophobic!block!to!impact!packing.!!!Adding!crossAlinking!sites!or!coilAcoil!
domains!could!be!useful!in!controlling!packing.!!Also,!tuning!the!transition!
temperature!closer!to!body!temperature!would!be!needed!to!created!more!
biologically!relevant!constructs.!!!
C"

A"

B"

B"

!
Figure!7.8:!CryoATEM!micrographs!of!the!wormAlike!micelle!assemblies!of!the!ELPA
oleosin!fusion!(VPGAG)40AOleoAhis.!!Micrographs!show!the!formation!of!high!aspect!
ratio!wormAlike!micelles.!!All!samples!are!in!water!at!150!μM.!!Scale!bars:!200!nm.!
!
!

7.3.5!Blending!protein!with!lipids!and!polymers!
An!interesting!prospect!for!oleosin!mutants!is!the!opportunity!to!blend!with!lipids!
and/or!polymers.!!Proteins!have!been!blended!into!lipid!and!polymer!membranes!to!
provide!biological!functionality!to!the!resulting!structures.25,26!!The!rich!phase!
behavior!of!lipids!and!polymers!is!well!known!but!the!ability!to!functionalize!these!
!
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materials!is!difficult!and!usually!requires!additional!reactions!post!assembly.!!
Therefore,!if!one!could!engineering!an!oleosin!mutant!to!directly!interact!with!these!
systems,!functionality!could!be!easily!incorporated.!!For!instance,!if!a!soluble!oleosin!
mutant!was!created!that!naturally!blended!into!polymersomes,!one!could!imagine!
making!polymersomes!that!are!targeted!to!any!cell!type!simply!by!fusing!the!target!
ligand!to!the!oleosin.!!!For!blending!into!membranes!created!by!thin!film!
rehydration,!a!mutant!would!need!to!be!expressed!that!is!stable!at!higher!
temperatures!for!the!rehydration!process.!!It!is!unclear!which!family!of!mutants!
would!offer!the!best!opportunity!for!success,!therefore!pilot!experiments!should!be!
completed!looking!at!a!wide!range!of!mutants!before!experimenting!with!a!specific!
family.!!!
!
Blending!into!membranes!can!also!be!achieved!through!microfluidics.!!
Polymersomes!have!been!created!through!microfluidics.27!!Initial!studies!have!
shown!that!oleosin!does!interact!with!the!membrane!forcing!large!changes!in!the!
curvature!of!the!protein.!!This!membrane!interaction!is!not!limited!to!oleosin.!!BSA!
and!green!fluorescent!protein!(GFP)!have!been!shown!to!interact!with!the!
membrane!as!well.!!BSA!has!some!known!surfactant!character,!but!GFP!is!
considered!a!very!hydrophilic!protein.28,29!!It!is!hypothesized!that!the!protein!is!
driven!to!the!interface!and!then!trapped!in!the!PEG!brush!of!the!polymersome!as!the!
organic!solvent!evaporates.!!Designing!an!oleosin!mutant!that!will!intercalate!into!
the!membrane!without!altering!the!membrane!properties!would!allow!for!simple!
functionalization.!!
!
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A"

B"

C"

D"

E"

F"

!!!!!!!

!!!!!!!

Figure!7.9:!A!and!B)!DIC!images!of!microfluidic!vesicles!with!OleosinA30!
encapsulated!within!the!interior.!!The!protein!clearly!interacts!with!the!polymer!to!
force!sharp,!high!curvature!turns!in!the!membrane.!!C!and!D)!DIC!and!fluorescent!
images!of!the!encapsulation!of!eGFP!within!a!microfluidic!vesicle.!!The!inclusion!of!
eGFP!does!not!affect!the!shape!of!the!membrane!as!observed!with!OleosinA30.!!E!and!
F)!DIC!and!fluorescent!images!of!microfluidic!vesicles!created!with!eGFP!in!the!outer!
phase.!!eGFP!clearly!intercalates!into!the!outside!membrane!and!visibly!affects!the!
structure!of!the!shell.!!The!mechanism!for!eGFP!interaction!with!the!membrane!is!
unknown.!!

!
!

!
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Appendix 1: DNA Primers
!

Oleosin mutants: Truncations and point mutations
Sequence
Name
HA_OLEO_
S_P1
GC HA_OLEO_
AS_P2

O phobic S
O phobic AS
O philic 1 S

O philic 2 S

O philic 3 S
O philic 1
AS
O philic 2
AS
O philic 3
AS
O philic 2 S
New
O philic 2
AS New
O philic 3
AS New

!

Purpose
S primer for the Nterminus of WT-oleo
AS primer for the Cterminus of WT-oleo
Equivalent to S25. Cut
the hydrophilic Nterminal arm down to 25
amino acids
Equivalent to AS40. Cut
hydrophilic C-terminal
arm to 40 amino acids
WT-oleosin primer on the
end of the N-terminal
hydrophilic arm
2nd sense primer to
remove hydrophobic
amino acids to make -65-.
Does not prime
3rd sense primer to
remove hydrophobic
amino acids to make -65-.
Used with oleophi-1AS
WT-oleosin primer on the
end of the C-terminal
hydrophilic arm. Used
with oleophi-3S
2nd antisense primer to
remove hydrophobic
amino acids to make -65-.
Does not prime
3rd antisense primer to
remove hydrophobic
amino acids to make -65-.
Does not prime
2nd sense primer to
remove hydrophobic
amino acids to make -65-.
Used with oleophi 2AS
2nd antisense primer to
remove hydrophobic
amino acids to make -65-.
Used with oleophi 2S
3rd antisense primer to
remove hydrophobic
amino acids to make -65-.

Sequence
AGATATACCCATATGGCCACCACAACCTACGACC
TTTCTCACCCTCGAGTTTCCCCCCTTCTTTTCGCCC
TTC

AAGGAGATACATATGCGCCATGATCAACAC
TATATGAATCTCGAGGCCCTGGTCACC
AGATATACCCATATGGCCACCACAACCTACGACC

CAATAACCGGAATCTTGTTTGG

TAACGCGGTCGACAATGTCGGTTCC

AAAGAGTGGGAGCTCAAAGG

GTAACAGCTGGCGCAATTGGGCTTG

TGTTCTAAGGCCAATAACTCCCCGG

AAGATAACCGGAATCTTGTTTGGTTTAGC
AATCCCTCTGGACTGGAACCGACATTGTCGACCG
CGTTAACCCGAACGTACC
TAAACCAAACAAGATTCCGGTTATCTTGCCGGTT
GAGG

191!

Used with oleophi-1S

Oleo2 - 2S

S primer to created
shorter version of
Oleopho. Does not prime
AS primer to created
shorter version of
Oleopho
New oleopho2 S primer
(first one bad)
Cuts the N-terminal
domain to 7 amino acids
Cuts the C-terminal
domain to 7 amino acids
Cuts the N-terminal
domain to 12 amino acids
Cuts the C-terminal
domain to 12 amino acids
Cuts the N-terminal
domain to 17 amino acids
Cuts the C-terminal
domain to 17 amino acids
Cuts the N-terminal
domain to 37 amino acids
Cuts the C-terminal
domain to 37 amino acids
Cuts the N-terminal
domain to 42 amino acids
Cuts the C-terminal
domain to 32 amino acids
Cuts the N-terminal
domain to 22 amino acids
Cuts the N-terminal
domain to 27 amino acids
Cuts the C-terminal
domain to 27 amino acids
4th sense primer for
oleopho
Primers used to create
Oleo2. This protein
copied the N-terminus
hydrophilic arm to the cterminus. Never cloned

Oleo2 - 3S

Used with Oleo2 - 2S

ATCACCCTCGGCCAGAAGACGAAGG

Oleo2 - 1AS

Used with Oleo2 - 2S

ATGACCATAAACCCGGTAACCGCAAGC

Oleo2 - 2AS

Used with Oleo2 - 2S

TTCTGGCCGAGGGTGATACCGGCTAAACC

Oleo-pho2-S
Oleo-pho2AS
oleo_pho2_S
2
Oleosin-S7
Oleosin-AS7
Oleosin S12
Oleosin AS12
Oleosin S17
Oleosin AS17
Oleosin S37
Oleosin AS37
Oleosin S42
Oleosin AS32
Oleosin S22
Oleosin S27
Oleosin AS27
Oleopho24S

!

AAGGAGATACATATGACCGGTGACAGACTCACC
TATATGAATCTCGAGGCCCGTATACTCCCCCACAT
CC
TACTGATGCCATATGACCGGTGACAGACTCACC
AAGGAGATAGGATCCCCCTCAACCGGCAAGATAA
TGG
TATATGAATCTCGAGCACATAATCCCTCTGG
AAGGAGATAGGATCCCGCCAGCAACAAGG
AAGGAGATAGGATCCCGCCAGCAACAAGG
AAGGAGATAGGATCCCTCACCCACCCACAGC
TATATGAATCTCGAGATACTCCCCCACATCC
AAGGAGATAGGATCCCGCCACCATGTCACC
TATATGAATCTCGAGACCCATTTCATGG
AAGGAGATAGGATCCACCACAACCTACGACC
TATATGAATCTCGAGCGTATGCTGTATCTTCTGG
AAGGAGATAGGATCCCACACCGGTGACAGACTCA
CC
AAGGAGATAGGATCCTACCGCCATGATCAACACA
CC
TATATGAATCTCGAGCTGGCCCAAGTCCTTCG
AAGGAGATACATATGACCGGTGACAGACTCACCC
ACCCACAGCGCCAGC

TACCGGGTTTATGGTCATCATGGCCTTACTTCC

192!

Oleo2 - 3AS

Used with Oleo2 - 2S
Cut the N-terminal
hydrophilic arm off (only
good for -87-)
AS to cut off the Cterminal arm. No good.
Replaces previous 0870AS (only good for 87-)
Replacements for oleo2 2S primer
Replacements for oleo2 3S primer
Replacements for oleo2 2AS primer
Replacements for oleo2 3AS primer
Cuts the N-terminal
hydrophilic arm to 24
Cuts to N-terminal
hydrophilic arm to 16
Cuts the N-terminal
hydrophilic arm to 3 (-65)
Cuts the N-terminal
hydrophobic domain to 30
(-65-)
Cuts the N-terminal
hydrophobic domain to 20
(-65-)
Cuts the N-terminal
hydrophobic domain to 11
(-65-)
Creation of -30hydrophobic domain
Used with 30phi-2S to
make -30- hydrophobic
block
Used with 30phi-2S to
make -30- hydrophobic
block
Used with 30phi-2S to
make -30- hydrophobic
block. No good

TATATGAATCTCGAGTTTCCCCCCTTCTTTTCG

CATAATCCCTCTGAAACCCGGTAACCGCAAGC

-45-2S

Replaces 30phi-2AS
Primers used to create 45- hydrophobic block
Primers used to create 45- hydrophobic block

-45-2AS

Primers used to create -

CATAATCCCTCTGGAACGTACCCGAAG

0-87-0 S
0-87-0 AS
0-87-0 AS 2
oleo2 2S
oleo2 3S
oleo1 2AS
oleo2 2AS
S24
S16
S3
AS30
AS20
AS11
30phi-2S
30phi-3AS
30phi-3S
30phi-2AS
oleo30 2AS
-45-1AS

!

AAGGAGATAGGATCCGTCATCATGGCCTTACTTC
C
TATATGAATCTCGAGTCGAGAACCGACATTGTCG
ACC
TATATGAATCTCGAGAACCGACATTGTCGACC
ATGGTCATCATGGCCTTACTTCC
TCGGCCAGAAGACGAAGG
ATGATGACCATAAACCCGGTAACCGCAAGC
TCGTCTTCTGGCCGAGGGTGATACCGGCTAAACC
AGTCATCTACATATGCACCACCACCACCACCACG
ATCAACACACC
AGTCATCTACATATGCACCACCACCACCACCACA
CCCACCCACAGC
AGTCATCTACATATGCACCACCACCACCACCACG
GCAAGATAATGG
TAGATGACTCTCGAGTCAGAATATAACAAACAGC
TAGATGACTCTCGAGTCAGAGCCCGATAACC
TAGATGACTCTCGAGTCAGATACCGGTTAAACC
AACCGGCAAGCTCGCTCTCGCGACTCC
AGAGCGAGCTTGCCGGTTGAGG
TACCGGGTTTCAGAGGGATTATGTGAAGG
ATCCCTCTGAAACCCGGTAACC

GAGGGTGATCTTGCCGGTTGAGG
CCTCAACCGGCAAGATCACCCTCGTCG

193!

45- hydrophobic block
-45-3S

Primers used to create 45- hydrophobic block

GGTACGTTCCAGAGGGATTATG

-30-G 1AS

Primers to create -30-G

GCACCGAGAGCGAGCTTGCCGGTTGAGG

-30-G 2S

Primers to create -30-G

CCTCAACCGGCAAGCTCGCTCTCGGTGC

-30-G 2AS

Primers to create -30-G

CCTTCACATAATCCCTCTGAAACCCGGTAACACC

-30-G 3S

GGTGTTACCGGGTTTCAGAGGGATTATGTGAAGG

-30- TAT 2S

Primers to create -30-G
Change restriction site to
BamHI for Oleosin-30
Add RGD tag onto the Nterminus of oleo arm
Add DRG tag onto the Nterminus of oleo arm
Add TAT tag onto the Nterminus of oleo arm
Add TAT tag onto the Nterminus of oleo arm

-35- 1AS

Primers to create -35-

GAGCCCGATAACCGTCTTGCCGGTTGAGG

-35- 2S

Primers to create -35-

TCAACCGGCAAGACGGTTATCGGGCTCG

-35- 2AS

Primers to create -35-

TTCACATAATCCCTCTGAGTCAAAAACC

-35- 3S

TTTTTGACTCAGAGGGATTATGTGAAGG

P2A phobY
S

Primers to create -35Make -30-G-P2A block
for RLP fusion
Make -30-G-P2A block
for RLP fusion
Add a Y at the beginning
of P2A block for RLP
fusion

30 P2G S

Make -30-G-P2G block

30 P2G AS

Make -30-G-P2G block
Adds 2 negative charges
to the N-terminus arm
Adds 2 negative charges
to the C-terminus arm
Adds 4 negative charges
to the N-terminus arm
Adds 4 negative charges
to the C-terminus arm

30mutant4S
-30- RGD S
-30- DRG S
-30- TAT 1S

P2A phob S
P2A phob
stop AS

30G2NS
30G2NAS
30G4NS
30G4NAS

TTGTCTTATGGATCCTGGACCACAACCTACG
ATATGTTTACATATGCGCGGCGATAGCGGCGGTG
GCGGTAGC
ATATGTTTACATATGGATCGCGGCAGCGGCGGTG
GCGGTAGC
AACGTCGTCAGCGTCGTCGTCCGCAGGGCGGTGG
CGGTAGC
ATATGTTTACATATGGGTCGTAAAAAACGTCGTC
AGC

AATATCTGTGGATCCCTCGCTCTCGGTGC
ACAGATATTCTCGAGTCACTGAAACCCGGTAACA
CC
AATATCTGTGGATCCTATCTCGCTCTCGGTGC
GGTGTTATAGGTTTCAGCGGTGTTATTGTTGGAGC
GATGGGTATAGCG
ACCGCTGAAACCTATAACACCAAACAGCCCAGTC
GCACCGAGAGC
AATTACTATGGATCCGATGACACCACAACCTACG
CTCGAGTCAGTCATCGTGGTGGTGGTGGTGGTGTT
TCCCCCCTTCTTTTCG
AATTACTATGGATCCGATGACGATGACACCACAA
CCTACG
CTCGAGTCAGTCATCGTCATCGTGGTGGTGGTGGT
GGTGTTTCCCCCCTTCTTTTCG

Diblocks and Half Oleosins
Sequence
Name
HalfoleoCter
mS

!

Purpose
N-terminal primer for the first
half oleosin (protein didn't
express)

Sequence
AAGGAGATACATATGGCGATGATAGCGATT
GG
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HalfoleoCter
m AS

Cuts the protein in half (AS
primer) (protein didn't express)

halfoleo3 - S
halfoleo3 AS
HalfO AS W
stop

S primer for 1/2 oleo3

halfO3S2

BU-AS2

S for half oleo with proline knot
AS for half oleo with proline
knot
Build up primer 1 - Prime with
BUAS1
Build up AS primer 1 - prime
with BU S1
Build up S primer 2 - prime with
BU AS2
Build up AS primer 2 - prime
with BU S2

Hblock1S

Oligos for Pho1

Hblock1AS

Oligos for Pho1

Hblock2S

Oligos for Pho2

Hblock2AS

Hblock3AS

Oligos for Pho2
Primers for -30-G hydrophobic
block (Pho3)
Primers for -30-G hydrophobic
block (Pho3)

phil1S

Primers for Phi1

AATTAATGACATATGGCCACCACAACC

phil1AS

Primers for Phi1

phil2S

Primers for Phi2

Phil2AS
pho1 AS
stop
pho2 AS
stop
Pho3 AS
Stop

Primers for Phi2
Primer to add stop codon to
Pho1
Primer to add stop codon to
Pho2
Primer to add stop codon to
Pho3

TACATAAATGGATCCCTTGCCGGTTGAGG
AATTAATGACATATGAGGGATTATGTGAAG
G
TACATAAATGGATCCTTTCCCCCCTTCTTTT
CG

Phi1 6His

Primers to add 6-his tag to Phi1

halfO3AS2
BU-S1
BU-AS1
BS-S2

Hblock3S

!

AS primer for above
Diblock half oleosin with stop
codon

TATATGAATCTCGAGCTTCTGGCCCAAGTCC
GGATCCCACCACCACCACCACCACGCCACC
ACAACCTACG
AGTCATCTATCACGCTATCATCGCTGG
AGTCATCTACTCGAGTCACCACGCTATCATC
GCTGG
AGTCATCTAGGATCCCACCACCACCACCAC
CACGCCACCACAACCTACG
AGTCATCTACTCGAGTCACGCTATCATCGCT
GG
AGTCATCTACATATGCACCACCACCACCAC
CACACCCAACCCCAACGCCATGATCAAC
CCAAACAAGATTCCTATGCGCTTGCGCTGG
TGGGTTCTGTCACCGTGTTGATCATGG
GGAATCTTGTTTGGTTTAGGTATCCTCGTCG
GGGTTATCGGGCTCGCTCTCG
TAGATGACTCTCGAGTCAGAATATAACAAA
CAGCGGCGCGAGAGCGAGC
GATCCTGGTTTGGTGGCTTCGGCGGTTTCGG
GGGTTTCGGTGGCTTTGGCGGTTTTGGTGGT
TTCGGCGGCTTTGGCGGTC
TCGAGACCGCCAAAGCCGCCGAAACCACCA
AAACCGCCAAAGCCACCGAAACCCCCGAAA
CCGCCGAAGCCACCAAACCAG
GATCCTGGGGTGGCTGGGGCGGTTTTGGGG
GTTTCGGTGGCCTGGGCGGTCTGGGTGGTG
TGGGCGGCGCGGGCGGTC
TCGAGACCGCCCGCGCCGCCCACACCACCC
AGACCGCCCAGGCCACCGAAACCCCCAAAA
CCGCCCCAGCCACCCCAG
TTTATCCATGGATCCTGGCTCGCTCTCGGTG
C
TAGTTATTACTCGAGAAACCCGGTAACACC

ATCTAAATTCTCGAGTCAACCGCCAAAGCC
ATCTAAATTCTCGAGTCAACCGCCCGCGCC
GCCCAC
ATCTAAATTCTCGAGTCAAAACCCGGTAAC
ACC
AATTAATGACATATGCACCACCACCACCAC
CACGCCACCACAACC
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Phi2 6His

Primers to add 6-his tag to Phi1

P2A Nhalf S
P2A Nhalf
AS

Diblock of oleosin-30-G-P2A

P2A Chalf S
P2A Chalf
AS

Diblock of oleosin-30-G-P2A

Diblock of oleosin-30-G-P2A

Diblock of oleosin-30-G-P2A

AATTAATGACATATGCACCACCACCACCAC
CACAGGGATTATGTGAAGG
ATATTACTAGGATCCAAAAAACACCACCAC
CACCACCACACCACAACCTACG
ATGATAATTCTCGAGTCACTGAAACCCGGT
AACACC
ATATCTATAGGATCCCTCGCTCTCGGTGC
ATAATGTATCTCGAGTCATTTTTTGTGGTGG
TGGTGGTGGTGTTTCCCCCCTTCTTTTCG

Tags, fusions, and sequencing
Sequence
Name
Avitag S
Avitag AS
avitag 2S
avitag 2AS
T7 promoter
T7 Reverse
S_TAT_Lin
ker
AS_TAT_Li
nker
-30-W1S1
-30-W1AS2
-30-W2S1
-30-W2AS2
-30-W3AS
S GFP
AS GFP

S linker
AS linker

!

Purpose
Oligo for Avitag. Missing site.
Use ones labeled New
Oligo for Avitag. Missing site.
Use ones labeled New
Sense primer to make avitag
BamUK vector
Antisense of above
S Primer for vector in colony
PCR
AS Primer for vector in colony
PCR
S TAT-linker for TAT-Bamuk
AS tat-linker for TAT-BamUK
Sense primer for Oleosin-30 Trp
mutant 1
Antisense primer for Oleosin-30
Trp mutant 1
Sense primer for Oleosin-30 Trp
mutant 2
Antisense primer for Oleosin-30
Trp mutant 2
Antisense primer for Oleosin-30
Trp mutant 3
Sense primer for eGFP
AS primer for eGPF (prime off
RP vector)
Primers with AS linker to make
(GGGGS) 3 with a 12 base pair
overhang on the S side with
eGFP
Primes with S linker to make
(GGGGS)3 with BamHI on 3'

Sequence
TACTGATGCCATATGGGTCTGAACGACATC
TTCGAGGCTCAGAAAATCG
TATATGAATGGATCCTTCGTGCCATTCGATT
TTCTGAGCCTCG
TATGGGTCTGAACGACATCTTCGAGGCTCA
GAAAATCGAATGGCACGAAG
GATCCTTCGTGCCATTCGATTTTCTGAGCCT
CGAAGATGTCGTTCAGACCCA
TAATACGACTCACTATAGGG
TATGCTAGTTATTGCTCAG
TCAATGCATATGGGTCGTAAAAAACGTCGT
CAGCGTCGTCGTCCGCAGGGTGGTGGTTCT
CATTGAGGATCCAGAACCACCACCAGAACC
ACCACCAGAACCACCACCAGAACCACCACC
GCTGTTTGTTATATGGAGCCCTGTTATTGTT
CC
GGAACAATAACAGGGCTCCATATAACAAAC
AGC
GCTTGCGGTTACCGGGTGGCAGAGGGATTA
TGTGAAGG
CCTTCACATAATCCCTCTGCCACCCGGTAAC
CGCAAGC
TCCTGATATCTCGAGCCATTTCCCCCCTTCT
TTTCG
ATCGGTATACATATGGTGAGCAAGGGCGAG
G
TACTAGGATGGATCCGTACAGCTCGTCC
GGACGAGCTGTACGGCGGTGGCGGTAGCGG
AGGTGGCGGGTC
TACTAGGATGGATCCCGAGCCACCCCCACC
AGACCCGCCACCTCC
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end
Cterm E11
S3
Cterm E11
AS2
her2 C2G S
her2 C2G
AS
Her2AS no
linker
30S her2 no
linker
TAT1S
RGDS 1AS
RGDS 2AS
RGD1ASne
w
RGD2ASne
w
egfp Bam
AS
Her2-nde1-S
Her2-1AS
Her2-2AS

47E32 1S
47E32 2S
47E22-30-62
1AS
47E22-30-62
S2
47E12-30-62
1AS
47E12-30-62
S2

!

Primers to create 47E11-30-62
Primers to create 47E11-30-62
Primers to mutant C to G in
Her2-linker
Primers to mutant C to G in
Her2-linker
Removing the linker attached to
Her2
Removing the linker attached to
Her2
Adding TAT to the N-terminus
of oleosin
Adding RGD after the 6-his tag
on the C-terminus. Mistake:
Actually DRG
Adding RGD after the 6-his tag
on the C-terminus. Mistake:
Actually DRG
Adding RGD after the 6-his tag
on the C-terminus
Adding RGD after the 6-his tag
on the C-terminus
Adds xho1 site onto C-terminus
of eGFP
Add nde1 site onto the Nterminus of Her2
Add a linker onto the C-terminus
of Her2
Add a linker onto the C-terminus
of Her2
S primer to make one section of
47E32-30-62. Used with
Oleosin Oleo2 3AS
S primer to make one section of
47E32-30-62. Used with
Oleosin Oleo2 3AS
AS primer to make one section
of 47E22-30-62. Used with
Oleosin S42
S primer to make one section of
47E22-30-62. Used with
Oleosin Oleo2 3AS
AS primer to make one section
of 47E12-30-62. Used with
Oleosin S42
S primer to make one section of
47E12-30-62. Used with
Oleosin Oleo2 3AS

CTTGCAGGATGTGGACGACGACGACAAAGG
GGAGTATACG
CGTATACTCCCCTTTGTCGTCGTCGTCCACA
TCCTGCAACTTCC
GATGCGCAGGCGCCGAAAGGCGGCGGTGG
CGGTAGC
GCTACCGCCACCGCCGCCTTTCGGCGCCTGC
GCATC
GGTTGTGGTGGATCCTTTCGGCGCCTGC
GCAGGCGCCGAAAGGATCCACCACAACC
AACGTCGTCAGCGTCGTCGTCCGCAGGGAT
CCACCACAACC
ATCGTGATGGTGGTGATGGTGTTTCCCCCCT
TCTTTTCG
TGAACAGATCTCGAGTCAGCTGCCGCGATC
GTGATGGTGGTGATGGTG
GCCGTGATGGTGGTGATGGTGTTTCCCCCCT
TCTTTTCG
TGAACAGATCTCGAGTCAGCTATCGCCGCG
GTGATGGTGGTGATGGTG
ATCTAAAATGGATCCCTTGTACAGCTCG
TTAGATTCTCATATGGTGGATAACAAATTTA
AC
ACCAGACCCGCCACCTCCGCTACCGCCACC
GCCGCATTTCGGCGCCTGC
AATTAGAGGATCCGCTACCGCCACCGCCCG
AGCCACCCCCACCAGACCCG
AAATATGAACATGACGACGACGACAAAGTC
ACCACCACC
TATATCTAGGATCCACCACAACCTACGACC
GCCACCATGACGACGACGAC
CCAATACCGCCATGACGACGACGACAAAGA
TAATTAGTAT
AAATATCTACATGACGACGACGACAAAGAT
CAACACACC
GGTGACAGACTCACCCACGACGACGACGAC
AAACCATAAAGGTA
AATTAACATCACGACGACGACGACAAACCA
CAGCGCCAGC
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RLP fusions
Sequence
Name
45 phob S
45 phob AS
65 phob S
65 phob AS
45phobAS
stop
65phobAS
stop
RLP3-E-30GS
-30-GF 1S
-30-GF 1AS
-30-GF 2S
-30-GF 2AS
-30-GF 3AS
-65- phob W
S
RLP1_S
RLP1_AS
RLP1F_S
RLP1F_AS

Purpose
Isolate -45- block for fusion to
RLP3
Isolate -45- block for fusion to
RLP3
Isolate -65- block for fusion to
RLP3
Isolate -65- block for fusion to
RLP3
Add stop codon to end of -45block
Add stop codon to end of -65block
Add entrokinase site between
RLP3 and -30-G
Primers to make hydrophobic
block rich in G and F
Primers to make hydrophobic
block rich in G and F
Primers to make hydrophobic
block rich in G and F
Primers to make hydrophobic
block rich in G and F
Primers to make hydrophobic
block rich in G and F
Add a W at the beginning of the
hydrophobic block when fused
to RLP
Oligos to make RLP1 with
KGAP
Oligos to make RLP1 with
KGAP
Oligos to make RLP1 with
FGAP
Oligos to make RLP1 with
FGAP

Sequence
AATATCTGTGGATCCATCACCCTCGTCG
ACAGATATTCTCGAGGAACGTACCCGAAG
AATATCTGTGGATCCATAACCGGAATC
ACAGATATTCTCGAGGACTGGAACCGAC
ACAGATATTCTCGAGTCAGAACGTACCCGA
AG
ACAGATATTCTCGAGTCAGACTGGAACCGA
C
TTTATCCATGGATCCGACGACGACGACAAA
TGGCTCGCTCTCGGTGC
TTCGCGACTCCGCTGTTTGGTGTTTTTATAG
GTTTCAGC
AATAAACGCTATACCCATCGCGGATGGAAC
AATAACAGG
TTTATCCATGGATCCTTTCTCGCTCTCGGTTT
CGCGACTCC
TAACGAAACCCGCAAGCCCAATAAACGCTA
TACC
GTAACTATACTCGAGTCAAAACCCGGTAAC
GAAACC
AATATCTGTGGATCCTGGATAACCGGAATC
GATCTGGCGGCCGCCCGTCTGATAGCAAAG
GCGCACCGGGTGGTGGTAACG
GATCCGTTACCACCACCCGGTGCGCCTTTGC
TATCAGACGGGCGGCCGCCA
GATCTGGCGGCCGCCCGTCTGATAGCTTTG
GCGCACCGGGTGGTGGTAACG
GATCCGTTACCACCACCCGGTGCGCCAAAG
CTATCAGACGGGCGGCCGCCA

Charged Oleosin Mutants
Sequence
Name

30GminusW
1S

!

Purpose

Primer to extend arms to make
all anionic arms

Sequence
GATCAGCATGATCAACACACCGGTGACCAG
CTCACCCACCCACAGGACCAGCAACAAGGC
CCCTCAACCGGCGAACTCGCTCTCGGTGCG
ACTCC
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30GminusW
2S

Primer to extend arms to make
all anionic arms

30GminusW
1AS

Primer to extend arms to make
all anionic arms

30GminusW
2AS

Primer to extend arms to make
all anionic arms

30GminusW
3AS
GminusW
35S
GminusW
42AS
GminusW
25S
GminusW
30AS

Primer to extend arms to make
all anionic arms

87-W S

87-W AS

65-W S

65-W AS

45-W S

45-W AS

!

Truncation of Oleosin-30-G-W
Truncation of Oleosin-30-G-W
Truncation of Oleosin-30-G-W
Truncation of Oleosin-30-G-W
Primer off of the -87hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.
Primer off of the -87hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.
Primer off of the -65hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.
Primer off of the -65hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.
Primer off of the -45hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.
Primer off of the -45hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.

AATTCAATAGGATCCGAAGCCACCACAACC
AACGACCAGCACCATGTCACCACCACCCAA
CCCCAAGATCAGCATGATCAACACACC
TATCTGCTGGCCCAAGTCGTTCGTGTTCTGG
CCCGTCTGCTCCCCCACATCCTGCAATTCCC
CGTTCACGTTATCCTGCCACTGAAACCCGGT
AACACC
TTCTGCCCTTCGTTCCCACCACCCTGACCCT
GACCCTGGCCCTGGTCACCCATTTCATGGGC
CGTATGCTGTATCTGCTGGCCCAAGTCG
TTTATGAATCTCGAGTCAGTCATCGTGGTGG
TGGTGGTGGTGGTTCCCCCCTTCGTTCTGCC
CTTCGTTCCCACC
AATATTCATGGATCCCAGCACCATGTCACC
TTTAGATATCTCGAGTCAGTCATCGTGGTGG
TGGTGGTGGTGACCCATTTCATGG
AATATTCATGGATCCGATCAGCATGATCAA
CACACC
TTTAGATATCTCGAGTCAGTCATCGTGGTGG
TGGTGGTGGTGCAAGTCGTTCGTGTTCTGG
GATCAGCATGATCAACACACCGGTGACCAG
CTCACCCACCCACAGGACCAGCAACAAGGC
CCCTCAACCGGCGAAATAATGGTCATCATG
G
TATCTGCTGGCCCAAGTCGTTCGTGTTCTGG
CCCGTCTGCTCCCCCACATCCTGCAATTCCC
CGTTCACGTTATCCTGCCAGACTGGAACCG
ACATTGTCG
GATCAGCATGATCAACACACCGGTGACCAG
CTCACCCACCCACAGGACCAGCAACAAGGC
CCCTCAACCGGCGAAATAACCGGAATCTTG
TTTGG
TATCTGCTGGCCCAAGTCGTTCGTGTTCTGG
CCCGTCTGCTCCCCCACATCCTGCAATTCCC
CGTTCACGTTATCCTGCCAGACTGGAACCG
ACATTGTCG
GATCAGCATGATCAACACACCGGTGACCAG
CTCACCCACCCACAGGACCAGCAACAAGGC
CCCTCAACCGGCGAAATCACCCTCGTCG
TATCTGCTGGCCCAAGTCGTTCGTGTTCTGG
CCCGTCTGCTCCCCCACATCCTGCAATTCCC
CGTTCACGTTATCCTGCCAGAACGTACCCG
AAGTC
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30-W S

30-W AS

!

Primer off of the -30hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.
Primer off of the -30hydrophobic core to make
negative arms. Use the Oleosin30-G-W primers to continue to
extend the arms.

30G+ W S
30G+ W AS

Primer used to make -30-G+W

30G+W 1S

Primer used to make -30-G+W

30G+W 2S

Primer used to make -30-G+W

30G+W 3S

Primer used to make -30-G+W

30G+W 1AS

Primer used to make -30-G+W

30G+W 2AS

Primer used to make -30-G+W

30G+W 3AS

Primer used to make -30-G+W

30G+W 4AS

Primer used to make -30-G+W

30G+W 5AS

Primer used to make -30-G+W

30G+W 6AS

Primer used to make -30-G+W

30G+W 7AS

Primer used to make -30-G+W

30G+W 8AS

Primer used to make -30-G+W

Primer used to make -30-G+W

GATCAGCATGATCAACACACCGGTGACCAG
CTCACCCACCCACAGGACCAGCAACAAGGC
CCCTCAACCGGCGAACTCGCTCTCGCGACT
CC
TATCTGCTGGCCCAAGTCGTTCGTGTTCTGG
CCCGTCTGCTCCCCCACATCCTGCAATTCCC
CGTTCACGTTATCCTGCCAAAACCCGGTAA
CCGCAAGC
GTTACCGGGTTTCAGTGGAACAAAGTGAAG
G
CCTTCACTTTGTTCCACTGAAACCCGGTAAC
AACCCCAAAAACGCCATAACCAACACACCG
GTAACAGACTCACCCACC
AAAAACCGCCACCATGTCACCACCACCCAA
CCCCAAAAACG
ATAACTTATGGATCCGCCACCACAACCAAA
AACCGCCACC
TGAAACCTATAACACCAAACAGCGGAGTCG
CACCGAGAGCGAGCTTGC
ATCGCTATACCCATCGCTGGAACAATAACA
GGGCTGAAACCTATAACACC
TTCCACTGAAACCCGGTAACACCCGCAAGC
CCAATCGCTATACCCATCG
TTTCTGCCCCACGTTCTGCAACTTCCCCTTC
ACTTTGTTCCACTGAAACC
TATCTTCTGGCCCAAGTTCTTCGTCTTCTGG
CCCGTTTTCTGCCCCACG
TGGCCCTGGTTACCCATCTGATGGGCCGTAT
GCTGTATCTTCTGG
TTCGCCCCTGTTTCCCACCACCCTGACCCTG
ACCCTGGCCCTGGTTACC
ATATAGTATCTCGAGTTTCCCCCCCTGTTTT
CGCCCCTGTTTCC
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Appendix 2: DNA Sequences
Name (s)
BamUK
cloning sites

Avitag

TAT-linker

!

Description
Cloning sites for
BamUK. This is useful
for sequencing to make
sure that you don't have
the original gene.
Avi-tag gene (biotin
binding site). Can be
added to the N-terminus
of the protein and
reacted with BirA to
bind biotin specifically
to the K in the
sequence.
TAT ligand can be
fused to the N-terminus
to provide cell binding.
There is a (GGGGS)3
linker between the
protein and the tag.

DNA sequence
ATACATATGGGATCCATGGCCGGAATTCGAGCTCC
GTCGACAAGCTTGCGGCCGCACTCGAGCACCACCA
CCACCACCACTGA

GGTCTGAACGACATCTTCGAGGCTCAGAAAATCG
AATGGCACGAA

TCAATGCATATGGGTCGTAAAAAACGTCGTCAGC
GTCGTCGTCCGCAGGGTGGTGGTTCTGGTGGTGGT
TCTGGTGGTGGTTCTGGTGGTGGTTCTGGATCCTC
AATG

Oleosin, 4287-57

Full length wild type
sunflower seed. Low
expression. Inclusion
bodies. Low solubility
in aqueous solutions.
Soluble in
organic/aqueous
mixtures.

ATGGCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGATAATGGTCA
TCATGGCCTTACTTCCAATAACCGGAATCTTGTTT
GGTTTAGCCGGTATCACCCTCGTCGGGACGGTTAT
CGGGCTCGCTCTCGCGACTGGAGGCGGTGGGAGC
GCGATGATAGCGATTGGGCTTGCGGTTACCGGGT
TTTTGACTTCGGGTACGTTCGGGTTAACGGGGTTA
AGCTCGTTGTCGTATTTGTTTAATATGGTGAGGCG
GTCGACAATGTCGGTTCCAGTCCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAGGGTGAGAA
AGAATTT

7-87-7

Truncation mutant of
42-87-63 where both
hydrophilic arms are
truncated to 7 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

GGATCCCCCTCAACCGGCAAGATAATGGTCATCA
TGGCCTTACTTCCAATAACCGGAATCTTGTTTGGT
TTAGCCGGTATCACCCTCGTCGGGACGGTTATCGG
GCTCGCTCTCGCGACTCCGCTGTTTGTTATATTCA
GCCCTGTTATTGTTCCAGCGATGATAGCGATTGGG
CTTGCGGTTACCGGGTTTTTGACTTCGGGTACGTT
CGGGTTAACGGGGTTAAGCTCGTTGTCGTATTTGT
TTAATATGGTGAGGCGGTCGACAATGTCGGTTCC
AGTCCAGAGGGATTATGTGCTCGAG
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7-87-57

42-87-7

12-87-27

7-87-12

!

Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm is truncated to 7
amino acids and the Cterminal arm remains
the full length. Low
expression. Inclusion
bodies. Low solubility
in aqueous solutions.
Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm remains the native
length and the Cterminal arm is
truncated to 7 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm is truncated to 27
amino acids and the Cterminal arm is
truncated to 27 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm is truncated to 7
amino acids and the Cterminal arm is
truncated to 12 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

GGATCCCCCTCAACCGGCAAGATAATGGTCATCA
TGGCCTTACTTCCAATAACCGGAATCTTGTTTGGT
TTAGCCGGTATCACCCTCGTCGGGACGGTTATCGG
GCTCGCTCTCGCGACTCCGCTGTTTGTTATATTCA
GCCCTGTTATTGTTCCAGCGATGATAGCGATTGGG
CTTGCGGTTACCGGGTTTTTGACTTCGGGTACGTT
CGGGTTAACGGGGTTAAGCTCGTTGTCGTATTTGT
TTAATATGGTGAGGCGGTCGACAATGTCGGTTCC
AGTCCAGAGGGATTATGTGAAGGGGAAGTTGCAG
GATGTGGGGGAGTATACGGGCCAGAAGACGAAG
GACTTGGGCCAGAAGATACAGCATACGGCCCATG
AAATGGGTGACCAGGGCCAGGGTCAGGGTCAGG
GTGGTGGGAAAGAAGGGCGAAAAGAAGGGGGGA
AACTCGAG
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGATAATGGTCA
TCATGGCCTTACTTCCAATAACCGGAATCTTGTTT
GGTTTAGCCGGTATCACCCTCGTCGGGACGGTTAT
CGGGCTCGCTCTCGCGACTCCGCTGTTTGTTATAT
TCAGCCCTGTTATTGTTCCAGCGATGATAGCGATT
GGGCTTGCGGTTACCGGGTTTTTGACTTCGGGTAC
GTTCGGGTTAACGGGGTTAAGCTCGTTGTCGTATT
TGTTTAATATGGTGAGGCGGTCGACAATGTCGGTT
CCAGTCCAGAGGGATTATGTGCTCGAG
GGATCCCGCCAGCAACAAGGCCCCTCAACCGGCA
AGATAATGGTCATCATGGCCTTACTTCCAATAACC
GGAATCTTGTTTGGTTTAGCCGGTATCACCCTCGT
CGGGACGGTTATCGGGCTCGCTCTCGCGACTCCG
CTGTTTGTTATATTCAGCCCTGTTATTGTTCCAGC
GATGATAGCGATTGGGCTTGCGGTTACCGGGTTTT
TGACTTCGGGTACGTTCGGGTTAACGGGGTTAAG
CTCGTTGTCGTATTTGTTTAATATGGTGAGGCGGT
CGACAATGTCGGTTCCAGTCCAGAGGGATTATGT
GAAGGGGAAGTTGCAGGATGTGGGGGAGTATAC
GGGCCAGAAGACGAAGGACTTGGGCCAGCTCGA
G
GGATCCCCCTCAACCGGCAAGATAATGGTCATCA
TGGCCTTACTTCCAATAACCGGAATCTTGTTTGGT
TTAGCCGGTATCACCCTCGTCGGGACGGTTATCGG
GCTCGCTCTCGCGACTCCGCTGTTTGTTATATTCA
GCCCTGTTATTGTTCCAGCGATGATAGCGATTGGG
CTTGCGGTTACCGGGTTTTTGACTTCGGGTACGTT
CGGGTTAACGGGGTTAAGCTCGTTGTCGTATTTGT
TTAATATGGTGAGGCGGTCGACAATGTCGGTTCC
AGTCCAGAGGGATTATGTGAAGGGGAAGTTGCAG
CTCGAG
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12-87-12

22-87-37

42-87-32

!

Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm is truncated to 12
amino acids and the Cterminal arm is
truncated to 12 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm is truncated to 22
amino acids and the Cterminal arm is
truncated to 37 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm remains the native
length and the Cterminal arm is
truncated to 32 amino
acids.Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

GGATCCCGCCAGCAACAAGGCCCCTCAACCGGCA
AGATAATGGTCATCATGGCCTTACTTCCAATAACC
GGAATCTTGTTTGGTTTAGCCGGTATCACCCTCGT
CGGGACGGTTATCGGGCTCGCTCTCGCGACTCCG
CTGTTTGTTATATTCAGCCCTGTTATTGTTCCAGC
GATGATAGCGATTGGGCTTGCGGTTACCGGGTTTT
TGACTTCGGGTACGTTCGGGTTAACGGGGTTAAG
CTCGTTGTCGTATTTGTTTAATATGGTGAGGCGGT
CGACAATGTCGGTTCCAGTCCAGAGGGATTATGT
GAAGGGGAAGTTGCAGCTCGAG
GGATCCCACACCGGTGACAGACTCACCCACCCAC
AGCGCCAGCAACAAGGCCCCTCAACCGGCAAGAT
AATGGTCATCATGGCCTTACTTCCAATAACCGGA
ATCTTGTTTGGTTTAGCCGGTATCACCCTCGTCGG
GACGGTTATCGGGCTCGCTCTCGCGACTCCGCTGT
TTGTTATATTCAGCCCTGTTATTGTTCCAGCGATG
ATAGCGATTGGGCTTGCGGTTACCGGGTTTTTGAC
TTCGGGTACGTTCGGGTTAACGGGGTTAAGCTCGT
TGTCGTATTTGTTTAATATGGTGAGGCGGTCGACA
ATGTCGGTTCCAGTCCAGAGGGATTATGTGAAGG
GGAAGTTGCAGGATGTGGGGGAGTATACGGGCCA
GAAGACGAAGGACTTGGGCCAGAAGATACAGCA
TACGGCCCATGAAATGGGTCTCGAG
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGATAATGGTCA
TCATGGCCTTACTTCCAATAACCGGAATCTTGTTT
GGTTTAGCCGGTATCACCCTCGTCGGGACGGTTAT
CGGGCTCGCTCTCGCGACTCCGCTGTTTGTTATAT
TCAGCCCTGTTATTGTTCCAGCGATGATAGCGATT
GGGCTTGCGGTTACCGGGTTTTTGACTTCGGGTAC
GTTCGGGTTAACGGGGTTAAGCTCGTTGTCGTATT
TGTTTAATATGGTGAGGCGGTCGACAATGTCGGTT
CCAGTCCAGAGGGATTATGTGAAGGGGAAGTTGC
AGGATGTGGGGGAGTATACGGGCCAGAAGACGA
AGGACTTGGGCCAGAAGATACAGCATACGCTCGA
G

203!

!

17-87-17,
Oleo phobic

Truncation mutant of
42-87-63 where the Nterminal hydrophilic
arm is truncated to 17
amino acids and the Cterminal arm is
truncated to 17 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

CATATGCGCCATGATCAACACACCGGTGACAGAC
TCACCCACCCACAGCGCCAGCAACAAGGCCCCTC
AACCGGCAAGATAATGGTCATCATGGCCTTACTT
CCAATAACCGGAATCTTGTTTGGTTTAGCCGGTAT
CACCCTCGTCGGGACGGTTATCGGGCTCGCTCTCG
CGACTCCGCTGTTTGTTATATTCAGCCCTGTTATT
GTTCCAGCGATGATAGCGATTGGGCTTGCGGTTA
CCGGGTTTTTGACTTCGGGTACGTTCGGGTTAACG
GGGTTAAGCTCGTTGTCGTATTTGTTTAATATGGT
GAGGCGGTCGACAATGTCGGTTCCAGTCCAGAGG
GATTATGTGAAGGGGAAGTTGCAGGATGTGGGGG
AGTATACGGGCCAGAAGACGAAGGACTTGGGCCA
GAAGATACAGCATACGGCCCATGAAATGGGTGAC
CAGGGCCTCGAGCACCACCACCACCACCAC

27-87-12

Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm is truncated to 27
amino acids and the Cterminal arm is
truncated to 12 amino
acids. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

GGATCCTACCGCCATGATCAACACACCGGTGACA
GACTCACCCACCCACAGCGCCAGCAACAAGGCCC
CTCAACCGGCAAGATAATGGTCATCATGGCCTTA
CTTCCAATAACCGGAATCTTGTTTGGTTTAGCCGG
TATCACCCTCGTCGGGACGGTTATCGGGCTCGCTC
TCGCGACTCCGCTGTTTGTTATATTCAGCCCTGTT
ATTGTTCCAGCGATGATAGCGATTGGGCTTGCGGT
TACCGGGTTTTTGACTTCGGGTACGTTCGGGTTAA
CGGGGTTAAGCTCGTTGTCGTATTTGTTTAATATG
GTGAGGCGGTCGACAATGTCGGTTCCAGTCCAGA
GGGATTATGTGAAGGGGAAGTTGCAGCTCGAG

22-87-12

. Low expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

42-65-57,
oleo philic

Truncation mutant of
42-87-57 where the
hydrophobic domain is
truncated at both
junction points leaving
65 amino acids in the
core. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

GGATCCCACACCGGTGACAGACTCACCCACCCAC
AGCGCCAGCAACAAGGCCCCTCAACCGGCAAGAT
AATGGTCATCATGGCCTTACTTCCAATAACCGGA
ATCTTGTTTGGTTTAGCCGGTATCACCCTCGTCGG
GACGGTTATCGGGCTCGCTCTCGCGACTCCGCTGT
TTGTTATATTCAGCCCTGTTATTGTTCCAGCGATG
ATAGCGATTGGGCTTGCGGTTACCGGGTTTTTGAC
TTCGGGTACGTTCGGGTTAACGGGGTTAAGCTCGT
TGTCGTATTTGTTTAATATGGTGAGGCGGTCGACA
ATGTCGGTTCCAGTCCAGAGGGATTATGTGAAGG
GGAAGTTGCAGCTCGAG
CATATGGCCACCACAACCTACGACCGCCACCATG
TCACCACCACCCAACCCCAATACCGCCATGATCA
ACACACCGGTGACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGATAACCG
GAATCTTGTTTGGTTTAACCGGTATCACCCTCGTC
GGGACGGTTATCGGGCTCGCTCTCGCGACTCCGCT
GTTTGTTATATTCAGCCCTGTTATTGTTCCAGCGA
TGATAGCGATTGGGCTTGCGGTTACCGGGTTTTTG
ACTTCGGGTACGTTCGGGTTAACGCGGTCGACAA
TGTCGGTTCCAGTCCAGAGGGATTATGTGAAGGG
GAAGTTGCAGGATGTGGGGGAGTATACGGGCCAG
AAGACGAAGGACTTGGGCCAGAAGATACAGCAT
ACGGCCCATGAAATGGGTGACCAGGGCCAGGGTC
AGGGTCAGGGTGGTGGGAAAGAAGGGCGAAAAG
AAGGGGGGAAACTCGAGCACCACCACCACCACCA
C

204!

7-65-7

12-65-12

17-65-17

27-65-27

!

Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm remains the native
length and the Cterminal arm is
truncated to 32 amino
acids. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm is truncated to 12
amino acids and the Cterminal arm is
truncated to 12 amino
acids. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm is truncated to 17
amino acids and the Cterminal arm is
truncated to 17 amino
acids. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm is truncated to 27
amino acids and the Cterminal arm is
truncated to 27 amino
acids. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.

GGATCCCCCTCAACCGGCAAGATAATGGGAATCT
TGTTTGGTTTAACCGGTATCACCCTCGTCGGGACG
GTTATCGGGCTCGCTCTCGCGACTCCGCTGTTTGT
TATATTCAGCCCTGTTATTGTTCCAGCGATGATAG
CGATTGGGCTTGCGGTTACCGGGTTTTTGACTTCG
GGTACGTTCGGGTTAACGCGGTCGACAATGTCGG
TTCCAGTCCAGAGGGATTATGTGCTCGAG

GGATCCCGCCAGCAACAAGGCCCCTCAACCGGCA
AGATAACCGGAATCTTGTTTGGTTTAACCGGTATC
ACCCTCGTCGGGACGGTTATCGGGCTCGCTCTCGC
GACTCCGCTGTTTGTTATATTCAGCCCTGTTATTG
TTCCAGCGATGATAGCGATTGGGCTTGCGGTTACC
GGGTTTTTGACTTCGGGTACGTTCGGGTTAACGCG
GTCGACAATGTCGGTTCCAGTCCAGAGGGAT

CTCACCCACCCACAGCGCCAGCAACAAGGCCCCT
CAACCGGCAAGATAACCGGAATCTTGTTTGGTTT
AACCGGTATCACCCTCGTCGGGACGGTTATCGGG
CTCGCTCTCGCGACTCCGCTGTTTGTTATATTCAG
CCCTGTTATTGTTCCAGCGATGATAGCGATTGGGC
TTGCGGTTACCGGGTTTTTGACTTCGGGTACGTTC
GGGTTAACGCGGTCGACAATGTCGGTTCCAGTCC
AGAGGGATTATGTGAAGGGGAAGTTGCAGGATGT
GGGGGAGTATCTCGAG
ATGGGTCTGAACGACATCTTCGAGGCTCAGAAAA
TCGAATGGCACGAAGGATCCTACCGCCATGATCA
ACACACCGGTGACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGATAACCG
GAATCTTGTTTGGTTTAACCGGTATCACCCTCGTC
GGGACGGTTATCGGGCTCGCTCTCGCGACTCCGCT
GTTTGTTATATTCAGCCCTGTTATTGTTCCAGCGA
TGATAGCGATTGGGCTTGCGGTTACCGGGTTTTTG
ACTTCGGGTACGTTCGGGTTAACGCGGTCGACAA
TGTCGGTTCCAGTCCAGAGGGATTATGTGAAGGG
GAAGTTGCAGGATGTGGGGGAGTATACGGGCCAG
AAGACGAAGGACTTGGGCCAGCTCGAGCACCACC
ACCACCACCAC

205!

42-65-7

7-65-57

17-65-17-tat

RGD-GGGS27-65-27

!

Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm remains the native
length and the Cterminal arm is
truncated to 7 amino
acids. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm is truncated to 7
amino acids and the Cterminal arm remains
the native length. High
expression. Inclusion
bodies. Low solubility
in aqueous solutions.
Soluble in
organic/aqueous
mixtures.
Truncation mutant of
42-65-63 where the Nterminal hydrophilic
arm is truncated to 17
amino acids and the Cterminal arm is
truncated to 17 amino
acids. High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
27-65-27 with a
terminal RGD site on
the N-terminus. High
expression. Inclusion
bodies. Low solubility
in aqueous solutions.
Soluble in
organic/aqueous
mixtures.

GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGATAATGGGAA
TCTTGTTTGGTTTAACCGGTATCACCCTCGTCGGG
ACGGTTATCGGGCTCGCTCTCGCGACTCCGCTGTT
TGTTATATTCAGCCCTGTTATTGTTCCAGCGATGA
TAGCGATTGGGCTTGCGGTTACCGGGTTTTTGACT
TCGGGTACGTTCGGGTTAACGCGGTCGACAATGT
CGGTTCCAGTCCAGAGGGATTATGTGCTCGAG

GGATCCCCCTCAACCGGCAAGATAACCGGAATCT
TGTTTGGTTTAACCGGTATCACCCTCGTCGGGACG
GTTATCGGGCTCGCTCTCGCGACTCCGCTGTTTGT
TATATTCAGCCCTGTTATTGTTCCAGCGATGATAG
CGATTGGGCTTGCGGTTACCGGGTTTTTGACTTCG
GGTACGTTCGGGTTAACGCGGTCGACAATGTCGG
TTCTCGAG

CATATGGGTCGTAAAAAACGTCGTCAGCGTCGTC
GTCCGCAGGGTGGTGGTTCTGGTGGTGGTTCTGGT
GGTGGTTCTGGTGGTGGTTCTGGATCCCTCACCCA
CCCACAGCGCCAGCAACAAGGCCCCTCAACCGGC
AAGATAACCGGAATCTTGTTTGGTTTAACCGGTAT
CACCCTCGTCGGGACGGTTATCGGGCTCGCTCTCG
CGACTCCGCTGTTTGTTATATTCAGCCCTGTTATT
GTTCCAGCGATGATAGCGATTGGGCTTGCGGTTA
CCGGGTTTTTGACTTCGGGTACGTTCGGGTTAACG
CGGTCGACAATGTCGGTTCCAGTCCAGAGGGATT
ATGTGAAGGGGAAGTTGCAGGATGTGGGGGAGTA
TCTCGAG
ATGCGCGGCGATAGCGGCGGCGGCGGATCCTACC
GCCATGATCAACACACCGGTGACAGACTCACCCA
CCCACAGCGCCAGCAACAAGGCCCCTCAACCGGC
AAGATAACCGGAATCTTGTTTGGTTTAACCGGTAT
CACCCTCGTCGGGACGGTTATCGGGCTCGCTCTCG
CGACTCCGCTGTTTGTTATATTCAGCCCTGTTATT
GTTCCAGCGATGATAGCGATTGGGCTTGCGGTTA
CCGGGTTTTTGACTTCGGGTACGTTCGGGTTAACG
CGGTCGACAATGTCGGTTCCAGTCCAGAGGGATT
ATGTGAAGGGGAAGTTGCAGGATGTGGGGGAGTA
TACGGGCCAGAAGACGAAGGACTTGGGCCAGCTC
GAGCACCACCACCACCACCAC

206!

27-65-27 no
avi

Half Oleo 3

BU

1/2O-N 2430

!

27-65-27 without the
avi-tag on the Nterminus. High
expression. Inclusion
bodies. Low solubility
in aqueous solutions.
Soluble in
organic/aqueous
mixtures.
A half oleosin mutant of
the N-terminal
hydrophilic block and
half of the 87
hydrophobic block cut
after the proline knot.
High expression.
Inclusion bodies. Low
solubility in aqueous
solutions. Soluble in
organic/aqueous
mixtures.
Bottom up approach.
Taking pieces of oleosin
and connecting them to
get the optimal 1/2
oleosin. Little to no
expression
Short 1/2 oleosin of the
N-terminal domain. 24
hydrophilic amino acids
and 30 hydrophobic
amino acids. Little to no
expression

1/2 O 65

Diblock mutant of
oleosin-65. Little to no
expression

1/2O 30

Diblock mutant of
oleosin-30. Little to no
expression

GGATCCTACCGCCATGATCAACACACCGGTGACA
GACTCACCCACCCACAGCGCCAGCAACAAGGCCC
CTCAACCGGCAAGATAACCGGAATCTTGTTTGGTT
TAACCGGTATCACCCTCGTCGGGACGGTTATCGG
GCTCGCTCTCGCGACTCCGCTGTTTGTTATATTCA
GCCCTGTTATTGTTCCAGCGATGATAGCGATTGGG
CTTGCGGTTACCGGGTTTTTGACTTCGGGTACGTT
CGGGTTAACGCGGTCGACAATGTCGGTTCCAGTC
CAGAGGGATTATGTGAAGGGGAAGTTGCAGGATG
TGGGGGAGTATACGGGCCAGAAGACGAAGGACTT
GGGCCAGCTCGAGCACCACCACCACCACCAC
GGATCCCACCACCACCACCACCACGCCACCACAA
CCTACGACCGCCACCATGTCACCACCACCCAACC
CCAATACCGCCATGATCAACACACCGGTGACAGA
CTCACCCACCCACAGCGCCAGCAACAAGGCCCCT
CAACCGGCAAGATAATGGTCATCATGGCCTTACT
TCCAATAACCGGAATCTTGTTTGGTTTAGCCGGTA
TCACCCTCGTCGGGACGGTTATCGGGCTCGCTCTC
GCGACTCCGCTGTTTGTTATATTCAGCCCTGTTAT
TGTTCCAGCGATGATAGCGTGACTCGAG
CATATGCACCACCACCACCACCACACCCAACCCC
AACGCCATGATCAACACGGTGACAGAACCCACCA
GCGCAAGCGCATAGGAATCTTGTTTGGTTTAGGT
ATCCTCGTCGGGGTTATCGGGCTCGCTCTCGCGCC
GCTGTTTGTTATATTCTGACTCGAG
CATATGCACCACCACCACCACCACGATCAACACA
CCGGTGACAGACTCACCCACCCACAGCGCCAGCA
ACAAGGCCCCTCAACCGGCAAGATAACCGGAATC
TTGTTTGGTTTAACCGGTATCACCCTCGTCGGGAC
GGTTATCGGGCTCGCTCTCGCGACTCCGCTGTTTG
TTATATTCTGACTCGAG
GGATCCCACCACCACCACCACCACGCCACCACAA
CCTACGACCGCCACCATGTCACCACCACCCAACC
CCAATACCGCCATGATCAACACACCGGTGACAGA
CTCACCCACCCACAGCGCCAGCAACAAGGCCCCT
CAACCGGCAAGATAACCGGAATCTTGTTTGGTTT
AACCGGTATCACCCTCGTCGGGACGGTTATCGGG
CTCGCTCTCGCGACTCCGCTGTTTGTTATATTCAG
CCCTGTTATTGTTCCAGCGATGATAGCGTGACTCG
AG
GGATCCCACCACCACCACCACCACGCCACCACAA
CCTACGACCGCCACCATGTCACCACCACCCAACC
CCAATACCGCCATGATCAACACACCGGTGACAGA
CTCACCCACCCACAGCGCCAGCAACAAGGCCCCT
CAACCGGCAAGCTCGCTCTCGCGACTCCGCTGTTT
GTTATATTCAGCCCTGTTATTGTTCCAGCGATGAT
AGCGTGACTCGAG

207!

half -30G+W

Diblock mutant of
Oleosin-30-G+W. Does
not express well.

Phi 1

Hydrophilic N-terminal
domain of oleosin. Not
for individual
expression.

Phi2

Hydrophilic C-terminal
domain of oleosin. Not
for individual
expression.

Pho1

Pho2

!

Hydrophobic block with
the sequence
(WFGGFGGFGGFGGF
GGFGGFGGFGG). Not
for individual
expression.
Hydrophobic block with
the sequence
(WGGWGGFGGFGGL
GGLGGVGGAGG).
Not for individual
expression.

Pho 3, -30-G
hydrophobic

Hydrophobic block of
oleosin-30-G. Not for
individual expression.

Phi1-Pho1

Fusion of Phi1-Pho1

Phi1-Pho2

Fusion of Phi1-Pho2

GGATCCCTCGCTCTCGGTGCGACTCCGCTGTTTGG
TGTTATAGGTTTCAGCCCTGTTATTGTTCCAGCGA
TGGGTATAGCGATTGGGCTTGCGGGTGTTACCGG
GTTTCAGTGGAACAAAGTGAAGGGGAAGTTGCAG
AACGTGGGGCAGAAAACGGGCCAGAAGACGAAG
AACTTGGGCCAGAAGATACAGCATACGGCCCATC
AGATGGGTAACCAGGGCCAGGGTCAGGGTCAGG
GTGGTGGGAAACAGGGGCGAAAACAGGGGGGGA
AACTCGAG
ATGCACCACCACCACCACCACGCCACCACAACCT
ACGACCGCCACCATGTCACCACCACCCAACCCCA
ATACCGCCATGATCAACACACCGGTGACAGACTC
ACCCACCCACAGCGCCAGCAACAAGGCCCCTCAA
CCGGCAAG
ATGCACCACCACCACCACCACAGGGATTATGTGA
AGGGGAAGTTGCAGGATGTGGGGGAGTATACGG
GCCAGAAGACGAAGGACTTGGGCCAGAAGATAC
AGCATACGGCCCATGAAATGGGTGACCAGGGCCA
GGGTCAGGGTCAGGGTGGTGGGAAAGAAGGGCG
AAAAGAAGGGGGGAAA
TGGTTTGGTGGCTTCGGCGGTTTCGGGGGTTTCGG
TGGCTTTGGCGGTTTTGGTGGTTTCGGCGGCTTTG
GCGGTTGACTCGAG

TGGGGTGGCTGGGGCGGTTTTGGGGGTTTCGGTG
GCCTGGGCGGTCTGGGTGGTGTGGGCGGCGCGGG
CGGTTGACTCGAG
CTCGCTCTCGGTGCGACTCCGCTGTTTGGTGTTAT
AGGTTTCAGCCCTGTTATTGTTCCAGCGATGGGTA
TAGCGATTGGGCTTGCGGGTGTTACCGGGTTTTGA
CTCGAG
ATGCACCACCACCACCACCACGCCACCACAACCT
ACGACCGCCACCATGTCACCACCACCCAACCCCA
ATACCGCCATGATCAACACACCGGTGACAGACTC
ACCCACCCACAGCGCCAGCAACAAGGCCCCTCAA
CCGGCAAGTGGGGATCCTTTGGTGGCTTCGGCGG
TTTCGGGGGTTTCGGTGGCTTTGGCGGTTTTGGTG
GTTTCGGCGGCTTTGGCGGTTGACTCGAG
ATGCACCACCACCACCACCACGCCACCACAACCT
ACGACCGCCACCATGTCACCACCACCCAACCCCA
ATACCGCCATGATCAACACACCGGTGACAGACTC
ACCCACCCACAGCGCCAGCAACAAGGCCCCTCAA
CCGGCAAGGGATCCTGGGGTGGCTGGGGCGGTTT
TGGGGGTTTCGGTGGCCTGGGCGGTCTGGGTGGT
GTGGGCGGCGCGGGCGGTTGACTCGAG

208!

Phi2-Pho1

Fusion of Phi2-Pho1

Phi2-Pho2

Fusion of Phi2-Pho2

42-30-57,
Oleosin-30, 30-, oleo30

Truncation mutant of
42-87-57 where the
hydrophobic domain is
truncated at both
junction points leaving
30 amino acids in the
core. High expression.
Inclusion bodies.
Soluble after refolding.
Sensitive to salt and
buffer concentrations

37-30-37

27-30-27

!

Truncation mutant of
42-30-63 where the Nterminal hydrophilic
arm is truncated to 37
amino acids and the Cterminal arm is
truncated to 37 amino
acids. High expression.
Inclusion bodies.
Soluble after refolding.
Sensitive to salt and
buffer concentrations
and will aggregate over
time.
Truncation mutant of
42-30-63 where the Nterminal hydrophilic
arm is truncated to 27
amino acids and the Cterminal arm is
truncated to 27 amino
acids. High expression.
Inclusion bodies.
Soluble after refolding.
Aggregation over time.

ATGCACCACCACCACCACCACAGGGATTATGTGA
AGGGGAAGTTGCAGGATGTGGGGGAGTATACGG
GCCAGAAGACGAAGGACTTGGGCCAGAAGATAC
AGCATACGGCCCATGAAATGGGTGACCAGGGCCA
GGGTCAGGGTCAGGGTGGTGGGAAAGAAGGGCG
AAAAGAAGGGGGGAAAGGATCC
ATGCACCACCACCACCACCACAGGGATTATGTGA
AGGGGAAGTTGCAGGATGTGGGGGAGTATACGG
GCCAGAAGACGAAGGACTTGGGCCAGAAGATAC
AGCATACGGCCCATGAAATGGGTGACCAGGGCCA
GGGTCAGGGTCAGGGTGGTGGGAAAGAAGGGCG
AAAAGAAGGGGGGAAAGGATCCTGGGGTGGCTG
GGGCGGTTTTGGGGGTTTCGGTGGCCTGGGCGGT
CTGGGTGGTGTGGGCGGCGCGGGCGGTTGACTCG
AGTTTGGTGGCTTCGGCGGTTTCGGGGGTTTCGGT
GGCTTTGGCGGTTTTGGTGGTTTCGGCGGCTTTGG
CGGTTGACTCGAG
CATATGACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGCTCGCTCTCG
CGACTCCGCTGTTTGTTATATTCAGCCCTGTTATT
GTTCCAGCGATGATAGCGATTGGGCTTGCGGTTA
CCGGGTTTCAGAGGGATTATGTGAAGGGGAAGTT
GCAGGATGTGGGGGAGTATACGGGCCAGAAGAC
GAAGGACTTGGGCCAGAAGATACAGCATACGGCC
CATGAAATGGGTGACCAGGGCCAGGGTCAGGGTC
AGGGTGGTGGGAAAGAAGGGCGAAAAGAAGGGG
GGAAACTCGAG
GGATCCCGCCACCATGTCACCACCACCCAACCCC
AATACCGCCATGATCAACACACCGGTGACAGACT
CACCCACCCACAGCGCCAGCAACAAGGCCCCTCA
ACCGGCAAGCTCGCTCTCGCGACTCCGCTGTTTGT
TATATTCAGCCCTGTTATTGTTCCAGCGATGATAG
CGATTGGGCTTGCGGTTACCGGGTTTCAGAGGGA
TTATGTGAAGGGGAAGTTGCAGGATGTGGGGGAG
TATACGGGCCAGAAGACGAAGGACTTGGGCCAGA
AGATACAGCATACGGCCCATGAAATGGGTCTCGA
G

GGATCCTACCGCCATGATCAACACACCGGCGACA
GACTCACCCACCCACAGCGCCAGCAACAAGGCCC
CTCAACCGGCAAGCTCGCTCTCGCGACTCCGCTGT
TTGTTATATTCAGCCCTGCTATTGTTCCAGCGATG
ATAGCGATTGGGCTTGCGGTTACCGGGTTTCAGA
GGGATTATGTGAAGGGGAAGTTGCAGGATGTGGG
GGAGTATACGGGCCAGAAGACGAAGGACTTGGG
CCAGCTCGAG

209!

17-30-17

egfp

!

Truncation mutant of
42-30-63 where the Nterminal hydrophilic
arm is truncated to 17
amino acids and the Cterminal arm is
truncated to 17 amino
acids. High expression.
Inclusion bodies. Low
solubility after refolding
and will heavily
aggregate after elution
from the column.

GGATCCCTCACCCACCCACAGCGCCAGCAACAAG
GCCCCTCAACCGGCAAGCTCGCTCTCGCGACTCC
GCTGTTTGTTATATTCAGCCCTGTTATTGTTCCAG
CGATGATAGCGATTGGGCTTGCGGTTACCGGGTTT
CAGAGGGATTATGTGAAGGGGAAGTTGCAGGATG
TGGGGGAGTATCTCGAG

eGFP with a 6-his tag
for purification.
Soluble. Expresses well

ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGG
TGGTGCCCATCCTGGTCGAGCTGGACGGCGACGT
AAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGA
AGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGA
AGCAGCACGACTTCTTCAAGTCCGCCATGCCCGA
AGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACA
GCCACAACGTCTATATCATGGCCGACAAGCAGAA
GAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACC
ACTACCAGCAGAACACCCCCATCGGCGACGGCCC
CGTGCTGCTGCCCGACAACCACTACCTGAGCACC
CAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGC
GCGATCACATGGTCCTGCTGGAGTTCGTGACCGC
CGCCGGGATCACTCTCGGCATGGACGAGCTGTAC
AAG

210!

egfp-27-6527

!

eGFP fusion to 27-6527. Does not express
well.

CATATGGTGAGCAAGGGCGAGGAGCTGTTCACCG
GGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGA
CGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAG
GGCGAGGGCGATGCCACCTACGGCAAGCTGACCC
TGAAGTTCATCTGCACCACCGGCAAGCTGCCCGT
GCCCTGGCCCACCCTCGTGACCACCCTGACCTACG
GCGTGCAGTGCTTCAGCCGCTACCCCGACCACAT
GAAGCAGCACGACTTCTTCAAGTCCGCCATGCCC
GAAGGCTACGTCCAGGAGCGCACCATCTTCTTCA
AGGACGACGGCAACTACAAGACCCGCGCCGAGGT
GAAGTTCGAGGGCGACACCCTGGTGAACCGCATC
GAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAA
CAGCCACAACGTCTATATCATGGCCGACAAGCAG
AAGAACGGCATCAAGGTGAACTTCAAGATCCGCC
ACAACATCGAGGACGGCAGCGTGCAGCTCGCCGA
CCACTACCAGCAGAACACCCCCATCGGCGACGGC
CCCGTGCTGCTGCCCGACAACCACTACCTGAGCA
CCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAA
GCGCGATCACATGGTCCTGCTGGAGTTCGTGACC
GCCGCCGGGATCACTCTCGGCATGGACGAGCTGT
ACGGATCCTACCGCCATGATCAACACACCGGTGA
CAGACTCACCCACCCACAGCGCCAGCAACAAGGC
CCCTCAACCGGCAAGATAACCGGAATCTTGTTTG
GTTTAACCGGTATCACCCTCGTCGGGACGGTTATC
GGGCTCGCTCTCGCGACTCCGCTGTTTGTTATATT
CAGCCCTGTTATTGTTCCAGCGATGATAGCGATTG
GGCTTGCGGTTACCGGGTTTTTGACTTCGGGTACG
TTCGGGTTAACGCGGTCGACAATGTCGGTTCCAGT
CCAGAGGGATTATGTGAAGGGGAAGTTGCAGGAT
GTGGGGGAGTATACGGGCCAGAAGACGAAGGAC
TTGGGCCAGCTCGAGCACCACCACCACCACCAC

211!

egfp-42-3063

!

eGFP fusion to oleosin30. Expressed but stuck
to the column

CATATGGTGAGCAAGGGCGAGGAGCTGTTCACCG
GGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGA
CGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAG
GGCGAGGGCGATGCCACCTACGGCAAGCTGACCC
TGAAGTTCATCTGCACCACCGGCAAGCTGCCCGT
GCCCTGGCCCACCCTCGTGACCACCCTGACCTACG
GCGTGCAGTGCTTCAGCCGCTACCCCGACCACAT
GAAGCAGCACGACTTCTTCAAGTCCGCCATGCCC
GAAGGCTACGTCCAGGAGCGCACCATCTTCTTCA
AGGACGACGGCAACTACAAGACCCGCGCCGAGGT
GAAGTTCGAGGGCGACACCCTGGTGAACCGCATC
GAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAA
CAGCCACAACGTCTATATCATGGCCGACAAGCAG
AAGAACGGCATCAAGGTGAACTTCAAGATCCGCC
ACAACATCGAGGACGGCAGCGTGCAGCTCGCCGA
CCACTACCAGCAGAACACCCCCATCGGCGACGGC
CCCGTGCTGCTGCCCGACAACCACTACCTGAGCA
CCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAA
GCGCGATCACATGGTCCTGCTGGAGTTCGTGACC
GCCGCCGGGATCACTCTCGGCATGGACGAGCTGT
ACGGATCCGCCACCACAACCTACGACCGCCACCA
TGTCACCACCACCCAACCCCAATACCGCCATGAT
CAACACACCGGTGACAGACTCACCCACCCACAGC
GCCAGCAACAAGGCCCCTCAACCGGCAAGCTCGC
TCTCGCGACTCCGCTGTTTGTTATATTCAGCCCTG
TTATTGTTCCAGCGATGATAGCGATTGGGCTTGCG
GTTACCGGGTTTCAGAGGGATTATGTGAAGGGGA
AGTTGCAGGATGTGGGGGAGTATACGGGCCAGAA
GACGAAGGACTTGGGCCAGAAGATACAGCATACG
GCCCATGAAATGGGTGACCAGGGCCAGGGTCAGG
GTCAGGGTGGTGGGAAAGAAGGGCGAAAAGAAG
GGGGGAAACTCGAG

212!

egfp-42-3027

!

eGFP fusion to 42-3027. This mutant was
created to see if the 6his tag was not exposed
in the egfp-42-30-63
mutant. Expressed but
stuck to the column

CATATGGTGAGCAAGGGCGAGGAGCTGTTCACCG
GGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGA
CGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAG
GGCGAGGGCGATGCCACCTACGGCAAGCTGACCC
TGAAGTTCATCTGCACCACCGGCAAGCTGCCCGT
GCCCTGGCCCACCCTCGTGACCACCCTGACCTACG
GCGTGCAGTGCTTCAGCCGCTACCCCGACCACAT
GAAGCAGCACGACTTCTTCAAGTCCGCCATGCCC
GAAGGCTACGTCCAGGAGCGCACCATCTTCTTCA
AGGACGACGGCAACTACAAGACCCGCGCCGAGGT
GAAGTTCGAGGGCGACACCCTGGTGAACCGCATC
GAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAA
CAGCCACAACGTCTATATCATGGCCGACAAGCAG
AAGAACGGCATCAAGGTGAACTTCAAGATCCGCC
ACAACATCGAGGACGGCAGCGTGCAGCTCGCCGA
CCACTACCAGCAGAACACCCCCATCGGCGACGGC
CCCGTGCTGCTGCCCGACAACCACTACCTGAGCA
CCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAA
GCGCGATCACATGGTCCTGCTGGAGTTCGTGACC
GCCGCCGGGATCACTCTCGGCATGGACGAGCTGT
ACGGATCCGCCACCACAACCTACGACCGCCACCA
TGTCACCACCACCCAACCCCAATACCGCCATGAT
CAACACACCGGTGACAGACTCACCCACCCACAGC
GCCAGCAACAAGGCCCCTCAACCGGCAAGCTCGC
TCTCGCGACTCCGCTGTTTGTTATATTCAGCCCTG
TTATTGTTCCAGCGATGATAGCGATTGGGCTTGCG
GTTACCGGGTTTCAGAGGGATTATGTGAAGGGGA
AGTTGCAGGATGTGGGGGAGTATACGGGCCAGAA
GACGAAGGACTTGGGCCAGCTCGAG
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egfp-42-3012

eGFP fusion to 42-3012. This mutant was
created to see if the 6his tag was not exposed
in the egfp-42-30-63
mutant. Expressed but
stuck to the column

DewA

Hydrophobin DewA.
Expressed well.
Soluble

DewAW

DewA with W mutated
in on the N-terminus to
allow for fluor and
A280. Expressed well,
soluble.

CATATGGTGAGCAAGGGCGAGGAGCTGTTCACCG
GGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGA
CGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAG
GGCGAGGGCGATGCCACCTACGGCAAGCTGACCC
TGAAGTTCATCTGCACCACCGGCAAGCTGCCCGT
GCCCTGGCCCACCCTCGTGACCACCCTGACCTACG
GCGTGCAGTGCTTCAGCCGCTACCCCGACCACAT
GAAGCAGCACGACTTCTTCAAGTCCGCCATGCCC
GAAGGCTACGTCCAGGAGCGCACCATCTTCTTCA
AGGACGACGGCAACTACAAGACCCGCGCCGAGGT
GAAGTTCGAGGGCGACACCCTGGTGAACCGCATC
GAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAA
CAGCCACAACGTCTATATCATGGCCGACAAGCAG
AAGAACGGCATCAAGGTGAACTTCAAGATCCGCC
ACAACATCGAGGACGGCAGCGTGCAGCTCGCCGA
CCACTACCAGCAGAACACCCCCATCGGCGACGGC
CCCGTGCTGCTGCCCGACAACCACTACCTGAGCA
CCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAA
GCGCGATCACATGGTCCTGCTGGAGTTCGTGACC
GCCGCCGGGATCACTCTCGGCATGGACGAGCTGT
ACGGATCCGCCACCACAACCTACGACCGCCACCA
TGTCACCACCACCCAACCCCAATACCGCCATGAT
CAACACACCGGTGACAGACTCACCCACCCACAGC
GCCAGCAACAAGGCCCCTCAACCGGCAAGCTCGC
TCTCGCGACTCCGCTGTTTGTTATATTCAGCCCTG
TTATTGTTCCAGCGATGATAGCGATTGGGCTTGCG
GTTACCGGGTTTCAGAGGGATTATGTGAAGGGGA
AGTTGCAGCTCGAG
GGATCCGCCCTCCCGGCCTCTGCCGCAAAGAACG
CGAAGCTGGCCACCTCGGCGGCCTTCGCCAAGCA
GGCTGAAGGCACCACCTGCAATGTCGGCTCGATC
GCTTGCTGCAACTCCCCCGCTGAGACCAACAACG
ACAGTCTGTTGAGCGGTCTGCTCGGTGCTGGCCTT
CTCAACGGGCTCTCGGGCAACACTGGCAGCGCCT
GCGCCAAGGCGAGCTTGATTGACCAGCTGGGTCT
GCTCGCTCTCGTCGACCACACTGAGGAAGGCCCC
GTCTGCAAGAACATCGTCGCTTGCTGCCCTGAGG
GAACCACTTGTGTTGCCGTCGACAACGCTGGCGC
CGGTACCAAGGCTGAGCTCGAG
GGATCCGCCCTCCCGGCCTCTGCCGCAAAGAACG
CGAAGCTGGCCACCTCGGCGGCCTTCGCCAAGCA
GGCTGAAGGCACCACCTGCAATGTCGGCTCGATC
GCTTGCTGCAACTCCCCCGCTGAGACCAACAACG
ACAGTCTGTGGAGCGGTCTGCTCGGTGCTGGCCTT
CTCAACGGGCTCTCGGGCAACACTGGCAGCGCCT
GCGCCAAGGCGAGCTTGATTGACCAGCTGGGTCT
GCTCGCTCTCGTCGACCACACTGAGGAAGGCCCC
GTCTGCAAGAACATCGTCGCTTGCTGCCCTGAGG
GAACCACTTGTGTTGCCGTCGACAACGCTGGCGC
CGGTACCAAGGCTGAGCTCGAG

214!

GPF-DewA

!

GFP tagged on the Nterminus of DewA.
Expressed well, soluble.

ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGG
TGGTGCCCATCCTGGTCGAGCTGGACGGCGACGT
AAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGA
AGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGA
AGCAGCACGACTTCTTCAAGTCCGCCATGCCCGA
AGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACA
GCCACAACGTCTATATCATGGCCGACAAGCAGAA
GAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACC
ACTACCAGCAGAACACCCCCATCGGCGACGGCCC
CGTGCTGCTGCCCGACAACCACTACCTGAGCACC
CAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGC
GCGATCACATGGTCCTGCTGGAGTTCGTGACCGC
CGCCGGGATCACTCTCGGCATGGACGAGCTGTAC
GGATCCTGGGCCCTCCCGGCCTCTGCCGCAAAGA
ACGCGAAGCTGGCCACCTCGGCGGCCTTCGCCAA
GCAGGCTGAAGGCACCACCTGCAATGTCGGCTCG
ATCGCTTGCTGCAACTCCCCCGCTGAGACCAACA
ACGACAGTCTGTTGAGCGGTCTGCTCGGTGCTGG
CCTTCTCAACGGGCTCTCGGGCAACACTGGCAGC
GCCTGCGCCAAGGCGAGCTTGATTGACCAGCTGG
GTCTGCTCGCTCTCGTCGACCACACTGAGGAAGG
CCCCGTCTGCAAGAACATCGTCGCTTGCTGCCCTG
AGGGAACCACTTGTGTTGCCGTCGACAACGCTGG
CGCCGGTACCAAGGCTGAGCTCGAGCACCACCAC
CACCACCAC

215!

GFP-linkerDewAW

-30- G+

!

DewAW with eGFPlinker on the Nterminus

CATATGCACCACCACCACCACCACGTGAGCAAGG
GCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCT
GGTCGAGCTGGACGGCGACGTAAACGGCCACAAG
TTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCA
CCTACGGCAAGCTGACCCTGAAGTTCATCTGCAC
CACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTC
GTGACCACCCTGACCTACGGCGTGCAGTGCTTCA
GCCGCTACCCCGACCACATGAAGCAGCACGACTT
CTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAG
GAGCGCACCATCTTCTTCAAGGACGACGGCAACT
ACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGA
CACCCTGGTGAACCGCATCGAGCTGAAGGGCATC
GACTTCAAGGAGGACGGCAACATCCTGGGGCACA
AGCTGGAGTACAACTACAACAGCCACAACGTCTA
TATCATGGCCGACAAGCAGAAGAACGGCATCAAG
GTGAACTTCAAGATCCGCCACAACATCGAGGACG
GCAGCGTGCAGCTCGCCGACCACTACCAGCAGAA
CACCCCCATCGGCGACGGCCCCGTGCTGCTGCCC
GACAACCACTACCTGAGCACCCAGTCCGCCCTGA
GCAAAGACCCCAACGAGAAGCGCGATCACATGGT
CCTGCTGGAGTTCGTGACCGCCGCCGGGATCACT
CTCGGCATGGACGAGCTGTACGGCGGTGGCGGTA
GCGGAGGTGGCGGGTCTGGTGGGGGTGGCTCGGG
ATCCGGATCCTGGGCCCTCCCGGCCTCTGCCGCAA
AGAACGCGAAGCTGGCCACCTCGGCGGCCTTCGC
CAAGCAGGCTGAAGGCACCACCTGCAATGTCGGC
TCGATCGCTTGCTGCAACTCCCCCGCTGAGACCAA
CAACGACAGTCTGTTGAGCGGTCTGCTCGGTGCT
GGCCTTCTCAACGGGCTCTCGGGCAACACTGGCA
GCGCCTGCGCCAAGGCGAGCTTGATTGACCAGCT
GGGTCTGCTCGCTCTCGTCGACCACACTGAGGAA
GGCCCCGTCTGCAAGAACATCGTCGCTTGCTGCCC
TGAGGGAACCACTTGTGTTGCCGTCGACAACGCT
GGCGCCGGTACCAAGGCTGAGTGACTCGAG

Point mutations in the
hydrophobic block to
add Gs. Also remove charge in arms.
Expresses well.
Inclusion bodies.
Soluble after
purification

GGATCCGCCACCACAACCAAAAACCGCCACCATG
TCACCACCACCCAACCCCAAAAACGCCATAACCA
ACACACCGGTAACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGCTCGCTC
TCGGTGCGACTCCGCTGTTTGGTGTTATAGGTTTC
AGCCCTGTTATTGTTCCAGCGATGGGTATAGCGAT
TGGGCTTGCGGGTGTTACCGGGTTTCAGAGGAAC
AAAGTGAAGGGGAAGTTGCAGAACGTGGGGCAG
AAAACGGGCCAGAAGACGAAGAACTTGGGCCAG
AAGATACAGCATACGGCCCATCAGATGGGTAACC
AGGGCCAGGGTCAGGGTCAGGGTGGTGGGAAAC
AGGGGCGAAAACAGGGGGGGAAACTCGAG
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-30-G+W

Oleosin-30G with all
positive hydrophilic
arms. A single W is
added for A280.
Expresses well.
Inclusion bodies.
Soluble after
purification

GFP-linker

eGFP with a linker for
fusion to other mutants.
Not made for
expression

GGATCCGCCACCACAACCAAAAACCGCCACCATG
TCACCACCACCCAACCCCAAAAACGCCATAACCA
ACACACCGGTAACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGCTCGCTC
TCGGTGCGACTCCGCTGTTTGGTGTTATAGGTTTC
AGCCCTGTTATTGTTCCAGCGATGGGTATAGCGAT
TGGGCTTGCGGGTGTTACCGGGTTTCAGTGGAAC
AAAGTGAAGGGGAAGTTGCAGAACGTGGGGCAG
AAAACGGGCCAGAAGACGAAGAACTTGGGCCAG
AAGATACAGCATACGGCCCATCAGATGGGTAACC
AGGGCCAGGGTCAGGGTCAGGGTGGTGGGAAAC
AGGGGCGAAAACAGGGGGGGAAACTCGAG
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGG
TGGTGCCCATCCTGGTCGAGCTGGACGGCGACGT
AAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGA
AGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGA
AGCAGCACGACTTCTTCAAGTCCGCCATGCCCGA
AGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACA
GCCACAACGTCTATATCATGGCCGACAAGCAGAA
GAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACC
ACTACCAGCAGAACACCCCCATCGGCGACGGCCC
CGTGCTGCTGCCCGACAACCACTACCTGAGCACC
CAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGC
GCGATCACATGGTCCTGCTGGAGTTCGTGACCGC
CGCCGGGATCACTCTCGGCATGGACGAGCTGTAC
GGCGGTGGCGGTAGCGGAGGTGGCGGGTCTGGTG
GGGGTGGCTCGGGATCC

217!

GFP-linker30-G+

!

-30-G+ with eGFPlinker on the Nterminus. Fusion kills
expression. Very little
purified as the majority
of the protein sticks to
the column.

ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGG
TGGTGCCCATCCTGGTCGAGCTGGACGGCGACGT
AAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGA
AGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGA
AGCAGCACGACTTCTTCAAGTCCGCCATGCCCGA
AGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACA
GCCACAACGTCTATATCATGGCCGACAAGCAGAA
GAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACC
ACTACCAGCAGAACACCCCCATCGGCGACGGCCC
CGTGCTGCTGCCCGACAACCACTACCTGAGCACC
CAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGC
GCGATCACATGGTCCTGCTGGAGTTCGTGACCGC
CGCCGGGATCACTCTCGGCATGGACGAGCTGTAC
GGCGGTGGCGGTAGCGGAGGTGGCGGGTCTGGTG
GGGGTGGCTCGGGATCCGCCACCACAACCAAAAA
CCGCCACCATGTCACCACCACCCAACCCCAAAAA
CGCCATAACCAACACACCGGTAACAGACTCACCC
ACCCACAGCGCCAGCAACAAGGCCCCTCAACCGG
CAAGCTCGCTCTCGGTGCGACTCCGCTGTTTGGTG
TTATAGGTTTCAGCCCTGTTATTGTTCCAGCGATG
GGTATAGCGATTGGGCTTGCGGGTGTTACCGGGT
TTCAGAGGAACAAAGTGAAGGGGAAGTTGCAGA
ACGTGGGGCAGAAAACGGGCCAGAAGACGAAGA
ACTTGGGCCAGAAGATACAGCATACGGCCCATCA
GATGGGTAACCAGGGCCAGGGTCAGGGTCAGGGT
GGTGGGAAACAGGGGCGAAAACAGGGGGGGAAA
CTCGAG

218!
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6-his-gfplinker-30-

eGFP fusion to oleosin30 with the 6-his tag on
the N-terminus.
Moving the 6-his tag
does not help with
purification

-30-W M1

Tryptophan mutant of
Oleosin-30. Expresses
well. Inclusion bodies.
Soluble after
purification.

ATGCACCACCACCACCACCACGTGAGCAAGGGCG
AGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGT
CGAGCTGGACGGCGACGTAAACGGCCACAAGTTC
AGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCT
ACGGCAAGCTGACCCTGAAGTTCATCTGCACCAC
CGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTG
ACCACCCTGACCTACGGCGTGCAGTGCTTCAGCC
GCTACCCCGACCACATGAAGCAGCACGACTTCTT
CAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAG
CGCACCATCTTCTTCAAGGACGACGGCAACTACA
AGACCCGCGCCGAGGTGAAGTTCGAGGGCGACAC
CCTGGTGAACCGCATCGAGCTGAAGGGCATCGAC
TTCAAGGAGGACGGCAACATCCTGGGGCACAAGC
TGGAGTACAACTACAACAGCCACAACGTCTATAT
CATGGCCGACAAGCAGAAGAACGGCATCAAGGT
GAACTTCAAGATCCGCCACAACATCGAGGACGGC
AGCGTGCAGCTCGCCGACCACTACCAGCAGAACA
CCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGA
CAACCACTACCTGAGCACCCAGTCCGCCCTGAGC
AAAGACCCCAACGAGAAGCGCGATCACATGGTCC
TGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTC
GGCATGGACGAGCTGTACGGCGGTGGCGGTAGCG
GAGGTGGCGGGTCTGGTGGGGGTGGCTCGGGATC
CACCACAACCTACGACCGCCACCATGTCACCACC
ACCCAACCCCAATACCGCCATGATCAACACACCG
GTGACAGACTCACCCACCCACAGCGCCAGCAACA
AGGCCCCTCAACCGGCAAGCTCGCTCTCGCGACT
CCGCTGTTTGTTATATTCAGCCCTGTTATTGTTCCA
GCGATGATAGCGATTGGGCTTGCGGTTACCGGGT
TTCAGAGGGATTATGTGAAGGGGAAGTTGCAGGA
TGTGGGGGAGTATACGGGCCAGAAGACGAAGGA
CTTGGGCCAGAAGATACAGCATACGGCCCATGAA
ATGGGTGACCAGGGCCAGGGTCAGGGTCAGGGTG
GTGGGAAAGAAGGGCGAAAAGAAGGGGGGAAAT
GA
ATGGGATCCACCACAACCTACGACCGCCACCATG
TCACCACCACCCAACCCCAATACCGCCATGATCA
ACACACCGGTGACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGCTCGCTC
TCGCGACTCCGCTGTTTGTTATATGGAGCCCTGTT
ATTGTTCCAGCGATGATAGCGATTGGGCTTGCGGT
TACCGGGTTTCAGAGGGATTATGTGAAGGGGAAG
TTGCAGGATGTGGGGGAGTATACGGGCCAGAAGA
CGAAGGACTTGGGCCAGAAGATACAGCATACGGC
CCATGAAATGGGTGACCAGGGCCAGGGTCAGGGT
CAGGGTGGTGGGAAAGAAGGGCGAAAAGAAGGG
GGGAAACTCGAG
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-30-W M2

Tryptophan mutant of
Oleosin-30. Expresses
well. Inclusion bodies.
Soluble after
purification.

-30- W M3

Tryptophan mutant of
Oleosin-30. Expresses
well. Inclusion bodies.
Soluble after
purification.

42-45-63

Truncation mutant of
42-87-63 where the
hydrophobic block was
truncated to 45 amino
acids. Expresses well.
Inclusion bodies.
Soluble after
purification.

ATGGGATCCACCACAACCTACGACCGCCACCATG
TCACCACCACCCAACCCCAATACCGCCATGATCA
ACACACCGGTGACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGCTCGCTC
TCGCGACTCCGCTGTTTGTTATATTCAGCCCTGTT
ATTGTTCCAGCGATGATAGCGATTGGGCTTGCGGT
TACCGGGTGGCAGAGGGATTATGTGAAGGGGAAG
TTGCAGGATGTGGGGGAGTATACGGGCCAGAAGA
CGAAGGACTTGGGCCAGAAGATACAGCATACGGC
CCATGAAATGGGTGACCAGGGCCAGGGTCAGGGT
CAGGGTGGTGGGAAAGAAGGGCGAAAAGAAGGG
GGGAAACTCGAG
ATGGGATCCACCACAACCTACGACCGCCACCATG
TCACCACCACCCAACCCCAATACCGCCATGATCA
ACACACCGGTGACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGCTCGCTC
TCGCGACTCCGCTGTTTGTTATATTCAGCCCTGTT
ATTGTTCCAGCGATGATAGCGATTGGGCTTGCGGT
TACCGGGTTTCAGAGGGATTATGTGAAGGGGAAG
TTGCAGGATGTGGGGGAGTATACGGGCCAGAAGA
CGAAGGACTTGGGCCAGAAGATACAGCATACGGC
CCATGAAATGGGTGACCAGGGCCAGGGTCAGGGT
CAGGGTGGTGGGAAAGAAGGGCGAAAAGAAGGG
GGGAAATGGCTCGAG
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGATCACCCTCG
TCGGGACGGTTATCGGGCTCGCTCTCGCGACTCCG
CTGTTTGTTATATTCAGCCCTGTTATTGTTCCAGC
GATGATAGCGATTGGGCTTGCGGTTACCGGGTTTT
TGACTTCGGGTACGTTCCAGAGGGATTATGTGAA
GGGGAAGTTGCAGGATGTGGGGGAGTATACGGGC
CAGAAGACGAAGGACTTGGGCCAGAAGATACAG
CATACGGCCCATGAAATGGGTGACCAGGGCCAGG
GTCAGGGTCAGGGTGGTGGGAAAGAAGGGCGAA
AAGAAGGGGGGAAACTCGAG
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Her2-Clinker-30-

Her2-linker fused to
oleosin-30. A single C
was added for dying.
The C caused
aggregation unless it
was reduced.

-30- W M1avi

The -30- W M1 mutant
with the avi tag on the
N-terminus. Expressed
well. Inclusion bodies.
Soluble after
purification.

42-30G-63, 30-G,
Oleosin-30G

The oleosin 30 mutant
with 5 glycines added
into the hydrophobic
block. Expressed better
than Oleosin-30.
Inclusion bodies.
Highly soluble after
purification. Used in
microbubble project

GTGGATAACAAATTTAACAAAGAAATGCGCAACG
CGTATTGGGAAATTGCGCTGCTGCCGAACCTGAA
CAACCAGCAGAAACGCGCGTTTATTCGCAGCCTG
TATGATGATCCGAGCCAGAGCGCGAACCTGCTGG
CGGAAGCGAAAAAACTGAACGATGCGCAGGCGC
CGGGATCCACCACAACCTACGACCGCCACCATGT
CACCACCACCCAACCCCAATACCGCCATGATCAA
CACACCGGTGACAGACTCACCCACCCACAGCGCC
AGCAACAAGGCCCCTCAACCGGCAAGCTCGCTCT
CGCGACTCCGCTGTTTGTTATATTCAGCCCTGTTA
TTGTTCCAGCGATGATAGCGATTGGGCTTGCGGTT
ACCGGGTTTCAGAGGGATTATGTGAAGGGGAAGT
TGCAGGATGTGGGGGAGTATACGGGCCAGAAGAC
GAAGGACTTGGGCCAGAAGATACAGCATACGGCC
CATGAAATGGGTGACCAGGGCCAGGGTCAGGGTC
AGGGTGGTGGGAAAGAAGGGCGAAAAGAAGGGG
GGAAACTCGAGCACCACCACCACCACCACTGAAA
ATGCGGCGGTGGCGGTAGCGGAGGTGGCGGGTCT
GGTGGGGGTGGCTCGGGCGGTGGCGGTAGC
ATGGGTCTGAACGACATCTTCGAGGCTCAGAAAA
TCGAATGGCACGAAGGATCCACCACAACCTACGA
CCGCCACCATGTCACCACCACCCAACCCCAATAC
CGCCATGATCAACACACCGGTGACAGACTCACCC
ACCCACAGCGCCAGCAACAAGGCCCCTCAACCGG
CAAGCTCGCTCTCGCGACTCCGCTGTTTGTTATAT
GGAGCCCTGTTATTGTTCCAGCGATGATAGCGATT
GGGCTTGCGGTTACCGGGTTTCAGAGGGATTATG
TGAAGGGGAAGTTGCAGGATGTGGGGGAGTATAC
GGGCCAGAAGACGAAGGACTTGGGCCAGAAGAT
ACAGCATACGGCCCATGAAATGGGTGACCAGGGC
CAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGGG
CGAAAAGAAGGGGGGAAACTCGAGCACCACCAC
CACCACCAC
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGCTCGCTCTCG
GTGCGACTCCGCTGTTTGGTGTTATAGGTTTCAGC
CCTGTTATTGTTCCAGCGATGGGTATAGCGATTGG
GCTTGCGGGTGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAGCACCACCA
CCACCACCAC
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eGFP-4230G-63

eGFP fused to oleosin30G. Used to label
microbubbles. Soluble.
Low expression.

46E32-30-62

Oleosin-30 with an
enterokinase site that
cuts the N-terminal arm
down to 32 amino acids.
Expressed well.
Inclusion bodies.
Soluble after
purification.

ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGG
TGGTGCCCATCCTGGTCGAGCTGGACGGCGACGT
AAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGA
AGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGA
AGCAGCACGACTTCTTCAAGTCCGCCATGCCCGA
AGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACA
GCCACAACGTCTATATCATGGCCGACAAGCAGAA
GAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACC
ACTACCAGCAGAACACCCCCATCGGCGACGGCCC
CGTGCTGCTGCCCGACAACCACTACCTGAGCACC
CAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGC
GCGATCACATGGTCCTGCTGGAGTTCGTGACCGCT
GCCGGGATCACTCTCGGCATGGACGAGCTGTACA
AGGGATCCACCACAACCTACGACCGCCACCATGT
CACCACCACCCAACCCCAATACCGCCATGATCAA
CACACCGGTGACAGACTCACCCACCCACAGCGCC
AGCAACAAGGCCCCTCAACCGGCAAGCTCGCTCT
CGGTGCGACTCCGCTGTTTGGTGTTATAGGTTTCA
GCCCTGTTATTGTTCCAGCGATGGGTATAGCGATT
GGGCTTGCGGGTGTTACCGGGTTTCAGAGGGATT
ATGTGAAGGGGAAGTTGCAGGATGTGGGGGAGTA
TACGGGCCAGAAGACGAAGGACTTGGGCCAGAA
GATACAGCATACGGCCCATGAAATGGGTGACCAG
GGCCAGGGTCAGGGTCAGGGTGGTGGGAAAGAA
GGGCGAAAAGAAGGGGGGAAACTCGAGCACCAC
CACCACCACCAC
GGATCCACCACAACCTACGACCGCCACCATGACG
ACGACGACAAAGTCACCACCACCCAACCCCAATA
CCGCCATGATCAACACACCGGTGACAGACTCACC
CACCCACAGCGCCAGCAACAAGGCCCCTCAACCG
GCAAGCTCGCTCTCGCGACTCCGCTGTTTGTTATA
TTCAGCCCTGTTATTGTTCCAGCGATGATAGCGAT
TGGGCTTGCGGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAGCACCACCA
CCACCACCACTGA
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47E22-30-62

Oleosin-30 with an
enterokinase site that
cuts the N-terminal arm
down to 22 amino acids.
Expressed well.
Inclusion bodies.
Soluble after
purification.

47E12-30-62

Oleosin-30 with an
enterokinase site that
cuts the N-terminal arm
down to 12 amino acids.
Enterokinase didn't cut
well due to proline after
site Expressed well.
Inclusion bodies.
Soluble after
purification.

47E11-30-62

Oleosin-30 with an
enterokinase site that
cuts the N-terminal arm
down to 11 amino acids.
Expressed well.
Inclusion bodies.
Soluble after
purification.

CATATGACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGACGACGA
CGACAAA/GATCAACACACCGGTGACAGACTCAC
CCACCCACAGCGCCAGCAACAAGGCCCCTCAACC
GGCAAGCTCGCTCTCGCGACTCCGCTGTTTGTTAT
ATTCAGCCCTGTTATTGTTCCAGCGATGATAGCGA
TTGGGCTTGCGGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAGCACCACCA
CCACCACCACTGA
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCAGACGACGAC
GACAAACAGCGCCAGCAACAAGGCCCCTCAACCG
GCAAGCTCGCTCTCGCGACTCCGCTGTTTGTTATA
TTCAGCCCTGTTATTGTTCCAGCGATGATAGCGAT
TGGGCTTGCGGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAGCACCACCA
CCACCACCACTGA
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCAGACGACGAC
GACAAACAGCGCCAGCAACAAGGCCCCTCAACCG
GCAAGCTCGCTCTCGCGACTCCGCTGTTTGTTATA
TTCAGCCCTGTTATTGTTCCAGCGATGATAGCGAT
TGGGCTTGCGGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAG
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GFP-linker42E32-30-63

42E32-30-63 with
eGFP-linker on the Nterminus. Fusion kills
expression. Very little
purified as the majority
of the protein sticks to
the column.

RLP3-Pho1

RLP3 resilin fusion to
Pho1. Little to no
expression

RLP3-pho2

Trimer of resilin-likepolypeptide fused to
Pho2. Expressed well.

ATGCACCACCACCACCACCACGTGAGCAAGGGCG
AGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGT
CGAGCTGGACGGCGACGTAAACGGCCACAAGTTC
AGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCT
ACGGCAAGCTGACCCTGAAGTTCATCTGCACCAC
CGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTG
ACCACCCTGACCTACGGCGTGCAGTGCTTCAGCC
GCTACCCCGACCACATGAAGCAGCACGACTTCTT
CAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAG
CGCACCATCTTCTTCAAGGACGACGGCAACTACA
AGACCCGCGCCGAGGTGAAGTTCGAGGGCGACAC
CCTGGTGAACCGCATCGAGCTGAAGGGCATCGAC
TTCAAGGAGGACGGCAACATCCTGGGGCACAAGC
TGGAGTACAACTACAACAGCCACAACGTCTATAT
CATGGCCGACAAGCAGAAGAACGGCATCAAGGT
GAACTTCAAGATCCGCCACAACATCGAGGACGGC
AGCGTGCAGCTCGCCGACCACTACCAGCAGAACA
CCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGA
CAACCACTACCTGAGCACCCAGTCCGCCCTGAGC
AAAGACCCCAACGAGAAGCGCGATCACATGGTCC
TGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTC
GGCATGGACGAGCTGTACGGCGGTGGCGGTAGCG
GAGGTGGCGGGTCTGGTGGGGGTGGCTCGGGATC
CACCACAACCTACGACCGCCACCATGACGACGAC
GACAAAGTCACCACCACCCAACCCCAATACCGCC
ATGATCAACACACCGGTGACAGACTCACCCACCC
ACAGCGCCAGCAACAAGGCCCCTCAACCGGCAAG
CTCGCTCTCGCGACTCCGCTGTTTGTTATATTCAG
CCCTGTTATTGTTCCAGCGATGATAGCGATTGGGC
TTGCGGTTACCGGGTTTCAGAGGGATTATGTGAA
GGGGAAGTTGCAGGATGTGGGGGAGTATACGGGC
CAGAAGACGAAGGACTTGGGCCAGAAGATACAG
CATACGGCCCATGAAATGGGTGACCAGGGCCAGG
GTCAGGGTCAGGGTGGTGGGAAAGAAGGGCGAA
AAGAAGGGGGGAAATGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCTGGTTTGGTGGCTTCGGCGGTTTCGGGG
GTTTCGGTGGCTTTGGCGGTTTTGGTGGTTTCGGC
GGCTTTGGCGGTTGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCTGGGGTGGCTGGGGCGGTTTTGGGGGT
TTCGGTGGCCTGGGCGGTCTGGGTGGTGTGGGCG
GCGCGGGCGGTTGA

224!

!

RLP3-pho3
(-30-G)

Trimer of resilin-likepolypeptide fused to
Pho3. Expressed well.
Soluble expression.

RLP3-half 30

Trimer of resilin-likepolypeptide fused to
half of the oleosin-30
hydrophobic block.
Expressed well.
Soluble expression.

RLP3-half 45

Trimer of resilin-likepolypeptide fused to
half of the oleosin-45
hydrophobic block.
Expressed well.
Soluble expression. No
A280.

RLP3-65-

Trimer of resilin-likepolypeptide fused to the
oleosin-65 hydrophobic
block. Expressed well.
Soluble expression. No
A280.

RLP3-half-65

Trimer of resilin-likepolypeptide fused to
half of the oleosin-65
hydrophobic block.
Expressed well.
Soluble expression. No
A280.

CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCTGGCTCGCTCTCGGTGCGACTCCGCTGT
TTGGTGTTATAGGTTTCAGCCCTGTTATTGTTCCA
GCGATGGGTATAGCGATTGGGCTTGCGGGTGTTA
CCGGGTTTTGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCTGGCTCGCTCTCGGGACTCCGCTGTTTG
TTATATTCAGCCCTGTTATTGTTCCAGCGATGATA
GCG
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCATCACCCTCGTCGGGACGGTTATCGGG
CTCGCTCTCGCGACTCCGCTGTTTGTTATATTCAG
CCCTGTTATTGTTCCAGCGATGATAGCGTGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCATAACCGGAATCTTGTTTGGTTTAACCG
GTATCACCCTCGTCGGGACGGTTATCGGGCTCGCT
CTCGCGACTCCGCTGTTTGTTATATTCAGCCCTGT
TATTGTTCCAGCGATGATAGCGATTGGGCTTGCGG
TTACCGGGTTTTTGACTTCGGGTACGTTCGGGTTA
ACGCGGTCGACAATGTCGGTTCCAGTCTGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCATAACCGGAATCTTGTTTGGTTTAACCG
GTATCACCCTCGTCGGGACGGTTATCGGGCTCGCT
CTCGCGACTCCGCTGTTTGTTATATTCAGCCCTGT
TATTGTTCCAGCGATGATAGCGTGA
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RLP3-oleo45

Trimer of resilin-likepolypeptide fused to the
oleosin-45 hydrophobic
block. Expressed well.
Soluble expression.

RLP2-30G-

RLP dimer fused to
Pho3 (-30-G). Little to
no expression.

RLP2-halfO

RLP dimer fused to
Pho3 (Half oleo 30).
Little to no expression.

RLP3-P2A

RLP3 resilin fused to
the hydrophobic block
of -30-G-P2A. No Y or
W

RLP3-30-G
P2AY

RLP3 resilin fused to
the hydrophobic block
of -30-G-P2A. Added a
Y at the intersection to
give A280

CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCATCACCCTCGTCGGGACGGTTATCGGG
CTCGCTCTCGCGACTCCGCTGTTTGTTATATTCAG
CCCTGTTATTGTTCCAGCGATGATAGCGATTGGGC
TTGCGGTTACCGGGTTTTTGACTTCGGGTACGTTC
TGA
CATATGCACCACCACCACCACCACAAGCTTAGAT
CTGGCGGCCGCCCGTCTGATAGCAAAGGCGCACC
GGGTGGTGGTAACAAGCTTAGATCTGGCGGCCGC
CCGTCTGATAGCAAAGGCGCACCGGGTGGTGGTA
ACGGATCCTGGCTCGCTCTCGGTGCGACTCCGCTG
TTTGGTGTTATAGGTTTCAGCCCTGTTATTGTTCC
AGCGATGGGTATAGCGATTGGGCTTGCGGGTGTT
ACCGGGTTTTGA
CATATGCACCACCACCACCACCACAAGCTTAGAT
CTGGCGGCCGCCCGTCTGATAGCAAAGGCGCACC
GGGTGGTGGTAACAAGCTTAGATCTGGCGGCCGC
CCGTCTGATAGCAAAGGCGCACCGGGTGGTGGTA
ACGGATCCTGGCTCGCTCTCGGGACTCCGCTGTTT
GTTATATTCAGCCCTGTTATTGTTCCAGCGATGAT
AGCG
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCCTCGCTCTCGGTGCGACTGCGCTGTTTG
GTGTTATAGGTTTCAGCGCTGTTATTGTTGCAGCG
ATGGGTATAGCGATTGGGCTTGCGGGTGTTACCG
GGTTTCAGTGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCCTATCTCGCTCTCGGTGCGACTGCGCTGT
TTGGTGTTATAGGTTTCAGCGCTGTTATTGTTGCA
GCGATGGGTATAGCGATTGGGCTTGCGGGTGTTA
CCGGGTTTCAGTGA
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-30-G-W

Oleosin-30G mutant
with anion arms.
Expresses very well.
Highly soluble.

35-30G-42 W

Truncation mutant of 30-G-W where the Nterminal arm is cut to 35
amino acids and the Cterminal arm is cut to 42
amino acids

25-30G-30 W

Truncation mutant of 30-G-W where the Nterminal arm is cut to 25
amino acids and the Cterminal arm is cut to 30
amino acids

-30-G N-C+

Zwitterionic mutant of
Oleosin-30G where the
N-terminal arm is
anionic and the Cterminal arm is cationic

GGATCCGAAGCCACCACAACCAACGACCAGCACC
ATGTCACCACCACCCAACCCCAAGATCAGCATGA
TCAACACACCGGTGACCAGCTCACCCACCCACAG
GACCAGCAACAAGGCCCCTCAACCGGCGAACTCG
CTCTCGGTGCGACTCCGCTGTTTGGTGTTATAGGT
TTCAGCCCTGTTATTGTTCCAGCGATGGGTATAGC
GATTGGGCTTGCGGGTGTTACCGGGTTTCAGTGGC
AGGATAACGTGAACGGGGAATTGCAGGATGTGGG
GGAGCAGACGGGCCAGAACACGAACGACTTGGG
CCAGCAGATACAGCATACGGCCCATGAAATGGGT
GACCAGGGCCAGGGTCAGGGTCAGGGTGGTGGG
AACGAAGGGCAGAACGAAGGGGGGAACCACCAC
CACCACCACCACGATGACTGACTCGAG
GGATCCCTCGCTCTCGGTGCGACTCCGCTGTTTGG
TGTTATAGGTTTCAGCCCTGTTATTGTTCCAGCGA
TGGGTATAGCGATTGGGCTTGCGGGTGTTACCGG
GTTTCAGTGGCAGGATAACGTGAACGGGGAATTG
CAGGATGTGGGGGAGCAGACGGGCCAGAACACG
AACGACTTGGGCCAGCAGATACAGCATACGGCCC
ATGAAATGGGTCACCACCACCACCACCACGATGA
CTGA
GGATCCGATCAGCATGATCAACACACCGGTGACC
AGCTCACCCACCCACAGGACCAGCAACAAGGCCC
CTCAACCGGCGAACTCGCTCTCGGTGCGACTCCG
CTGTTTGGTGTTATAGGTTTCAGCCCTGTTATTGTT
CCAGCGATGGGTATAGCGATTGGGCTTGCGGGTG
TTACCGGGTTTCAGTGGCAGGATAACGTGAACGG
GGAATTGCAGGATGTGGGGGAGCAGACGGGCCA
GAACACGAACGACTTGCACCACCACCACCACCAC
GATGACTGA
GGATCCGAAGCCACCACAACCAACGACCAGCACC
ATGTCACCACCACCCAACCCCAAGATCAGCATGA
TCAACACACCGGTGACCAGCTCACCCACCCACAG
GACCAGCAACAAGGCCCCTCAACCGGCGAACTCG
CTCTCGGTGCGACTCCGCTGTTTGGTGTTATAGGT
TTCAGCCCTGTTATTGTTCCAGCGATGGGTATAGC
GATTGGGCTTGCGGGTGTTACCGGGTTTCAGTGG
AGGAACAAAGTGAAGGGGAAGTTGCAGAACGTG
GGGCAGAAAACGGGCCAGAAGACGAAGAACTTG
GGCCAGAAGATACAGCATACGGCCCATCAGATGG
GTAACCAGGGCCAGGGTCAGGGTCAGGGTGGTGG
GAAACAGGGGCGAAAACAGGGGGGGAAACTCGA
G
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-30-G N+C-

Zwitterionic mutant of
Oleosin-30G where the
C-terminal arm is
anionic and the Nterminal arm is cationic.
Missing the W on the C
term, no A280

-30-G P2A

Oleosin-30G mutant
where the glycines are
replaced with alinines

37-30G-37
P2A

Truncation mutant of
oleosin-30G-P2A where
the N-terminal
hydrophilic arm is
truncated to 37 amino
acids and the C-terminal
hydrophilic arm is
truncated to 37 amino
acids

27-30G-32
P2A

Truncation mutant of
oleosin-30G-P2A where
the N-terminal
hydrophilic arm is
truncated to 27 amino
acids and the C-terminal
hydrophilic arm is
truncated to 32 amino
acids

42-30G-17
P2A

Truncation mutant of
oleosin-30G-P2A where
the N-terminal
hydrophilic arm remains
the native length and the
C-terminal hydrophilic
arm is truncated to 17
amino acids

GGATCCGCCACCACAACCAAAAACCGCCACCATG
TCACCACCACCCAACCCCAAAAACGCCATAACCA
ACACACCGGTAACAGACTCACCCACCCACAGCGC
CAGCAACAAGGCCCCTCAACCGGCAAGCTCGCTC
TCGGTGCGACTCCGCTGTTTGGTGTTATAGGTTTC
AGCCCTGTTATTGTTCCAGCGATGGGTATAGCGAT
TGGGCTTGCGGGTGTTACCGGGTTTCAGTGGCAG
GATAACGTGAACGGGGAATTGCAGGATGTGGGGG
AGCAGACGGGCCAGAACACGAACGACTTGGGCC
AGCAGATACAGCATACGGCCCATGAAATGGGTGA
CCAGGGCCAGGGTCAGGGTCAGGGTGGTGGGAAC
GAAGGGCAGAACGAAGGGGGGAACCACCACCAC
CACCACCACGATGACTGACTCGAG
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGCTCGCTCTCG
GTGCGACTGCGCTGTTTGGTGTTATAGGTTTCAGC
GCTGTTATTGTTGCAGCGATGGGTATAGCGATTGG
GCTTGCGGGTGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATA
CGGGCCAGAAGACGAAGGACTTGGGCCAGAAGA
TACAGCATACGGCCCATGAAATGGGTGACCAGGG
CCAGGGTCAGGGTCAGGGTGGTGGGAAAGAAGG
GCGAAAAGAAGGGGGGAAACTCGAG
GGATCCCGCCACCATGTCACCACCACCCAACCCC
AATACCGCCATGATCAACACACCGGTGACAGACT
CACCCACCCACAGCGCCAGCAACAAGGCCCCTCA
ACCGGCAAGCTCGCTCTCGGTGCGACTGCGCTGTT
TGGTGTTATAGGTTTCAGCGCTGTTATTGTTGCAG
CGATGGGTATAGCGATTGGGCTTGCGGGTGTTAC
CGGGTTTCAGAGGGATTATGTGAAGGGGAAGTTG
CAGGATGTGGGGGAGTATACGGGCCAGAAGACG
AAGGACTTGGGCCAGAAGATACAGCATACGGCCC
ATGAAATGGGTCTCGAG
GGATCCTACCGCCATGATCAACACACCGGTGACA
GACTCACCCACCCACAGCGCCAGCAACAAGGCCC
CTCAACCGGCAAGCTCGCTCTCGGTGCGACTGCG
CTGTTTGGTGTTATAGGTTTCAGCGCTGTTATTGT
TGCAGCGATGGGTATAGCGATTGGGCTTGCGGGT
GTTACCGGGTTTCAGAGGGATTATGTGAAGGGGA
AGTTGCAGGATGTGGGGGAGTATACGGGCCAGAA
GACGAAGGACTTGGGCCAGAAGATACAGCATACG
CTCGAG
GGATCCACCACAACCTACGACCGCCACCATGTCA
CCACCACCCAACCCCAATACCGCCATGATCAACA
CACCGGTGACAGACTCACCCACCCACAGCGCCAG
CAACAAGGCCCCTCAACCGGCAAGCTCGCTCTCG
GTGCGACTGCGCTGTTTGGTGTTATAGGTTTCAGC
GCTGTTATTGTTGCAGCGATGGGTATAGCGATTGG
GCTTGCGGGTGTTACCGGGTTTCAGAGGGATTAT
GTGAAGGGGAAGTTGCAGGATGTGGGGGAGTATC
TCGAG
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Half P2A N

N-terminal diblock of
the Oleosin-30G-P2A
mutant. Little to no
expression

Half P2A C

C-terminal diblock of
the Oleosin-30G-P2A
mutant. Little to no
expression

Her2

Her 2 affibody.
Expresses very well.
Highly soluble.

Her2-30-G

Oleosin 30 with the
Her2 affibody fused to
the N-terminus.
Expressed well.
Inclusion bodies. Used
to target the
microbubbles.

GGATCCAAAAAACACCACCACCACCACCACACCA
CAACCTACGACCGCCACCATGTCACCACCACCCA
ACCCCAATACCGCCATGATCAACACACCGGTGAC
AGACTCACCCACCCACAGCGCCAGCAACAAGGCC
CCTCAACCGGCAAGCTCGCTCTCGGTGCGACTGC
GCTGTTTGGTGTTATAGGTTTCAGCGCTGTTATTG
TTGCAGCGATGGGTATAGCGATTGGGCTTGCGGG
TGTTACCGGGTTTCAGTGA
GGATCCCTCGCTCTCGGTGCGACTGCGCTGTTTGG
TGTTATAGGTTTCAGCGCTGTTATTGTTGCAGCGA
TGGGTATAGCGATTGGGCTTGCGGGTGTTACCGG
GTTTCAGAGGGATTATGTGAAGGGGAAGTTGCAG
GATGTGGGGGAGTATACGGGCCAGAAGACGAAG
GACTTGGGCCAGAAGATACAGCATACGGCCCATG
AAATGGGTGACCAGGGCCAGGGTCAGGGTCAGG
GTGGTGGGAAAGAAGGGCGAAAAGAAGGGGGGA
AACACCACCACCACCACCACAAAAAATGA
CATATGGTGGATAACAAATTTAACAAAGAAATGC
GCAACGCGTATTGGGAAATTGCGCTGCTGCCGAA
CCTGAACAACCAGCAGAAACGCGCGTTTATTCGC
AGCCTGTATGATGATCCGAGCCAGAGCGCGAACC
TGCTGGCGGAAGCGAAAAAACTGAACGATGCGCA
GGCGCCGAAACTCGAG
CATATGGTGGATAACAAATTTAACAAAGAAATGC
GCAACGCGTATTGGGAAATTGCGCTGCTGCCGAA
CCTGAACAACCAGCAGAAACGCGCGTTTATTCGC
AGCCTGTATGATGATCCGAGCCAGAGCGCGAACC
TGCTGGCGGAAGCGAAAAAACTGAACGATGCGCA
GGCGCCGAAAGGATCCACCACAACCTACGACCGC
CACCATGTCACCACCACCCAACCCCAATACCGCC
ATGATCAACACACCGGTGACAGACTCACCCACCC
ACAGCGCCAGCAACAAGGCCCCTCAACCGGCAAG
CTCGCTCTCGCGACTCCGCTGTTTGTTATATTCAG
CCCTGTTATTGTTCCAGCGATGATAGCGATTGGGC
TTGCGGTTACCGGGTTTCAGAGGGATTATGTGAA
GGGGAAGTTGCAGGATGTGGGGGAGTATACGGGC
CAGAAGACGAAGGACTTGGGCCAGAAGATACAG
CATACGGCCCATGAAATGGGTGACCAGGGCCAGG
GTCAGGGTCAGGGTGGTGGGAAAGAAGGGCGAA
AAGAAGGGGGGAAACTCGAGCACCACCACCACC
ACCACTGA
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Her2-30-GW

Her2 affibody fused to 30-G-W for FeO
targeting. Expresses
well. Targeting was no
successful with this
mutant.

-30-G 2N

Oleosin-30-G with 2
negative charges each
terminal arm.
Expressed well.

-30-G 4N

Oleosin-30-G with 4
negative charges each
terminal arm.
Expressed well.

CATATGGTGGATAACAAATTTAACAAAGAAATGC
GCAACGCGTATTGGGAAATTGCGCTGCTGCCGAA
CCTGAACAACCAGCAGAAACGCGCGTTTATTCGC
AGCCTGTATGATGATCCGAGCCAGAGCGCGAACC
TGCTGGCGGAAGCGAAAAAACTGAACGATGCGCA
GGCGCCGAAAGGATCCGAAGCCACCACAACCAAC
GACCAGCACCATGTCACCACCACCCAACCCCAAG
ATCAGCATGATCAACACACCGGTGACCAGCTCAC
CCACCCACAGGACCAGCAACAAGGCCCCTCAACC
GGCGAACTCGCTCTCGGTGCGACTCCGCTGTTTGG
TGTTATAGGTTTCAGCCCTGTTATTGTTCCAGCGA
TGGGTATAGCGATTGGGCTTGCGGGTGTTACCGG
GTTTCAGTGGCAGGATAACGTGAACGGGGAATTG
CAGGATGTGGGGGAGCAGACGGGCCAGAACACG
AACGACTTGGGCCAGCAGATACAGCATACGGCCC
ATGAAATGGGTGACCAGGGCCAGGGTCAGGGTCA
GGGTGGTGGGAACGAAGGGCAGAACGAAGGGGG
GAACCACCACCACCACCACCACGATGACTGACTC
GAG
GGATCCGATGACACCACAACCTACGACCGCCACC
ATGTCACCACCACCCAACCCCAATACCGCCATGA
TCAACACACCGGTGACAGACTCACCCACCCACAG
CGCCAGCAACAAGGCCCCTCAACCGGCAAGCTCG
CTCTCGGTGCGACTCCGCTGTTTGGTGTTATAGGT
TTCAGCCCTGTTATTGTTCCAGCGATGGGTATAGC
GATTGGGCTTGCGGGTGTTACCGGGTTTCAGAGG
GATTATGTGAAGGGGAAGTTGCAGGATGTGGGGG
AGTATACGGGCCAGAAGACGAAGGACTTGGGCCA
GAAGATACAGCATACGGCCCATGAAATGGGTGAC
CAGGGCCAGGGTCAGGGTCAGGGTGGTGGGAAA
GAAGGGCGAAAAGAAGGGGGGAAACACCACCAC
CACCACCACGATGACTGACTCGAG
GGATCCGATGACGATGACACCACAACCTACGACC
GCCACCATGTCACCACCACCCAACCCCAATACCG
CCATGATCAACACACCGGTGACAGACTCACCCAC
CCACAGCGCCAGCAACAAGGCCCCTCAACCGGCA
AGCTCGCTCTCGGTGCGACTCCGCTGTTTGGTGTT
ATAGGTTTCAGCCCTGTTATTGTTCCAGCGATGGG
TATAGCGATTGGGCTTGCGGGTGTTACCGGGTTTC
AGAGGGATTATGTGAAGGGGAAGTTGCAGGATGT
GGGGGAGTATACGGGCCAGAAGACGAAGGACTT
GGGCCAGAAGATACAGCATACGGCCCATGAAATG
GGTGACCAGGGCCAGGGTCAGGGTCAGGGTGGTG
GGAAAGAAGGGCGAAAAGAAGGGGGGAAACACC
ACCACCACCACCACGATGACGATGACTGACTCGA
G
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RLP6-halfO

RLP6 resilin fused to
the hydrophobic domain
of half oleosin.
Expression tested,
soluble.

RLP6-30G

RLP6 resilin fused to
the hydrophobic domain
of oleosin-30G.
Expression tested,
soluble.

87-W

Native oleosin with
highly anionic N- and
C- terminal arms. High
expression, soluble.

CATATGCACCATCACCACCaTCACAAGCTTAGATC
TGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCCG
GGCGGCGGCAACGGCGGCCGTCCGAGCGATTCTA
AAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTCC
GAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAAC
GGATCTGGCGGTCGTCCGTCAGACTCTAAAGGCG
CTCCGGGCGGCGGCAACGGCGGCCGTCCGAGCGA
TTCTAAAGGCGCGCCGGGTGGCGGCAATGGCGGT
CGTCCGAGTGATTCAAAAGGTGCTCCGGGCGGTG
GTAACGGATCCTGGCTCGCTCTCGGGACTCCGCTG
TTTGTTATATTCAGCCCTGTTATTGTTCCAGCGAT
GATAGCGTGACTCGAGCACCACCACCACCACCAC
TGA
CATATGCACCATCACCACCATCACAAGCTTAGAT
CTGGCGGTCGTCCGTCAGACTCTAAAGGCGCTCC
GGGCGGCGGCAACGGCGGCCGTCCGAGCGATTCT
AAAGGCGCGCCGGGTGGCGGCAATGGCGGTCGTC
CGAGTGATTCAAAAGGTGCTCCGGGCGGTGGTAA
CGGATCTGGCGGTCGTCCGTCAGACTCTAAAGGC
GCTCCGGGCGGCGGCAACGGCGGCCGTCCGAGCG
ATTCTAAAGGCGCGCCGGGTGGCGGCAATGGCGG
TCGTCCGAGTGATTCAAAAGGTGCTCCGGGCGGT
GGTAACGGATCCTGGCTCGCTCTCGGTGCGACTCC
GCTGTTTGGTGTTATAGGTTTCAGCCCTGTTATTG
TTCCAGCGATGGGTATAGCGATTGGGCTTGCGGG
TGTTACCGGGTTTTGACTCGAGCACCACCACCACC
ACCACTGA
GGATCCGAAGCCACCACAACCAACGACCAGCACC
ATGTCACCACCACCCAACCCCAAGATCAGCATGA
TCAACACACCGGTGACCAGCTCACCCACCCACAG
GACCAGCAACAAGGCCCCTCAACCGGCGAAATAA
TGGTCATCATGGCCTTACTTCCAATAACCGGAATC
TTGTTTGGTTTAGCCGGTATCACCCTCGTCGGGAC
GGTTATCGGGCTCGCTCTCGCGACTCCGCTGTTTG
TTATATTCAGCCCTGTTATTGTTCCAGCGATGATA
GCGATTGGGCTTGCGGTTACCGGGTTTTTGACTTC
GGGTACGTTCGGGTTAACGGGGTTAAGCTCGTTG
TCGTATTTGTTTAATATGGTGAGGCGGTCGACAAT
GTCGGTTCCAGTCTGGCAGGATAACGTGAACGGG
GAATTGCAGGATGTGGGGGAGCAGACGGGCCAG
AACACGAACGACTTGGGCCAGCAGATACAGCATA
CGGCCCATGAAATGGGTGACCAGGGCCAGGGTCA
GGGTCAGGGTGGTGGGAACGAAGGGCAGAACGA
AGGGGGGAACCACCACCACCACCACCACGATGAC
TGACTCGAG
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65-W

Oleosin-65 with highly
anionic N- and Cterminal arms. High
expression, soluble.

45-W

Oleosin-45 with highly
anionic N- and Cterminal arms. High
expression, soluble.

30-W

Oleosin-30 with highly
anionic N- and Cterminal arms. High
expression, soluble.

GGATCCGAAGCCACCACAACCAACGACCAGCACC
ATGTCACCACCACCCAACCCCAAGATCAGCATGA
TCAACACACCGGTGACCAGCTCACCCACCCACAG
GACCAGCAACAAGGCCCCTCAACCGGCGAAATAA
CCGGAATCTTGTTTGGTTTAACCGGTATCACCCTC
GTCGGGACGGTTATCGGGCTCGCTCTCGCGACTCC
GCTGTTTGTTATATTCAGCCCTGTTATTGTTCCAG
CGATGATAGCGATTGGGCTTGCGGTTACCGGGTTT
TTGACTTCGGGTACGTTCGGGTTAACGCGGTCGAC
AATGTCGGTTCCAGTCTGGCAGGATAACGTGAAC
GGGGAATTGCAGGATGTGGGGGAGCAGACGGGC
CAGAACACGAACGACTTGGGCCAGCAGATACAGC
ATACGGCCCATGAAATGGGTGACCAGGGCCAGGG
TCAGGGTCAGGGTGGTGGGAACGAAGGGCAGAA
CGAAGGGGGGAACCACCACCACCACCACCACGAT
GACTGACTCGAG
GGATCCGAAGCCACCACAACCAACGACCAGCACC
ATGTCACCACCACCCAACCCCAAGATCAGCATGA
TCAACACACCGGTGACCAGCTCACCCACCCACAG
GACCAGCAACAAGGCCCCTCAACCGGCGAAATCA
CCCTCGTCGGGACGGTTATCGGGCTCGCTCTCGCG
ACTCCGCTGTTTGTTATATTCAGCCCTGTTATTGTT
CCAGCGATGATAGCGATTGGGCTTGCGGTTACCG
GGTTTTTGACTTCGGGTACGTTCTGGCAGGATAAC
GTGAACGGGGAATTGCAGGATGTGGGGGAGCAG
ACGGGCCAGAACACGAACGACTTGGGCCAGCAG
ATACAGCATACGGCCCATGAAATGGGTGACCAGG
GCCAGGGTCAGGGTCAGGGTGGTGGGAACGAAG
GGCAGAACGAAGGGGGGAACCACCACCACCACC
ACCACGATGACTGACTCGAG
GGATCCGAAGCCACCACAACCAACGACCAGCACC
ATGTCACCACCACCCAACCCCAAGATCAGCATGA
TCAACACACCGGTGACCAGCTCACCCACCCACAG
GACCAGCAACAAGGCCCCTCAACCGGCGAACTCG
CTCTCGCGACTCCGCTGTTTGTTATATTCAGCCCT
GTTATTGTTCCAGCGATGATAGCGATTGGGCTTGC
GGTTACCGGGTTTTGGCAGGATAACGTGAACGGG
GAATTGCAGGATGTGGGGGAGCAGACGGGCCAG
AACACGAACGACTTGGGCCAGCAGATACAGCATA
CGGCCCATGAAATGGGTGACCAGGGCCAGGGTCA
GGGTCAGGGTGGTGGGAACGAAGGGCAGAACGA
AGGGGGGAACCACCACCACCACCACCACGATGAC
TGACTCGAG
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